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This study was conducted to determine if electroporation could deliver 
membrane-impermeant molecules intracellularly to intact, physiologically competent 
monolayers that mimic the intestinal epithelium. The long-term effects of electroporation 
on these monolayers were studied to determine the kinetics with which monolayers 
recover barrier function. The ability of electroporation to introduce biologically active 
molecules, e.g., plasmid DNA and siRNA, into these monolayers, to either express a 
protein of interest or modify cellular function, was also studied.  
Results showed that intracellular uptake of calcein, a small tracer molecule, and 
bovine serum albumin, a globular protein, occurred uniformly throughout the monolayers 
and increased as a function of voltage, pulse length, and pulse number. There was no 
significant difference in uptake resulting from single and multiple pulses of the same total 
exposure time. Barrier function recovery depended on the electroporation conditions 
applied, with some monolayers recovering normal physiologic function within a day.  
Electroporation also increased the permeability of the monolayers to calcein and BSA, 
possibly through a combination of increased paracellular and transmonolayer transport. 
When compared to cationic lipid transfection (lipofection), transfection of 
intestinal epithelial monolayers with reporter plasmids by electroporation was more 
efficient in situations where high concentrations of DNA, and as a result, higher levels of 
expression were needed.  Although uptake of DNA was high after electroporation and 
increased with increasing amounts of DNA, overall expreseion efficiency was still low 
(~3%).  Electroporation-mediated transfection of intestinal epithelial monolayers with a 
 
 xviii
plasmid that expressed inflammation inhibitor protein, IκBα, was not always successful, 
probably because of low levels of protein expression. Introduction of the much smaller 
siRNA molecules into the monolayers by electroporation, on the other hand, was very 
successful at inhibiting the production of the nuclear envelope proteins lamin A and 
lamin C. 
The results of these experiments demonstrated that electroporation can introduce a 
wide variety of molecules intracellularly into model intestinal epithelia. These results 
should be useful to identify optimal electroporation conditions for transporting drugs, 
proteins, and genes into intestinal and, possibly, other epithelia for local drug and gene 






1.  INTRODUCTION 
 
 
Inflammatory intestinal disorders such as cholera and Crohn’s disease are of 
widespread concern because of their prevalence in both developing and developed 
countries (Blaser et al., 2002; Targan et al., 2003).  The study and treatment of these, and 
other, disorders could be facilitated by the ability to introduce therapeutic drugs, proteins, 
or genes into intestinal epithelium. The unique features that define intestinal epithelium 
in vivo can be partially modeled in vitro by cell lines such as the Caco-2 and T84 lines. 
When cultured as monolayers on porous membranes, these cells exhibit the same 
structural polarity and functional characteristics of intestinal epithelial cells found in vivo 
(Madara et al., 1987; Shaw, 1996b). However, both in vitro and in vivo intestinal 
epithelium have well developed barrier functions that make it difficult to introduce 
exogenous agents. The similarity between these cells and in vivo epithelium makes them 
especially useful for our study of the ability of electroporation to deliver compounds 
intracellularly to polarized epithelial monolayers. 
Electroporation involves the application of a short electric pulse that transiently 
disrupts cellular membranes and thereby transports membrane-impermeant molecules 
into the cytosol and/or nucleus (Chang et al., 1992).  The electric field is typically applied 
as one or more short (µs to ms) pulses with a rectangular or exponential-decay waveform.  
The resulting increase in cell permeability is thought to be due to the formation of short-
lived aqueous pathways (“pores”) in the plasma membrane (Weaver, 1993), which can be 
reversible or irreversible depending upon the field strength, length, and number of pulses. 
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Although the exact molecular mechanisms of how electroporation affects the cell 
membrane are not fully understood, this phenomenon has been widely employed as a 
research tool to transfect cells with exogenous proteins or genes (Baron et al., 2000) and, 
more recently, to transport drugs across the skin for local or systemic therapy (Prausnitz, 
1999), and to enhance chemotherapeutic delivery into tumors (Heller et al., 1999).  
This study was conducted to determine whether electroporation could be used to 
uniformly and efficiently deliver macromolecules into polarized intestinal epithelial 
monolayers that mimic in vivo epithelium.  The dependence of molecular uptake, short-
term cell viability, and long-term monolayer recovery kinetics on electroporation 
parameters was quantified and used to help guide future experiments.  Since confluent 
intestinal epithelial monolayers are refractory to most conventional methods of gene 
transfection, electroporation was evaluated for its ability to transfect two reporter 
plasmids into these cells. The results of these transfections were compared to those of 
lipid-mediated transfection to determine which was more efficient. Finally, monolayers 






2.  INTESTINAL STRUCTURE, FUNCTION, AND PATHOLOGY 
 
The primary purpose of the gastrointestinal tract is to serve as the route by which 
nutrients are digested and absorbed from the foods we eat (Yamada et al., 1999).  
However, another necessary and important function of the tract is to act as a barrier to 
protect the body from pathogenic organisms and other harmful substances present in the 
intestinal lumen.  When this barrier malfunctions or is compromised, inflammatory 
responses may arise in the form of various intestinal diseases.  Diseases such as cholera 
and Crohn’s disease, both of which predominately affect the epithelial lining of the 
intestine, are of major public health importance because of their prevalence in both 
developing and industrialized countries (Blaser et al., 2002; Targan et al., 2003).   
 
2.1  Functional Anatomy of the Intestine 
 
The gastrointestinal tract is a hollow, continuous tube approximately 30 feet in 
length that winds through the body from mouth to anus (Figure 2.1) (Stalheim-Smith and 
Fitch, 1993).  After food has been ingested by the mouth, it passes down the esophagus 
into the stomach where it is broken down and digested under highly acidic conditions.  
The digested food passes from the stomach to the small intestine, where absorption 
occurs, and then into the large intestine (colon). Undigested material (feces) is eliminated 






Figure 2.1  Illustration of the entire gastrointestinal tract. The major organs of the tract, 
including the small and large intestines, have been identified. [Source: National Digestive 
Diseases Information Clearinghouse, 2003] 
 
The walls of the entire digestive tract are made up of four basic layers.  One or 
more of the layers may be specialized to suit the function of a particular organ. From the 
outer layer to the inner, these layers are the serosa, the muscularis externa, the 
submucosa, and the mucosa (Marieb, 2000) (Figure 2.2).  The serosa covers the exterior 
of the intestinal tube and is in contact with the peritoneal cavity. The muscularis externa 
is primarily composed of smooth muscle tissue and is responsible for the contractions 
necessary for segmentation (mixing food with digestive secretions) and peristalsis 
(propulsion of food forward through the tract). The submucosa is a layer of loose 
connective tissue housing a network of blood lymphatic vessels that extend into the 





Figure 2.2 Structural anatomy of the small intestine. The four layers of the intestinal wall 
as well as the structure of an epithelial cell and a villus are depicted. (Source: MSN 
Encarta, 1999) 
 
The mucosa is the layer that is of interest for this study.  It lies next to the lumen of 
the intestine and, therefore, is exposed to the external environment.  Its main functions 
are to 1) secrete mucus, digestive enzymes, or other products necessary for digestion, 2) 
absorb the digestive products, and 3) protect the body from the luminal contents and 
infection (Marieb, 2000).  The mucosal layer is lined with epithelium (the type depends 
on location), under which lies the lamina propria, a layer of connective tissue containing 
the blood supply for the epithelia, and the muscularis mucosa, a layer of smooth muscle. 
In the small and large intestine, the epithelial lining is made up of simple columnar 
epithelial cells specialized for secretion and absorption. The majority of nutrient 
absorption occurs in the small intestine because of several modifications that greatly 
increase the surface area available for absorption.  The plicae circulares (~1 cm folds of 
the submucosal and mucosal layers), villi (~1 mm fingerlike projections of the mucosa 
that extend from the plicae circulares), and microvilli (~ 1 µm hair-like projections of the 
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plasma membrane of the absorptive epithelial cells that line the villi)  all serve to increase 
the surface area of the small intestine for maximum absorption (Stalheim-Smith and 
Fitch, 1993). In fact, these features increase intestinal surface area by ~600 times relative 
to that of a comparable smooth surfaced tube (Stalheim-Smith and Fitch, 1993) and they 
allow the small intestine to absorb 90-95% of the nutrients that enter (Stalheim-Smith and 
Fitch, 1993; Marieb, 2000). 
 
2.1.1 Epithelial Cell Structure and Function 
 
Epithelial cells typically line the surfaces of organs, body cavities, and, in general, 
all parts of the body exposed to the external environment (e.g., skin, respiratory tract, 
digestive tract) (Burkitt et al., 1993).  In the small intestine, some of the characteristics of 
intestinal epithelial cells include apical-basal polarity, a basement membrane, specialized 
intercellular junctions, and a capacity to regenerate (Shaw, 1996a) (Figure 2.3).   
The polarity of the epithelial cells refers to the structural and functional distinction 
between the apical and basolateral (basal and lateral) membranes of the cells (Shaw, 
1996b; Marieb, 2000).  The apical (upper) membrane is exposed to the lumen and 
exhibits microvilli for increased absorption.  The cell nucleus is typically located towards 
the basal (lower) end of the cell. The basal surface is also the location of cellular 
attachment to the basement membrane. The basement membrane is composed of laminin 
and other glycoproteins secreted by the cells above it and collagen secreted by the 
fibroblasts in the connective tissue layer below. It is across the basal surface and the 
basement membrane that the transport of signaling molecules and nutrients to and from 




Figure 2.3 Drawing of an absorptive intestinal epithelial cell (enterocyte). Several types 
of intercellular junctions found on the cell serve to regulate processes such as nutrient 
absorption and intercellular communication. 
 
There are three categories of intercellular junctions that serve as connections 
between adjacent cells and between the cells and the basement membrane: 1) tight 
junctions, 2) adhering junctions, and 3) gap junctions.  Tight junctions form a continuous 
band around the circumference of the cell, delineating the apical aspect from the 
basolateral aspect (Burkitt et al., 1993).  These junctions regulate the flow of material 
across the epithelial lining, by allowing ions and nutrients to pass through the space 
between the cells and preventing the passage of luminal contents (e.g., undigested food, 
microorganisms, and other foreign material), thus giving the epithelium its barrier 
function (Shaw, 1996b).  
Adhering junctions bind adjacent cells of the epithelium together and also serve as 
anchors for the cells’ cytoskeletal networks (Burkitt et al., 1993).  The belt desmosome 
(or zonula adherens) encircles the entire cell just below the tight junction, while the spot 












hemidesmosome is typically found anchoring the cell to the basement membrane 
(Histology, ; Burkitt et al., 1993; Shaw, 1996b).  Gap junctions, or communicating 
junctions, allow the passage of small molecules (< 2 nm) from the cytoplasm of one cell 
to that of an adjacent cell (Burkitt et al., 1993).  Cells can communicate with and aid each 
other through these junctions by exchanging nutrients and signaling molecules that 
regulate growth and development. 
The intestinal epithelium undergoes a natural process of self-renewal in which 
epithelial cells arise from stem cells located in crypts at the base of each villus. The new 
epithelial cells migrate up the villi and are eventually shed at their tips.  In this process, 
the epithelium is renewed every 3-6 days (Marieb, 2000).  Intestinal epithelial cells can 
also be shed or killed off due to physical, chemical, or microbial injury. In order to 
maintain function, the epithelium must be able to regenerate quickly to replace lost cells 
(Madara, 1999). This process of regeneration, in which mature epithelial cells rapidly 
dedifferentiate and proliferate, will be discussed in more detail in Chapter 7. 
Together, all of the characteristics of intestinal epithelium discussed above 
demonstrate that these cells function as a unit. Thus, the epithelium should be considered 
not as a collection of independent cells, but as a functional tissue. 
 
2.2  Experimental Models of the Intestinal Epithelium 
 
Epithelia can be cultured under in vitro conditions and used to obtain a better 
understanding of the structure and function of the epithelial lining of the intestine as well 
as a tool for studying intestinal diseases.  Two cell lines commonly used for research are 
the Caco-2 and T84 lines, both of which are derived from human colon carcinoma.  As 
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illustrated in Figure 2.4, when these cells are cultured as monolayers on microporous 
membranes, they develop monolayers that exhibit many of the same structural (e.g., 
polarity, intercellular tight junctions, and presence of microvilli) and functional (e.g., 
enzyme secretion and transport systems) characteristics of the absorptive intestinal 
epithelial cells found in vivo (Shaw, 1996a). 
Caco-2 cells were isolated from human colon adenocarcinoma and initially 
cultured by Fogh et al. (1977a; 1977b).  These cells grow as monolayers and when 
confluent, differentiate into polarized columnar epithelial cells similar to those present on 
the villi of the small intestine. They have a well developed brush border (microvilli) and 
intercellular junctions and are also able to express digestive enzymes and other products.  
Caco-2 monolayers are the most widely used epithelial models for studying drug 
absorption in the intestine (Artursson et al., 2001).  Experiments with various drugs have 
shown that Caco-2 monolayers have absorption properties that make them useful for 
predicting both active and passive transport in intestinal tissues (Artursson and Karlsson, 
1991; Bailey et al., 1996; Rubas et al., 1996; Anderle et al., 1998; Karlsson et al., 1999; 
Palm et al., 1999; Artursson et al., 2001; Krishna et al., 2001).   
T84 cells were derived from a lung metastasis of a human colon carcinoma 
(Dharmsathaphorn et al., 1984).  These cells also grow to form tight monolayers of 
polarized columnar epithelial cells with microvilli on their apical membranes and 
intercellular junctions; however, in many ways, they are more similar to the colonic 
epithelium from which they originated (Dharmsathaphorn et al., 1984; Madara et al., 
1987). T84 monolayers have been used as models of the intestine in several areas





Figure 2.4  Electron micrographs of (A) Caco-2 and (B) T84 monolayers and (C) in vivo colonic epithelium. MV = microvilli, N = 
nucleus, BM = basement membrane, C = capillary. (Madara et al., 1987; Burkitt et al., 1993) 
 












of research including studies about intestinal barrier function (Madara and 
Dharmsathaphorn, 1985) and wound repair (Nusrat et al., 1992), transepithelial 
electrolyte transport (Dharmsathaphorn and Madara, 1990), neutrophil migration across 
intestinal epithelia (Parkos, 1997), and bacterial invasion of intestinal epithelium 
(McCormick et al., 1993). 
Although epithelial models have the advantage of being structurally simple, 
inexpensive, and relatively easy to work with compared to animal models, there are some 
limitations to these models.  The primary limitation is that cultured epithelia are usually 
cancerous lines and are not a substitute for the more complex epithelium found in vivo.  
Cultured epithelia are grown on a flat substrate as monolayers, not on villi as they would 
in vivo. In addition, the many cell types that are present in normal epithelium, e.g., 
lymphocytes, mucus-producing goblet cells, etc., are not present in culture (Shaw, 
1996b).  Also, the characteristics that are desired in model epithelium (e.g., barrier 
function and polarity) are the same characteristics that make it difficult to manipulate 
these models through the introduction of different molecules by conventional means.  
Despite these disadvantages, epithelial cell monolayers have still been one of the most 
useful tools for studying different aspects of intestinal structure and function, including 
the mechanisms of how inflammatory diseases affect intestinal epithelium.  
 
 
2.3  Inflammatory Intestinal Disorders 
Inflammatory intestinal disorders typically arise when the epithelial barrier is not 
functioning properly or when harmful organisms or substances come into contact with the 
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epithelium.  There are two classes of inflammatory intestinal diseases with which we are 
primarily concerned: enteric infections and inflammatory bowel disease. 
 
2.3.1  Enteric Infections 
Enteric infections are caused by complex interactions of the epithelial lining of 
the intestinal tract with pathogens such as viruses (e.g., rotavirus), bacteria (e.g., 
Salmonella, Vibrio cholerae, and Escherichia coli), or parasites (e.g., parasitic worms) 
(Blaser et al., 2002).  Some pathogens, such as V. cholerae, secrete soluble toxins that 
cause disease (Sears and Acheson, 2002), while others, such as salmonella, physically 
invade the epithelium (Pegues et al., 2002).  Many of these pathogens, or their by-
products, have been shown to cause an innate immune response in the form of 
inflammation in intestinal epithelial cells (Eckmann et al., 1993; Schuerer-Maly et al., 
1994; Jung et al., 1995; Li et al., 1998; McCormick et al., 1998; Elewaut et al., 1999).  
The symptoms of infection by proinflammatory organisms include abdominal cramping, 
nausea, bloody and/or purulent diarrhea, fever, and dehydration (Smith and Lamont, 
1989).   
Is has been estimated that close to 1 billion people worldwide become ill from 
these infections (Greenberg et al., 1999); developing countries are especially hard hit 
because effective sanitary measures for the proper handling and treatment of food, water, 
and sewage may not be in place (Black and Lanata, 2002).  Infections in industrial 
countries are still a cause for concern. In the United States alone, there are over 200 
million cases of gastric inflammation each year (Sobel and Tauxe, 2002). Of this number, 
38% of cases are caused by viral, bacterial, or parasitic infections of known origin 
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leading to almost 200,000 hospitalizations and 3000 deaths per year (Sobel and Tauxe, 
2002). People typically become infected when new pathogens arise or when they become 
lax in taking precautions, as evidenced by reports of the detection of contaminated 
foodstuffs.   
In most cases, treatment consists of allowing the infection to run its course while 
replacing fluids the patient has lost because of diarrhea. For more severe or prolonged 
cases sometimes accompanied by nausea or vomiting, antibiotic, antiemetic, and 
antisecretory drugs may be prescribed (Soltis, 2002). Antidiarrheal medications may also 
be prescribed in some cases, but are usually avoided because they can slow down 
elimination of the organisms (Mayo, 1994).   
 
2.3.2  Inflammatory Bowel Disease 
Inflammatory bowel disease (IBD) is the term used to collectively describe two 
disorders: ulcerative colitis and Crohn's disease.  Both diseases are characterized by 
chronic inflammation of the intestinal tract. Currently it is estimated that IBD affects 
approximately 1 million people in the United States (CCFA, 2003a).  Unlike many 
infectious diseases, IBD is more prevalent in Western countries, e.g., North America, 
northern Europe, etc., and in people of European descent.  Ulcerative colitis and Crohn’s 
disease affect men and women almost equally and it appears that genetic, as well as 
environmental, factors may play a role in both diseases (Karlinger et al., 2000).  The 
exact cause of IBD is not known, although many theories have been put forth. The most 
popular theory is that the body’s immune system is triggered by the presence of foreign 
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substance, e.g., bacteria (commensal or foreign) or viruses in the intestine, leading to 
ongoing, uncontrolled inflammation (CCFA, 2003a, b).  
 
2.3.2.1   Ulcerative Colitis 
Ulcerative colitis (UC) is a chronic, relapsing condition that causes inflammation 
resulting in small ulcers and abscesses in the mucosal epithelial lining of the large 
intestine (colon) (CCFA, 2003b). Inflammation typically occurs in the rectum and 
sigmoid colon and can spread into the rest of the colon.  In rare cases, UC can be found in 
the ileum, the lower section of the small intestine.  People of any age can develop UC, 
but the highest incidence of occurrence is found between the ages of 15 and 30 (NDDIC, 
2003b; Targan et al., 2003). The primary symptoms of UC are abdominal pain and 
bloody diarrhea, but other symptoms, such as fever, rectal bleeding, nausea, fatigue, and 
weight loss, are also common. Complications that can result from severe UC include 
toxic megacolon (enlargement and paralysis of the colon) and an increased risk of colon 
cancer. 
 
2.3.2.2   Crohn’s Disease 
Crohn's disease (CD) is also a chronic condition that leads to inflammation of the 
intestine.  In contrast to ulcerative colitis, CD involves multiple layers of the entire 
intestinal wall in an inflammatory process that can affect any part of the gastrointestinal 
tract from mouth to anus (CCFA, 2003a).  The majority of cases, however, primarily 
involve the small intestine and/or the colon. Also unlike UC, which is characterized by 
contiguous inflammation of the intestinal lining, CD tends to affect the intestine in 
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patches, so that normal intestine is separated by areas of diseased tissue. CD can also 
occur at any age, but most often begins between the ages of 14 and 24 (NDDIC, 2003a; 
Targan et al., 2003).  The symptoms of CD are very similar to those of UC including 
abdominal pain, diarrhea, rectal bleeding, weight loss, and fever. Complications that can 
result from CD include intestinal obstruction, development of abscesses (pus filled 
masses) and fistulas (abnormal channels between the intestine and bladder, skin, or other 
parts of the intestine).   
 
2.3.2.3   Diagnosis and Treatment of IBD 
Diagnosis of ulcerative colitis and Crohn’s disease can be very difficult because the 
symptoms and pathologic features are similar to each other and to those of other intestinal 
disorders, e.g., irritable bowel syndrome and certain infectious diseases.  The techniques 
that are used to aid in diagnosis include blood and urine analysis, stool examination, x-
rays, diagnostic ultrasound, and endoscopic procedures.  Endoscopy is used to image the 
intestine and is the most helpful at distinguishing between UC and CD. Biopsies of 
intestinal tissue may be taken during the procedure for observation on a microscope. 
There are no drug-based cures for IBD so treatment is usually aimed at controlling the 
inflammatory immune response with systemic anti-inflammatory drugs and/or 
immunosuppressive drugs (Egan and Sandborn, 2003). Mesalamine, sulfasalazine and 
several other modified forms of the anti-inflammatory drug 5-aminosalicylic acid (5-
ASA), have been the standard for treating mild to moderate UC and CD affecting the 
colon for many years. Corticosteroids, such as prednisone and prednisolone, are another 
family of anti-inflammatory agents used to treat people with severe IBD and those who 
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do not respond to the various 5-ASA formulations.  Long term therapy with 
immunosuppressive drugs, such as azathiopine and 6-mercaptopurine, may be necessary 
for treating IBD patients that do not respond to standard treatment. Although extended 
use of some of these medications can cause serious side effects, combinations of the 
medications described above can sometimes cause both UC and CD to go into remission 
for months or even years.  Most patients, however, will have one or more relapses during 
their lifetime (Targan et al., 2003). 
Surgical removal of the colon or other affected parts is performed as a last resort, 
i.e., if IBD becomes life threatening, if the patient is not responding to the drug therapy, 
or if there are indications of cancer. Surgery can cure ulcerative colitis, but only reduces 
the symptoms of Crohn’s disease (NDDIC, 2003b, a).  Several surgical options are 
available for treating UC, although a total cure is only achieved by removal of the entire 
colon and rectum.  For some patients, only the colon and the diseased inner layer of the 
rectum need to be removed. Surgery for CD usually involves correcting intestinal 
blockages, removing fistulas, and surgical removal of the diseases portions of the 
intestine followed by reattachment of the remaining segments.  Inflammation, however, 
tends to reoccur in areas next to the removed portion. As a result, the majority of CD 
surgical patients will need second operations at some point (Baert et al., 2003). 
 
 
2.4  Cellular Inflammatory Pathway 
The search for an effective cure or treatment for inflammatory intestinal diseases 
can be aided by developing a better understanding of the inflammatory reaction of cells 
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on a molecular level.  Laboratory models such as the ones described in Section 2.2 have 
been very helpful in elucidating events that occur during inflammation (Jung et al., 1995; 
Elewaut et al., 1999).  Inflammation is a tightly controlled process that arises in response 
to a physical or chemical injury.  It is characterized by 1) an increase in blood flow 
leading to reddening (hyperemia) of the affected area, 2) leakage of vascular fluids 
leading to swelling (edema), and 3) an influx of immune inflammatory cells (e.g., 
neutrophils, leukocytes, macrophages) necessary to destroy or inhibit harmful stimuli and 
repair any damaged tissue (Stalheim-Smith and Fitch, 1993). 
The trigger for the initiation of an inflammatory reaction could be invasion by a 
virus or bacterium, physical or chemical injury to tissue, the presence of bacterial 
products, or the secondary release of inflammatory cytokines like tumor necrosis factor 
(TNF) or interleukin-1 (IL-1), which function in cell-to-cell communication.  All of these 
pro-inflammatory stimuli activate signal transduction pathways in epithelial cells and 
other cells. One of the better-defined pro-inflammatory pathways, NFκB is illustrated in 
Figure 2.5 in a simplified diagram.  This pathway is known to play a role in bacterial 
infections (Elewaut et al., 1999), IBD and other chronic inflammatory disorders 
(Schreiber et al., 1998; Makarov, 2000; Tak and Firestein, 2001), apoptosis (Yamamoto 





Figure 2.5  Simplified diagram of the NFκB-mediated inflammatory signal transduction 
pathway in a cell.  NFκB activation plays a role in several inflammatory disorders, but 
also helps to regulate normal cellular functions. 















NFκB and IκB each represent a family of proteins, however, these names will be 
used to collectively describe these proteins to make the explanation more clear.  NFκB is 
a DNA-binding transcription factor that is active in the nucleus.  It is sequestered in the 
cytoplasm because of its binding with IκB, which masks its nuclear localization signal 
(Baeuerle, 1998). When proinflammatory stimuli (cytokines, UV, bacterial by products) 
come into contact with epithelial cells, they are recognized by specific receptors on the 
cell surface which lead to the activation of  the IκB kinase (IKK) complex, a 900 kDa 
multi-unit protein complex located in the cytoplasm (DiDonato et al., 1997). IKK in turn 
catalyzes the phosphorylation of two serine residues on the 37 kDa inhibitor protein IκB, 
which is found in a complex with nuclear factor kappaB (NFκB) (Zandi et al., 1998).  
Upon phosphorylation, IκB is polyubiquitinated by the enzyme ubiquitin ligase E3, 
which targets IκB for degradation by the 26S proteosome (Baldwin, 1996).  When IκB is 
degraded, NFκB’s nuclear localization signal is exposed and the protein is free to 
translocate to the nucleus (DiDonato et al., 1995).   
When the released NFκB migrates into the nucleus, it binds to target genes at the 
promoter region to induce the expression of a wide variety of inflammatory mediators, 
such as interleukin-8 (IL-8), that may trigger inflammation in other cells and/or attract 
cells involved in host immunity to the site of invasion or injury.  NFκB also plays a role 
in the regulation of cellular adhesion, cell growth and proliferation (Baldwin, 1996).  To 
terminate the inflammatory response, NFκB also induces expression of IκB, which binds 
to and dissociates NFκB from the promoter and transports it back to the cytoplasm in a 
negative feedback loop (Zabel and Baeuerle, 1990). 
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Chronic diseases, such as IBD, are considered to be diseases in which the genes 
that regulate inflammation are inappropriately activated and/or can't be "turned off".  In 
fact, many of the medications used to treat IBD act by inhibiting NFκB activation either 
directly or indirectly (Yamamoto and Gaynor, 2001). For example, corticosteroids appear 
to act by two primary mechanisms: direct interaction with NFκB to prevent DNA binding 
and upregulation of IκB levels to enhance retention of NFκB in the cytoplasm. 
Sulfasalazine acts by inhibiting phosphorylation of IκB and, as a result, its degradation.  
Immunosuppressive drugs can act to inhibit the proteasome that degrades IκB after 
phosphorylation or inhibit the migration of NFκB from the cytoplasm to the nucleus. 
Several research studies have focused on finding other ways to inhibit one or more 
of the steps that play a role in inflammation.  Methods such as inhibiting the kinases that 
phosphorylate IκB (Baeuerle, 1998), inhibiting the enzymes that ubiquitinate and degrade 
phosphorylated IκB (Beg and Baldwin, 1993; Thanos and Maniatis, 1995; Yaron et al., 
1997), and inhibiting NFκB by introducing exogenous IκB into the cell (Read et al., 
1994; Elewaut et al., 1999) have been investigated.  In the latter case, a variation of 
which will be explored in this study, the additional IκB could bind the free NFκB and 
prevent it from entering the nucleus and initiating the expression of inflammatory genes.  
Techniques such as electroporation could be very valuable for delivering IκB and other 





3.  ELECTROPORATION 
 
3.1  Theory of Electroporation 
Electroporation is a technique that has been used extensively for incorporating 
membrane impermeable molecules, e.g., DNA (Cataldo et al., 1998), proteins (Prausnitz 
et al., 1994), or drugs (Heller et al., 1999), into cells.  It involves the application of an 
electric field pulse to cause the transient increase in permeability of the lipid bilayer of 
cellular membranes.  The electric field is usually applied for short periods of time (on the 
order of microseconds to milliseconds), as a single pulse or as multiple pulses, and, 
typically, has a rectangular or exponential-decay wave form.  Although electroporation is 
a widely used method, the exact molecular mechanism of how it affects the cell 
membrane is not completely understood.  However, electrical measurements have shown 
that electroporation causes the transmembrane potential of a cell, which is normally 
around 70 mV, to increase to a threshold of a few hundred millivolts (Chang et al., 1992).  
Above this threshold, a breakdown of the membrane occurs and an increase in the cell 
membrane’s permeability is observed (Ho and Mittal, 1996; Weaver and Chizmadzhev, 
1996).   
The enhanced permeability of the cell is thought to be the result of the formation of 
transient, hydrophilic, aqueous pathways ("pores") in its membrane (Chernomordik, 
1992; Weaver, 1993).  The hypothesis is that the precursors to these pathways are 
hydrophobic pores (Figure 3.1A), which expand to a critical radius and then change 
conformation to more stable hydrophilic pores (Figure 3.1B) that require less energy to 
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maintain (Weaver, 1993). These aqueous pores may be reversible or irreversible 
depending upon electrical parameters such as electric field strength, pulse length, and 
number of pulses.  Typically, the pore sizes are greater than or equal to a nanometer and 
take anywhere from milliseconds to a few minutes to reseal.  Transport of 
macromolecules into cells via these pores can take place by one or more of the following 
mechanisms: diffusion (Xie et al., 1990), electro-osmosis (Dimitrov and Sowers, 1990), 
or electrophoresis (Klenchin et al., 1991).  One study found that depending upon the 
electrical conditions and molecule size, transport can take place during the pulse by 
electrophoresis and/or electro-osmosis and after the pulse by diffusion (Prausnitz et al., 





Figure 3.1 Diagram of the (A) hydrophobic and (B) hydrophilic pore structures 
hypothesized to form during electroporation (Weaver, 1993). 
 
 
3.2  Electroporation of Monolayers 
 
Several researchers have demonstrated that electroporation can be successfully 




(Gift and Weaver, 1995), bacteria (Taketo, 1988), plant cells (Saunders and Bates, 1992), 
and red blood cells (Dimitrov and Sowers, 1990). In most of these studies, adherent cells 
were chemically or physically removed from their support and then electroporated in 
suspension. This type of electroporation is not meaningful for some cells, e.g., epithelial 
cells, because it poorly mimics in vivo cell function and geometry found in tissues. 
While there is an extensive amount of research about electroporation of cells in 
suspension, in comparison, little research has been performed to study electroporation of 
cells as monolayers, and even less with intestinal epithelial cell monolayers.  Studies of 
electroporation of cells in monolayers (Liang et al., 1988; Kwee et al., 1990; Kwee and 
Celis, 1991; Zheng and Chang, 1991; Kwee et al., 1992; Ghosh et al., 1993; Raptis et al., 
1995a; Raptis et al., 1995b; Yang et al., 1995; Bright et al., 1996; Wegener et al., 2002; 
Muller et al., 2003), have involved cells that were not epithelial, did not originate from 
the intestine, or were not of human origin, which limits their ability to model human 
intestinal tissue function. In related studies, Leonard et al. (2000b; 2000a), used 
iontophoresis to electrophoretically enhance transport across intestinal epithelium, but did 
not employ electroporation and, therefore, did not deliver molecules into cells. Thus, the 
ability to electroporate functional human intestinal epithelium and thereby transport 
molecules intracellularly has not yet been established. 
 
 
3.3  Applications of Electroporation 
 
Although the exact molecular mechanisms of how electroporation affects the cell 
membrane are not fully understood, this phenomenon has been widely employed as a 
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research tool to transfect cells with exogenous proteins or genes (Baron et al., 2000; 
Canatella and Prausnitz, 2001), to transform plant cells (Chowrira et al., 1995), to sample 
cytosolic contents (Neumann et al., 1989), to transport drugs across the skin for local or 
systemic therapy (Prausnitz, 1999) and to enhance chemotherapeutic delivery into tumors 
(Heller et al., 1999).  
Electroporation has gained most of its popularity as a tool for transfecting cells 
with nucleic acids such as plasmids. Plasmids are small, double-stranded, circular DNA 
molecules that replicate in prokaryotic cells.  In purified form, a recombinant plasmid 
with a eukaryotic promoter upstream of a coding sequence can be transfected, or 
delivered, into a eukaryotic cell to have a particular gene expressed.  The gene must 
undergo transcription (synthesis of messenger RNA from the DNA template) and 
translation (synthesis of proteins from the RNA template) in order for expression to occur 
and could have some biologic therapeutic activity.  Depending upon where the plasmid 
DNA localizes, expression can be transient (plasmid does not integrate into cell 
chromosome) or stable (plasmid integrates into the genomic DNA).  
 In addition to electroporation, there are several other methods used to introduce 
exogenous genes into cells and tissues including 1) calcium phosphate coprecipitation 
(Conn et al., 1998), 2) DEAE dextran (diethylaminoethyl-dextran) (Schwartz and 
Rosenberg, 1998), 3) microinjection (Yaron et al., 1997), 4) viral vectors (Hicks et al., 
1998; Thomas et al., 2003), 5) sonication (Greenleaf et al., 1998), and 6) cationic lipids 
(Tseng et al., 1997; Bichko, 1998). Table 3.1 lists some of the major advantages and 




Table 3.1 Comparison of the advantages and disadvantages of common gene transfection 
methods. 
 
Transfection Method Advantages Disadvantages 
Calcium phosphate 
• Commonly used 
• Relatively inexpensive 
• Useful for stable and 
transient transfection 
 
• Cell toxicity 
• Cell type dependent 
(does not work in 
difficult to transfect 
cell lines) 
• DNA degradation in 
endosomes 
DEAE-dextran 
• Ease of use 
• High efficiency 
• Useful for transient 
transfection 
• Cell toxicity 
• Cell type dependent 
(does not work in 
difficult to transfect 
cell lines) 
• DNA degradation in 
endosomes 
• Not useful for stable 
transfection 
Microinjection • Ability to inject DNA directly into nucleus 
• Special equipment 
• Labor intensive 
• Difficult to perform 
on large numbers of 
cells 




Sonication • Cell type independent 
• Special equipment 
• Low transfection 
efficiency 
Cationic lipids • Ease of use 
• High efficiency 







Cationic lipids have rapidly become one of the most common methods of 
transfection being used today. Lipid-mediated transfection (lipofection) involves the 
formation of complexes with DNA through the ionic interactions between the positively 
charged lipid and the negatively charged DNA molecule. The resulting lipophilic 
complex is then either endocytosed or binds to the cell and the DNA released through an 
unknown mechanism (Tseng et al., 1997).  Although lipofection can be very efficient, 
some differentiated cell lines, including Caco-2 cells (Uduehi et al., 1999), are resistant to 
this form of transfection.  
Since electroporation generally does not affect long-term cell function and can be 
performed on almost any cell type, it shows great promise as a tool for targeted drug 
delivery and gene therapy.  We propose to use electroporation as a tool for incorporating 
several macromolecules into epithelial cell monolayers that model intestinal epithelia. If 
successful, these models can be manipulated through the use of genetic material or 
proteins for the purpose of studying cellular processes or mimicking actual diseases.  
Experimental drugs or gene-based therapies can also be tested on these disease models, 
thus reducing the need for research animals.  New or improved therapeutic techniques 
(e.g., an endoscopic-like device) could also be developed based on the success of using 




4.  EXPERIMENTAL METHODS AND PROCEDURES 
 
4.1  General Experimental Methods 
4.1.1  Cell Culture 
The Caco-2 and T84 tumor cell lines were chosen to model the intestinal 
epithelium. Both cell lines were derived from human colon carcinomas (Fogh et al., 
1977a; Dharmsathaphorn et al., 1984) and when cultured on microporous membranes, 
they exhibit many of the same structural and functional characteristics of in vivo 
intestinal epithelium (see Chapter 2). This makes them very useful as models of the 
intestinal epithelium. 
Caco-2 cells (American Type Culture Collection, Manassas, VA) were cultured in 
tissue culture flasks using standard complete media consisting of Dulbecco's Modified 
Eagle's Medium (DMEM) supplemented with 10% (v/v) heat-inactivated fetal bovine 
serum, 100 IU/ml penicillin, 100 µg/ml streptomycin, 2 mM L-glutamine, 10 mM 
HEPES buffer (Mediatech, Herndon, VA), and 0.1 mM non-essential amino acids.  T84 
cells were cultured in a 1:1 mixture of DMEM and Ham's F-12 Nutrient Mixture 
supplemented with 6% (v/v) heat-inactivated newborn calf serum, 15 mM HEPES buffer, 
14 mM NaHCO3, and antibiotics (40 µg/ml penicillin, 8 µg/ml ampicillin, and 90 µg/ml 
streptomycin).  Unless otherwise stated, all media ingredients were obtained from Life 
Technologies, now Invitrogen (Carlsbad, CA). Both cell types were cultured in a 37oC, 
5% CO2 environment and were passaged using standard cell culture techniques 




4.1.2  Monolayer Culture 
 
To grow intact, polarized monolayers, harvested cells were seeded onto collagen-
coated Transwell microporous cell culture inserts (Corning Costar, Acton, MA) in six-
well culture plates using well-established techniques (Madara et al., 1992).  Caco-2 cells 
were seeded at a density of ~4 x 104 cells per ml onto polyester membrane inserts with a 
growth area of 4.7 cm2 and a pore size of 0.4 µm (Costar #3450).  Unless otherwise 
stated, T84 cells were seeded at a density of ~3 x 105 cells per ml onto polycarbonate 
inserts with a growth area of 4.7 cm2 and pore size of 3 µm (Costar #3414). Caco-2 cells 
were cultured on membranes with smaller pores because they are known to grow through 
pores larger than 1 µm and form a monolayer on the other side of the membrane (Tucker 
et al., 1992).  
Monolayers of both cell lines were incubated in a 5% CO2, 37oC environment in 
their respective growth media and allowed to grow to confluence. Caco-2 monolayers 
were allowed to remain in culture for 14-28 days, while T84 monolayers were cultured 
for 7-14 days.  Spent media was replaced with fresh media approximately every 48 hours.  
 
4.1.3  Transepithelial Resistance Measurements 
 
To ensure monolayer integrity, the transepithelial electrical resistance (TEER) of 
each monolayer was measured.  In initial experiments with these monolayers, TEER was 
measured by connecting the apical and basal media to calomel and Ag·AgCl electrodes 
using agar bridges as described previously (Madara et al., 1992). A voltage clamp system 
(Model 558-C5, Dept. of Bioengineering, University of Iowa, Iowa City) measured the 
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transepithelial voltage generated in response to a small current (60 µamps for Caco-2’s 
and 25 µamps for T84’s). Ohm’s law was then used to calculate the resistance of the 
monolayers. The resistance of empty monolayer culture inserts was subtracted from the 
total resistance to obtain the resistance of the monolayer alone. A disadvantage of using 
this method was that the apparatus was not easily transported because of its bulkiness. In 
addition, this method required monolayers to be exposed to the external environment in 
order for measurements to be made. As a result, if the monolayers had not achieved 
maximal resistance at the time of measurement, they could not be placed back in 
incubation because of the potential for contamination.  
An alternative apparatus sold by Millipore called the Millicell ERS (Millipore, 
Bedford, MA) was found to work quite well for measuring monolayer resistance under 
aseptic conditions. This apparatus consisted of a much smaller portable ohmmeter (Figure 
4.1) and incorporated the use of portable ‘chopstick’ electrodes, which could be easily 
sterilized with ethanol. The use of this system allowed us to track the resistance of the 
monolayers post-seeding, while still maintaining sterility. Because the chopstick 
electrodes may not provide an accurate resistance for the entire monolayer, but only for 
the region in which the measurement was made, readings were taken at three points 
around the monolayer and then averaged. 
TEER values of 500-600 ohm⋅cm2 for Caco-2 monolayers (Artursson et al., 1996) 
and 1500-3000 ohm⋅cm2 for T84 monolayers (Dharmsathaphorn and Madara, 1990) are 




Figure 4.1 Millicell ERS apparatus used to measure the transepithelial electrical 
resistance (TEER) of Caco-2 and T84 monolayers. [Source: Millipore, Inc.] 
 
 
monolayers. Monolayers with lower than normal resistances were considered unable to 
maintain proper physiology and either were allowed to continue in culture until the 
desired resistance was reached, or were discarded. 
 Prior to electroporation, monolayers were rinsed with warm Hanks’ Balanced 
Salts Solution (HBSS+) with Ca2+ and Mg2+ (Sigma Chemical, St. Louis, MO) 
supplemented with 10 mM HEPES and then placed in fresh electroporation medium 
(serum-free DMEM buffered with 25 mM HEPES).  The presence of calcium in the rinse 
solution is necessary to maintain the integrity of monolayer tight junctions (Gonzalez-
Mariscal et al., 1990).  Since the rinse step could affect the resistance, the monolayers 
were returned to a 37oC environment for 15-20 minutes until resistance recovered to 




4.2  Electroporation of Intestinal Epithelial Monolayers 
4.2.1  Electroporation Apparatus 
Electroporation was carried out using a high voltage pulser (BTX ElectroCell 
Manipulator 600, Genetronics, San Diego, CA) coupled with an adherent-cell cuvette 
with parallel, 4-mm gap, aluminum electrodes (InSitu™ Electroporation System, Thermo 
Hybaid, Middlesex, UK) (Figure 4.2). The BTX pulser supplied exponential-decay pulses 
and was capable of delivering voltages ranging from 10 V to 2500 V. By adjusting the 
resistance and/or the capacitance of the system, a wide range of pulse lengths could also 
be delivered. Multiple pulses required an interpulse spacing of at least 15 seconds to 
allow the pulser to recharge after delivering a pulse. The InSitu System was developed 
especially for electroporating adherent cells cultured on microporous membrane inserts. 
The inserts on which the monolayers were cultured fit inside the cuvettes as illustrated in 
Figure 4.3. 
 
4.2.2  Electroporation Protocol 
Exponential decay electric pulses were delivered at room temperature for voltages 
ranging from 30 to 400 volts, pulse lengths ranging from 1 to 20 ms, and pulse numbers 
ranging from 1 to 20 pulses. For multiple pulse conditions, the interpulse spacing was 
~20 s. An oscilloscope (HP54602B, Hewlett Packard, Colorado Springs, CO) and a 10:1 
voltage probe (Hewlett Packard) were used to measure the applied voltages and pulse 
lengths.  For all experiments, the voltages are reported as the voltage applied to the 
electroporation cuvette. Voltages across the monolayer are expected to be much less (see 






Figure 4.2  Electroporation system used for treating adherent monolayers. The BTX ECM 
600 (A) was used to deliver exponentially decaying pulses to monolayers housed in the 






Figure 4.3  Diagram of polarized epithelial monolayer grown on a microporous 
membrane inside an electroporation cuvette. Electrodes located above and below the 





decay pulse, i.e., the time it takes for the voltage to drop from its maximum value to 1/e 
(~37%) of its maximum value (see Figure 4.4). Control monolayers were treated in the 
same manner, but were not pulsed.  
 
4.2.3  Estimating Voltage Across the Monolayer 
 
The voltage across the monolayers should be less than the voltage applied by the 
pulser due to voltage drops across the electrode-medium interface and within the culture 
medium.  The voltage across the monolayers can be estimated by first electroporating a 
monolayer of cells and measuring the voltage (VAPPLIED) and current (IAPPLIED) applied by 
the pulser using an oscilloscope (Hewlett Packard) and a current monitor (#411, Pearson 
Electronics, Palo Alto, CA). Figure 4.4 shows representative voltage and current traces 
that can be used to determine the voltage across the monolayer. The traces were recorded 
using BenchLink XL software (Agilent Technologies, Palo Alto, CA).  
The total resistance of the electroporation cuvette with cells, RTOTAL, was then 
calculated using Ohm’s law. Next, the cells were removed from the cell culture insert by 
trypsinization (see Section 4.3.2), and the same electrical condition was applied to the 
cell-free insert. Again voltage and current were measured and used to calculate the 
resistance of the cuvette with no monolayer, RCUVETTE. The difference between RTOTAL 
and RCUVETTE results in the approximate resistance of the monolayer during the pulse, 
RMONOLAYER.  Since the monolayer and the total system are in series with each other, the 
current through the monolayer is equal to the current through the total system. The 





Figure 4.4 Representative current and voltage traces captured by the oscilloscope. Pulse 
length is determined as the length of time it takes for the voltage to fall from its 
maximum to 1/e (~2.718) its maximum. The x-axis represents time and the y-axis 
represents voltage. In this image, the scale for the x-axis is 200 µs/division.  The scale for 
the y-axis is 50 V/division for the lower trace and 1 V/division for the upper trace. The 





















VV  (4.1) 
 
Although the procedure for determining the voltage across the monolayer 
appears to be straightforward, there was some difficulty obtaining values that made sense. 
As illustrated in Figure 4.5, in many cases, subtracting the resistance of the cuvette from 
the resistance of the total system (RMONOLAYER) resulted in negative values. The 
variability seen in these measurements could perhaps be due to differences in monolayer 
integrity, cuvette geometry, electrical conditions, and other small changes in the 
experimental conditions that affected the calculation.  Because of this uncertainty in 
determining the voltage across the monolayer, all voltages reported in this study are the 
voltages applied to the cuvettes. 
 
4.2.4  Fluorescent Uptake Marker Molecules 
Two molecules were initially used to measure delivery to cells: calcein (623 Da, 
0.6 nm radius) and fluorescein-labeled bovine serum albumin (BSA; 66,000 Da, 3.5 nm 
radius) (Molecular Probes, Eugene, OR). Both molecules are membrane-impermeant and 
fluoresce green when excited at 488 nm. A 1.5 ml1 solution of electroporation medium 
containing 100 µM calcein or 10 µM BSA was placed on the apical (upper) side of a 
monolayer to model luminal administration of drugs. The monolayer was incubated for at 
least 5 minutes with the fluorescent molecules, placed in a cuvette with 3 ml of  
                                                 
1 Note: The instruction manual for the InSitu System recommended 800 µL of medium on the apical side of 
the monolayers. This volume was not sufficient to allow the upper electrode to contact the medium and, as 






Figure 4.5 Current and voltage traces used to determine total resistance of the system 
with cells (A; RTOTAL) and without cells (B; RCUVETTE). A monolayer of cells was 
electroporated at the reported condition. The cells were then trypsinized from the 
membrane and the same insert was electroporated again. This is an example of the results 


























electroporation medium on the basal (lower) side, and pulsed.  Immediately after pulsing, 
the monolayers were placed in a 37oC dry incubator with warm DMEM on the basolateral 
side to recover for at least 15 minutes and were then incubated further until experiments 
with other monolayers were completed (≤ 1 h). 
 
4.3  Fluorescence Analysis of Electroporation 
Cell viability and molecular uptake of the fluorescent molecules were visualized 
and quantified using fluorescence microscopy and flow cytometry, respectively.  
Fluorescence microscopy (both epifluorescence and confocal) allowed us to verify uptake 
of marker molecules, as well as the localization of the molecules.  Flow cytometry 
provided quantitative, statistically relevant information about the number of cells and 
their fluorescence properties.  
 
4.3.1  Epifluorescence and Confocal Microscopy  
Table 4.1 shows excitation and emission values for uptake and viability markers, 
as well as the various other dyes that were used to identify structures within the 
monolayers. Conventional epifluorescence images were made using an Olympus IX-70 
inverted system microscope (Olympus America, Inc., Lake Success, NY) with a 
fluorescence attachment (IX-FLA inverted fluorescence observation attachment; 
Olympus).  A short-arc, mercury lamp (OSRAM, Munich, Germany) was used to excite 
red and green fluorophores, which were detected with 515 nm and 610 nm longpass 
filters, respectively.  Images were collected using a Spot RT™ Digital Camera 
(Diagnostics Instruments, Sterling Heights, MI) controlled by ImagePro Plus (ver.4.5, 
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Media Cybernetics, Carlsbad, CA) acquisition software. For analysis by conventional 
fluorescence microscopy, monolayers were imaged from the bottom of their inserts, 
which were seated in six-well plates. The media was replaced with HBSS+ to avoid 
background fluorescence from the phenol red present in DMEM.  
 
 
















Calcein Uptake 488 494 517 Green 





Expression 488 489 509 Green 
Propidium Iodide Viability 488, 543 536 617 Red 
Hoechst 33342 Nucleus 351 347 483 Blue 
FM 4-64 Lipid 543 515 640 Red 
 
 
Unlike conventional fluorescence microscopy, which detects fluorescence 
throughout the entire sample, Laser Scanning Confocal Microscopy (LSCM) detects 
fluorescence only within the focal plane, while filtering out out-of-focus light. This 
allows one to optically section a 3-dimensional sample (e.g., a tissue) and obtain 
information from successive x-y planes while moving in the z-direction. This series of 
planes can then be digitally reassembled to provide a 3-D reconstruction of the sample.  
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For analysis by confocal microscopy after electroporation, monolayers were 
washed with HBSS+ as described above to remove residual media and marker molecules 
and then fixed in 3.7% paraformaldehyde solution at room temperature for 20-30 
minutes.  The fixed monolayers were washed again with HBSS+ and the membranes on 
which the monolayers were cultured were then excised from the inserts. The membranes 
were mounted onto microscope slides using a fluorescence antifade reagent as mounting 
medium (SlowFade, Molecular Probes)2.  A laser scanning confocal microscope (LSM 
510, Carl Zeiss Inc., Thornwood, NY) equipped with argon (351 nm and 488 nm) and 
helium-neon (HeNe; 543 nm) lasers was used to visualize incorporation and localization 
of calcein, BSA, and several other fluorophores in the monolayers.  
Although fluorescence microscopy is very useful for qualitative analysis of the 
incorporation of marker molecules within the monolayers, quantitative information about 
how many molecules are take up is not so easily obtained, which is why flow cytometry 
is so useful. This technique allows one to observe the physical and fluorescence 
properties of individual cells and ultimately calculate the amount of uptake in each cell. 
 
4.3.2  Flow Cytometry  
 
Flow cytometry is one of the most widely used methods for measuring the 
properties of cells and other particles. The technique is based on the flow of particles in 
single file past a laser source.  As the cells pass the laser, information about the light 
scattering and fluorescence properties of the cells is collected. Light that is scattered in 
the forward direction (forward scatter, FSC) because of diffraction provides information 
about the size of the cells. Light scattered at 90o to the beam is referred to as side scatter 
                                                 
2 Phenylenediamine also works well as an antifade reagent. 
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(SSC) and is an indicator of the granularity within the cell and the surface characteristics 
of the cell.  
In a flow cytometer, the fluorescence of the cells is detected by a series of 
mirrors, filters, and splitters, which send the emitted light to a particular channel. Green 
fluorescence, such as that emitted by calcein, is typically detected in the FL1 channel. 
Orange-red fluorescence is usually detected in the FL2 channel. Red fluorescence is 
detected in channel FL3. These capabilities, along with the ability to analyze thousands 
of cells in a short period of time, make flow cytometry very useful in aiding our efforts to 
quantify molecular uptake and viability of the cells after electroporation.   
 
4.3.2.1  Dissociation of Monolayers for Flow Cytometry 
 
Since flow cytometry requires cells to be in single-cell suspensions, monolayers 
were dissociated after electroporation was completed to allow quantification of the 
fluorescence and scattering properties of each individual cell. Each monolayer was 
washed in warmed HBSS+ (with calcium and magnesium) to remove media and free 
calcein and BSA.  A 0.5 ml solution containing 0.25% trypsin and 0.1% EDTA 
(Mediatech) warmed to 37oC was applied apically and basally to dissociate the 
monolayers into individual cells.  The apical volume of trypsin was then neutralized 5 
minutes later (after incubation of monolayers in 37oC incubator) by the addition of 3 ml 
of serum-supplemented DMEM.  The cell suspensions were washed by centrifuging and 
decanting 4 times using cold PBS to remove any residual trypsin, media, calcein, or BSA.  
The first wash (3.5 ml) was done using a Beckman Coulter GS-6R centrifuge (3200 rpm, 
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1660 rcf).  The remaining washes (0.5 ml) were done using an Eppendorf 5415C 
microcentrifuge (3000 rpm, 735 rcf).  
After the final wash, cell pellets were prepared for flow cytometry analysis by 
resuspension in 0.5 ml of PBS with propidium iodide (Molecular Probes, Cat. #P-3566) 
and LinearFlow green fluorescent polystyrene microspheres (Molecular Probes, Cat. #L-
14821) added to make a final concentration of 10 µg/ml and 120,000 microspheres/ml, 
respectively.  Propidium iodide, which stains the nuclei of nonviable cells red, and the 
fluorescent microspheres, which serve as an internal volumetric standard, were used 
together to determine the fraction of cells remaining intact and viable after 
electroporation, as described below.  
 
4.3.2.2  Flow Cytometry Analysis 
Cell viability and molecular uptake of calcein and BSA were quantified using 
flow cytometry.  Data were collected using a FACSort or FACSCalibur flow cytometer 
and CellQuest software (Becton Dickinson, Franklin Lake, NJ). In later experiments, the 
more advanced BD LSR flow cytometer, controlled by FACSDiva software (Becton 
Dickinson), was used. Each sample was run until data from ~20,000 viable cells were 
collected by the cytometer.  The cytometer was able to distinguish between cells, 
microspheres, and cellular debris based on size and shape using light scatter 
measurements (forward scatter and side scatter) as illustrated in Figure 4.6A.  
For the FACSort and FACSCalibur cytometers, the samples were excited using a 
15-mW, 488-nm argon laser (Cyonics, now part of Uniphase Corp., San Jose, CA) to 





Figure 4.6  Representative density plots and histograms obtained by flow cytometry 
analysis of electroporated monolayers. (A) Cells and microspheres are identified on FSC 
vs. SSC plots and then (B) the cell population is further broken down into viable and 
dead cell populations based on propidium iodide fluorescence. (C,D) Fluorescence 
intensity histograms for the viable cell populations are then analyzed for an increase in 
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longpass filter and 530/30 nm bandpass filter, respectively. On the BD LSR flow 
cytometer, which was equipped with an argon laser (488 nm) and a HeNe laser (633 nm), 
FITC-like molecules and propidium iodide were detected using a 530/28 nm bandpass 
filter and 670 nm long pass filter, respectively. The concentration of viable cells in each 
sample was determined by multiplying the ratio of viable (propidium iodide negative) 
cells (Figure 4.6B) to microspheres by the known microsphere concentration. Percent 
viability could then be calculated by normalizing the viable cell concentration of each 
electroporated sample to the average concentration of the control samples. Calculating 
viability in this way takes into account cells that may have been physically destroyed 
during electroporation, as well as those remaining intact, but nonviable (Prausnitz et al., 
1993). It should be mentioned that cells stained with propidium iodide can be either 
necrotic (death by lysis) or in the late stages of apoptosis (programmed cell death). No 
distinction was made between the two types of cells in our analysis. 
The average calcein or BSA fluorescence intensity (see Figure 4.6C,D) of each 
sample was converted into the average number of molecules taken up by each viable cell 
using a set of quantitative, fluorescent calibration beads (Bangs Laboratories, Fishers, IN, 
Cat. #825) with fluorescence intensities (Figure 4.7A) that correspond to a known 
number of free fluorescein molecules, as described previously (Prausnitz et al., 1993). 
Briefly, a solution containing 2-3 drops of each of the four calibration bead suspensions 
was analyzed at the end of each flow cytometry experiment. Depending on the flow 
cytometry settings, the four bead populations had certain intensity values that showed a 
linear relationship with the number of fluorescein molecules associated with each 
population (see Figure 4.7B).  The average fluorescence intensities of the analyzed cell  
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Figure 4.7  Calculation of molecular uptake using MESF calibration beads. (A) MESF 
beads are run on the flow cytometer after each experiment to obtain four populations of 
different fluorescence intensities. (B) A calibration curve of the number of fluorescein 
molecules associated with each bead population vs. the fluorescence of that population is 
then made. The average fluorescence of each event in a histogram, such as the ones 
shown in Figure 4.6, is converted to the average number of molecules per cell using this 
curve. An arbitrary average fluorescence value of 45 was chosen for this example. 
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samples could then be converted to the average number of fluorescein molecules based 
on that linear relationship.   
Since the intensity of fluorescein is slightly different from that of calcein and 
BSA, a correction factor was employed to convert from the number of fluorescein 
molecules to the number of calcein or BSA molecules. The correction factor, which was 
calculated by fluorimetric analysis (Photon Technology International, South Brunswick, 
NJ) of equivalent concentrations of fluorescein and calcein or BSA, was determined to be 
1.01 ± 0.20 for calcein and 0.93 ± 0.14 for BSA. Flow cytometry results were analyzed 
using the WinMDI Flow Cytometry Application (Scripps Research Institute Flow 
Cytometry Core Facility, http://facs.scripps.edu/). 
 
 
4.4  Recovery of Monolayers After Electroporation 
4.4.1  Physical Recovery of Monolayers 
The recovery of monolayers after electroporation was measured using 
transepithelial resistance as an indicator of monolayer integrity.  Each monolayer was 
electroporated under sterile conditions in HEPES-buffered DMEM with electroporation 
pulse conditions of different strengths: “mild,” “moderate,” and “strong”.  Although we 
believe flow cytometry measurements underestimate the actual cell viability in this study, 
as explained in Chapter 7, conditions yielding approximately 90%, 70%, and 50% 
viability according to flow cytometry were used as indicators of mild, moderate, and 
strong electroporation conditions. For Caco-2 monolayers, the conditions that were used 
to give these viabilities were 50V – 1 ms, 50 V – 10 ms, and 100 V – 10 ms, respectively. 
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The conditions used for the T84 monolayers were 50 V – 5 ms, 50 V – 20 ms, and 200 V 
– 5 ms, respectively (see Chapter 6). Using the Millicell ERS, transepithelial resistance 
measurements were made immediately (<25 s) and every minute after the electroporation 
pulse for 5 min.  Successive measurements were made at 10, 15, and 30 min, 1, 2, 4, 6, 
12, and 24 h, and then each day for up to 14 days.  Media was replaced every 48 h.  
During the course of the experiment, it was observed that temperature had a 
significant effect on the resistance of the monolayers. The difference in resistance was 
especially evident when resistances of monolayers that remained at room temperature 
during electroporation were compared to subsequent resistances measured immediately 
after removal from the 37oC incubator. In order to minimize the effect of temperature on 
the recovery trends, electroporated monolayer resistances were normalized to those for 
unelectroporated monolayers. These normalized resistances were then normalized again 
to their initial (pre-electroporation) values. For each experiment, conditions were applied 
in triplicate and each experiment was repeated three times. 
 
4.4.2  Functional Recovery of Monolayers 
 
While conducting recovery experiments for T84 monolayers, samples of the 
basolateral medium (200 µl) were collected (an equal volume of fresh medium was added 
each time) at different time points after electroporation (0, 2, 4, 6, 12, 24 h) and tested for 
the presence of the inflammatory cytokine, IL-8. A colorimetric enzyme-linked 
immunosorbent assay (ELISA), which is used to detect a single protein in the presence of 
other proteins, helped determine the amount of IL-8 secreted after electroporation. IL-8 
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protein standards were prepared by making serial dilutions of a 20 ng/ml solution of 
recombinant human IL-8 protein (rhIL-8; R&D Systems, Minneapolis, MN).  
In a 96-well plate, the IL-8 present in the standards and samples was detected 
with an anti-human IL-8 capture antibody (α-hIL-8; 8 µg/ml; R&D Systems, 
Minneapolis, MN), an anti-human IL-8 detecting antibody purified from rabbit serum 
(7.6 µg/ml; Endogen, Woburn, MA), and an anti-rabbit, horseradish peroxidase-
conjugated antibody (71.5 ng/ml; Kirkegaard & Perry Laboratories, KPL, Gaithersburg, 
MD).  When a peroxidase substrate (SureBlue™ TMP Microwell Peroxidase Substrate, 
KPL) was added, a blue color developed. The plate was read on an absorbance plate 
reader (UVMax, Molecular Devices, Sunnyvale, CA) at a wavelength of 650 nm and the 
standard curve was used to determine the amount of IL-8 in each sample.  The linear 
portion of the standard curve typically ranged from 0.02 ng/ml to 1.25 ng/ml. 
 
 
4.5  Transport across Monolayers after Electroporation 
In addition to determining how many molecules are transported into the cells by 
electroporation, it was also of interest to determine whether electroporation enhanced the 
transport of molecules across the monolayers.  In some cases, treatment of a disease or 
delivery of a vaccine may require a drug to cross the epithelial barrier to be effective.  
Transport across the monolayer was evaluated using calcein and fluorescein-labeled BSA 
as representative small and large molecules.   
Monolayers of Caco-2 cells were cultured for 21-28 days as described above. 
Before starting the experiment, monolayers were washed and incubated in HBSS+ 
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supplemented with 25 mM HEPES at 37oC for 30 minutes to acclimate them to the 
solution. Several six-well plates with 2 ml of HBSS+ in each well were also placed in the 
incubator. Calcein or BSA was added to the apical compartment (1.5 ml) to give an 
extracellular concentration of either 100 µM or 10 µM. For early experiments, 
monolayers were monitored every 15 min for six hours and unelectroporated monolayers 
served as controls. In later experiments, the baseline permeability of each monolayer was 
obtained by transferring the inserts on which the monolayers were grown to new wells 
containing fresh HBSS+ at 30 minute intervals for 3 hours prior to electroporation.  
Electroporation was initially carried out using the mild and moderate 
electroporation conditions, 50 V - 1 ms and 50 V - 10 ms, respectively, used in the 
recovery experiments (Section 4.4). However, to determine whether permeability could 
be increased even further, ten 50 V - 1 ms pulses were also delivered to the monolayers. 
This condition has an effect that is essentially the same as the 50 V – 10 ms pulse (total 
exposure time is equivalent; see Section 6.2.3), but allows more time for diffusion of the 
markers across the cells between pulses. After electroporation, the inserts were 
transferred to fresh wells of HBSS+ every 30 minutes for three hours. With the exception 
of the time required to transfer the inserts and perform electroporation, monolayers were 
maintained at 37oC on an orbital plate shaker (RotoMix Model M50825; Barnstead 
Thermolyne, Dubuqe, IA) at ~90 rpm for the duration of the experiment. The 
transepithelial resistance of each monolayer was measured every hour for the three hours 
before and after electroporation.  The permeabilities of calcein and BSA across cell-free 
filters, collagen-coated cell-free filters, and monolayers fixed with 95% ethanol at -20°C 
for 20 minutes were also measured for comparison. 
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To evaluate the passive diffusion of calcein through the paracellular space 
(between the cells) when tight junctions are opened, the monolayers were incubated in 
HBSS- (without Ca2+ and Mg2+) for up to 40 minutes. Calcium is known to play a role in 
the maintenance of tight junctions (Gonzalez-Mariscal et al., 1990; Ma et al., 2000). 
Calcein in HBSS- (10 µM) was added apically and the monolayers were moved to fresh 
wells of basal HBSS- every 5 minutes. TEER was monitored to track the drop in 
resistance. After this treatment, the apical volume was replaced with calcein in HBSS+ 
(10 µM) and the monolayers were moved to fresh wells of basal HBSS+ every 5 minutes 
until TEER returned to about 90% of initial values.  
Samples of the basal solutions in each well were analyzed for calcein or BSA 
concentration using a fluorescence plate reader (FluoStar Galaxy, BMG Technologies, 
Germany). Samples of the apical solution, collected at the very beginning of the 
experiment and at the end of the experiment, were also analyzed. One hundred 
microliters of each sample were dispensed into opaque, black, 96-well plates (Costar# 
3944) along with known concentrations of the markers to make a standard curve. The 
plate was analyzed using an excitation wavelength of 485 nm and an emission of 520 nm.  
The apparent permeabilities of calcein and BSA, Papp (cm/s), were calculated 




dQP 1×=  (4.2) 
where dQ/dt is the rate at which the molecule of interest appears in the receiver solution 
(mol/s), Co is the initial concentration of the donor solution (mol/ml), and A is the growth 
area of the monolayer (4.7 cm2).  The appearance rate was calculated by plotting the 
accumulation of the number of moles of calcein or BSA in the samples collected versus 
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time and determining the slope of the resulting line. The initial concentration was 
measured from 50 µl samples taken from the apical solution at the start of each 3 hour 
period, i.e., at the start of measuring for baseline permeability and immediately before 
electroporation. Apical samples were diluted 1:1000 so that the fluorescence would not 
saturate the reader.  
The concentration of calcein and BSA in the apical samples was on the order of 10-
5 mol/L, although some concentrations were lower (perhaps due to dilution error). 
Concentrations of the two markers in the receiver solution were a few orders of 
magnitude less than the apical concentrations. Monolayers incubated with calcein had 
receiver sample concentrations on the order of 10-9 to 10-8 mol/L for unelectroporated 
monolayers and on the order of 5x10-8 to 10-7 for electroporated monolayers.  
Concentrations of BSA in the receiver solution samples ranged from 10-10 to 10-9 mol/l 




4.6  Reporter Plasmid Transfection 
 
4.6.1  Plasmid Amplification and Purification 
Two sets of plasmids that expressed either green fluorescent protein (GFP) or 
luciferase were used to evaluate electroporation as a tool for transfection of intestinal 
epithelial monolayers. The first set of plasmids, pEGFP-N1 (a GFP expression vector) 
and pGL3-Control (a luciferase expression vector sold by Promega, Madison, WI), were 
obtained in small amounts from BD Biosciences Clontech (Palo Alto, CA) and as a gift 
 
 51
from Dr. Harish Radhakrishna’s laboratory, respectively. In order to have enough DNA 
for experiments, the plasmids were transformed into E. coli bacteria, amplified, and 
finally purified using procedures detailed in Appendix B.  
Briefly, a small amount of either plasmid was introduced into competent E. coli 
cells by heat shock transformation.  To check the transformation, a small liquid culture of 
bacteria was used to isolate ~20 µg of plasmid using a Qiaprep Miniprep Spin Kit 
(Qiagen, Valencia, CA). One or two micrograms of the newly isolated and original 
plasmids were cut by restriction digest and the resulting linear fragments analyzed by 
electrophoresis on a 1% w/v agarose gel containing 0.5 µg/ml of the fluorescent dye 
ethidium bromide. This allowed us to verify that the size and construction of the newly 
grown plasmid was the same as that of the original plasmid obtained from the 
manufacturer. Gels were viewed on a UV light box (Transilluminator, VWR Scientific, 
West Chester, PA) to verify that there was sufficient separation between bands and 
photographed using the AlphaImager™ 2200 Documentation and Analysis System 
(Alpha Innotech Corp., San Leandro, CA). 
When the newly grown plasmid was confirmed to be the same as the original 
plasmid, a much larger bacterial culture was grown to isolate enough plasmid to use in 
experiments. The Qiagen Plasmid Giga Kit, which should yield ~10 mg of plasmid, was 
used to isolate and purify the plasmid according to the manufacturer’s instructions.  The  
purified plasmid was checked again on an agarose gel and its concentration was 
determined using a UV-capable spectrophotometer (Ultrospec 1100 pro, Biochrom Ltd, 
Cambridge, England) based on the relationship that 50 µg/ml of DNA has an optical 
density of 1.0. 
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Although amplifying and purifying the plasmid is very straightforward, the 
procedures required to do so for large amounts of plasmid were quite labor intensive, 
sometimes requiring as many as 3-4 days to complete. Many times the yields of the 
plasmid were relatively low (10-20% of the maximum yield) and variation in expression 
from different batches of plasmid could be large. For this reason, a switch was made to a 
new set of plasmids, the gWiz™ High Expression GFP (lot# 7018, 7491) and Luciferase 
(lot# 6591) vectors. These plasmids, which have modified promoters for increased 
protein expression, were developed by Gene Therapy Systems (San Diego, CA).  
Milligram quantities of both plasmids were obtained at a very reasonable price from 
Aldevron, Inc (Fargo, ND).  Using these plasmids saved time and money and minimized 




4.6.2  Green Fluorescent Protein Expression 
Green fluorescent protein (GFP) was originally isolated from the bioluminescent 
jellyfish, Aequorea victoria (Tsien, 1998). It has rapidly become one of the most widely 
used reporter genes for studying transfection.  The primary advantages of GFP are that its 
fluorescence is independent of the organism in which it is expressed and no other 
substrates or reagents are necessary for emission. In addition, the protein is very stable 
under many different conditions and its fluorescence can be observed in both live and 
fixed specimens (Schenborn and Groskreutz, 1999). 
Wild type, or native, GFP (wtGFP) emits green light (508 nm) when it is excited 
by ultraviolet (395 nm) or blue (475 nm) light (Tsien, 1998). Recently, however, the use 
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of enhanced GFP (EGFP) has become popular because of its red-shifted excitation 
spectrum, which makes its excitation peak at 490 nm. This wavelength is especially well 
suited for use with most flow cytometers and confocal microscopes, which typically have 
488 nm argon laser lines.  Another advantage of using EGFP is that it has 4 to 35-fold 
brighter fluorescence than wtGFP. Although GFP expression can provide quantitative 
information about the number of cells that were transected, the drawback is that it is not 
as sensitive an assay as other reporters. As a result, when the protein is expressed at low 
levels, it can be difficult to detect by both flow cytometry and fluorescence microscopy. 
Caco-2 and T84 monolayers were used for all GFP expression studies. Expression 
was assayed by fluorescence microscopy using the Olympus IX70 inverted microscope 
and the image acquisition software ImagePro Plus (Media Cybernetics). Monolayers 
were imaged in situ to track expression of the protein after transfection of the plasmid.  
GFP positive cells were identified and marked using the software program and an 
estimate of the density of cells showing GFP expression was made by dividing the 
number of GFP positive cells in a given field of view by the area of the field. The field 
area was determined by the software based on calibrations made with a micrometer under 
different powers of magnification. 
 
4.6.3  Luciferase Protein Expression 
Firefly luciferase is another commonly used reporter for evaluating gene 
transfection and expression. The ~61 kDa enzyme produced by a gene isolated from the 
firefly, Photinus pyralis, catalyzes the oxidation of its substrate, luciferin, in the presence 
of ATP and Mg2+ and produces light. The light emitted by this chemiluminescent reaction 
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occurs as a flash and then rapidly decays in seconds. With the addition of coenzyme A 
(CoA), light emission lasts for at least one minute. This sustained emission provides more 
reproducible results and increased sensitivity (Schenborn and Groskreutz, 1999). The 
light produced is directly related to the catalytic activity of luciferase and can be detected 
using a luminometer or a scintillation counter. Luminometers can detect as little as 0.001 
pg of luciferase, making luciferase one of the most sensitive reporters available. The 
primary disadvantage of the luciferase reporter assays is that since the cells are lysed to 
release the protein, it is not possible to obtain quantitative information about the number 
of cells that were transfected. 
T84 monolayers were used for all luciferase transfection experiments with 
electroporation and lipofection.  After the monolayers were treated and allowed to 
express luciferase, they were washed in PBS and lysed in 200 µL of Cell Culture Lysis 
Reagent (CCLR; Promega) according the manufacturer’s instructions. The cell lysate was 
assayed for luciferase expression in opaque, white 96-well plate (OptiPlate™-96, Packard 
Biosciences) using the Luciferase Assay System (Promega) and a plate reading 
luminometer (LumiCount™, Packard Biosciences, Perkin Elmer, Boston, MA). Since 
luminescence was constant for only 1 minute, no more than six wells were read at a time. 
Each well was read in triplicate and read for two seconds each time. The three readings 
were averaged for each well and are reported as relative light units (RLU). 
Luciferase expression in relative light units is usually normalized to the amount of 
protein present in the cell lysate, which corresponds to the number of cells present.  
Protein concentration was determined using the modified Bradford assay. The method is 
based on the addition of an acidic solution of the dye Brilliant Blue G to the protein 
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solution.  The complex formed between the dye and the protein shifts the dye absorption 
maximum from 465 nm to 595 nm. Either Bradford Reagent (Sigma Aldrich) or 5X Bio-
Rad Protein Assay Reagent (Bio-Rad) was mixed with the cell lysates in 96-well plates 
(Fisher Scientific). Serial dilutions of bovine serum albumin (BSA) were prepared in 
CCLR to serve as protein standards. Since the detergent present in CCLR interfered with 
the dye solution, the cell lysates and the BSA protein standards were diluted 1:10 in 
water.  A plate reading spectrophotometer (SpectraMAX, Molecular Devices) was used 
to read the plate at a wavelength of 595 nm.  The approximate protein concentration in 
each sample was calculated based on the BSA standard curve. 
 
4.6.4 Methods of Transfection 
4.6.4.1 Lipid-Mediated Transfection 
Two lipid-based transfection systems were used in these experiments. 
Lipofectin® Reagent (Invitrogen) is a 1:1 (w/w) mixture of two cationic lipids, DOTMA3 
and DOPE4. It was used in initial experiments to test the use of lipids for DNA 
transfection in subconfluent and confluent intestinal monolayers. The LipoTAXI® 
Mammalian Transfection Kit (Stratagene, La Jolla, CA) is a proprietary lipid formulation 
and was used in all subsequent DNA transfection experiments on confluent monolayers 
and for comparison with electroporation.  
Initial experiments with Lipofectin were conducted to become familiar with the 
process of transfecting monolayers with lipids. The protocol provided by the 
manufacturer was followed with little modification.  Subconfluent and confluent Caco-2 
                                                 
3 DOTMA: N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammounium chloride 
4 DOPE: dioleoyl phosphatidylethanolamine 
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and T84 monolayers were treated with either 30 µg or 60 µg of Lipofectin and either 5 µg 
or 10 µg of pEGFP-N1 in ~1.5 ml of 25 mM HEPES-buffered DMEM. Control 
monolayers were treated with DNA and no lipid.  The monolayers were incubated at 
37oC and checked for GFP expression by fluorescence microscopy at 24, 48, and 96 
hours after addition of the lipid. 
LipoTAXI, which, according to its manufacturer, is a low toxicity lipid solution, 
was used to deliver various plasmids to confluent T84 monolayers. For GFP expression 
experiments, monolayers were treated with either 0.05 mM or 0.08 mM LipoTAXI and 
10 µg pEGFP-N1. The gWiz-luciferase expression plasmid was used in the majority of 
the experimental comparisons with electroporation. Again the protocol supplied by the 
manufacturer was used with little modification. To identify the “optimum” condition that 
would be used for comparison with electroporation, the LipoTAXI concentration and 
amount of DNA was varied from 0 mM to 0.1 mM  and 5 µg to 30 µg, respectively. The 
monolayers remained in culture 24-72 hours after lipid addition depending on the 
experiment or the reporter being used. 
 
4.6.4.2  Electroporation-Mediated Transfection 
Confluent T84 monolayers were used for gene delivery experiments using 
electroporation.  The amount of plasmid DNA was varied from 5 µg to 60 µg, depending 
on the experiment and the plasmid. In all cases, the appropriate amount of DNA was 
diluted in 1 ml of 25 mM-buffered DMEM in a microcentrifuge tube.  The T84 
monolayers were washed once with DMEM and left with 2 ml of DMEM on the basal 
side. The DNA solution was then added drop-wise to the monolayers along with 0.5 ml 
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of DMEM (to bring the total volume to 1.5 ml for electroporation) and allowed to 
incubate with the monolayers at room temperature for ~20 min. It has been shown that a 
preincubation period with DNA increases transfection efficiency in cells (Xie et al., 1990; 
Klenchin et al., 1991). The TEER for each monolayer was measured prior to 
electroporation to ensure monolayer integrity. 
Many researchers have employed electroporation for in vivo gene delivery 
experiments (Oshima et al., 1998; Rols et al., 1998; Dujardin et al., 2001).  A common 
theme in some experiments is that increased transfection efficiency results when cells or 
tissues are first permeabilized with short (µs), high voltage pulses followed by 
electrophoresis of the DNA into the resulting holes using multiple low voltage, long 
pulses (ms) (Klenchin et al., 1991; Bureau et al., 2000; Satkauskas et al., 2002). A similar 
approach was used for the T84 monolayers using 300 V - 300 µs as our high voltage 
(HV) pulse and 25 V – 20 ms as our low voltage (LV) pulse. The high voltage condition 
was chosen because ~300 µs was the shortest pulse length the BTX pulser was capable of 
delivering. A quick TEER recovery test was conducted using this pulse length, to 
determine whether a 400V pulse would result in an acceptable length of recovery. 
However, since the monolayer pulsed with 300V recovered more quickly (1 day vs. ~4 
days), this voltage was chosen for our high voltage pulse.  
The high and low voltage pulses were applied as single pulses, multiple pulses, or 
in some combination of the two. In addition to varying the electroporation conditions, the 
amount of plasmid was also varied. Immediately after electroporation, the monolayers 
were transferred to a six-well plate with 2 ml of warm T84 growth medium in the wells. 
T84 medium with 24% calf serum (0.5 ml) was added apically to make a total volume of 
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2 ml with 6% serum. The monolayers were then placed in a 37°C incubator for 24-72 
hours (depending on the experiment) to allow expression of the protein of interest.  
 
4.6.5 DNA Uptake Protocol 
To evaluate DNA uptake (not expression) in the monolayers after lipofection and 
electroporation, plasmid DNA (either gWiz™-Luciferase or gWiz™-GFP) was stained 
with the high affinity nucleic acid stain YOYO®-1 iodide (YOYO-1; Molecular Probes). 
YOYO-1 can be excited at 488 nm with an argon laser and detected at 509 nm. Plasmid 
DNA was stained with YOYO-1 at a molar ratio of 100:1 (DNA bp:dye molecule).  This 
ratio corresponded to 150 µg of DNA and 2.3 µl of 1mM dye stock solution. The plasmid 
and DNA were mixed and incubated at room temperature for 60 minutes in a light 
sensitive microcentrifuge tube. Stained DNA was stored at ≤ 4°C.  Pre-stained DNA was 




4.7  IκB-Expression Plasmid Delivery 
As stated in the Background section, a potential treatment for chronic intestinal 
disorders could involve the use of gene therapy. Since electroporation has been used 
extensively as a gene delivery tool, it is very possible that it could be useful in this 
situation as well.   To evaluate whether electroporation could be used to inhibit the 
NFκB-mediated inflammatory pathway by gene delivery, a plasmid that expressed the 
inhibitory protein IκB was introduced into confluent T84 monolayers and monitored for 
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its effects on inflammation in the cells. The amplification and purification procedures 
used to grow up this plasmid can be found in the Appendix. 
 
4.7.1  Electroporation with IκB-HA Plasmid 
Confluent T84 monolayers were electroporated with 20 µg/ml of the plasmid 
pIκB-HA using the high voltage pulse plus multiple low voltage pulses protocol (see 
Section 4.6.4).  When the plasmid is introduced into cells it expresses the protein IκB 
with a hemagluttinin (HA) sequence incorporated into the protein. This tag allowed us to 
distinguish between endogenous IκB and the IκB expressed by the plasmid because the 
HA tag makes the expressed protein larger than the endogenous protein (43 kDa vs. 37 
kDa).  Monolayers electroporated with pEGFP-N1 and gWiz-Luc, as well as 
unelectroporated monolayers, were used as controls. Monolayers were allowed to recover 
and express the protein overnight (no more than 24 h) at 37°C. During the recovery 
period, samples (205 µl) of the basal medium were collected and tested for the presence 
of IL-8 by ELISA (See Appendix for protocol). This assay would tell us whether the IκB-
HA expressed during this time, inhibited the temporary inflammatory response observed 
after electroporation.  
After recovery, monolayers were stimulated basally for 6-8 hours with human 
tumor necrosis factor (hTNF-α; 10 µg/ml; R&D Systems) at a concentration of 10 ng/ml 
in complete medium. Samples of the basal medium were collected before and after TNF 
stimulation and tested for IL-8 secretion by ELISA. Both stimulated and unstimulated 




4.7.2  Analysis of IκB-HA Expression 
SDS-PAGE and Western blot analysis were used to determine whether IκB-HA 
was expressed. SDS-PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) 
involves the separation of proteins in a sample by electrophoresis through a 
polyacrylamide gel, which separates the proteins according to their molecular weights 
(larger proteins migrate more slowly through the gel). Western blotting involves the 
electrical transfer of the separated proteins to a nitrocellulose membrane and the 
subsequent detection of the protein of interest using a detecting antibody and a labeled 
reporting antibody.  Please see the appendix for solution recipes and more detailed 
descriptions of the different procedures. 
 After TNF stimulation, the monolayers were washed twice with HBSS+ and then 
lysed on ice in 500 µL of SDS lysis buffer using a rubber policeman.  Protein 
electrophoresis was carried out using the Lamelli discontinuous gel system (Sambrook et 
al., 1989; Sambrook and Russell, 2001) composed of a 12.5% polyacrylamide lower 
separating gel and a 4.5% polyacrylamide upper stacking gel, which were used to identify 
and detect both endogenous and expressed IκB. The gel was placed in a vertical 
electrophoresis system (Mini-PROTEAN 3 Cell System, Bio-Rad), connected to a DC 
power supply (PowerPac 300, Bio-Rad), and run at 100 V for approximately ~2 hrs.  
After the proteins were separated, they were transferred at 4°C by electrophoresis 
to a small piece of nitrocellulose membrane (Trans-Blot Transfer Medium; BioRad) at 
200 mA for 2 hours. The nitrocellulose membrane was then blocked and probed with the 
necessary antibodies. To detect the presence of IκB, two primary (1°) antibodies were 
used: 1) a mouse monoclonal antibody to hemagglutinin (α-HA, 1 mg/ml, Covance, 
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Berkeley, CA) to detect expressed IκB-HA and 2) a rabbit polyclonal IgG antibody to 
IκBα (α-IκBα, 0.2 mg/ml, Santa Cruz Biotechnology, Santa Cruz, CA) to detect both 
endogenous and expressed IκBα.  The 1° antibodies were diluted 1:200 for α-HA and 
1:1000 for α-IκBα. The 2° antibodies for α-HA and α-IκBα were, respectively, a 
peroxidase-conjugated goat antibody to mouse immunoglobulins (α-mouse HRP, 1 
mg/ml, ICN Pharmaceuticals, Aurora, OH) and a peroxidase-conjugated donkey antibody 
to rabbit immunoglobulins (α-rabbit HRP; Amersham Bioscience, Piscataway, NJ).  Both 
antibodies were diluted 1:1000.  
ECL™ Western Blotting Detection Reagents (Amersham Bioscience), which emit 
light in a chemiluminescent reaction with horseradish peroxidase, were used to detect the 
labeled proteins. The blot was then exposed to autoradiograph film (XOMAT; Eastman 
Kodak, Rochester, NY) for the following exposure times: 5 s, 30 s, 1 min, 2 min, 5 min, 
and 30 min, in a dark room.  The films were developed using a developer (M35 XOMAT 
Processor, Kodak) and the exposed protein bands observed on a light box.  Band 
intensities were quantified and compared using the publicly available ImageJ software 
(version 1.3, National Institutes of Health, http://rsb.info.nih.gov/ij/) 
 
 
4.8  IκB Plasmid Co-transfection Experiments 
After a few experiments with electroporating pIκB-HA alone into T84 monolayers, 
it was observed that IL-8 secretion was not being inhibited by the expressed IκB-HA. We 
surmised that IκB-HA was probably not being expressed in a high enough number of 
cells to completely inhibit IL-8 secretion by the monolayers because of low transfection 
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efficiency. It is possible that the IL-8 secretion by those cells that were not transfected 
with the plasmid overwhelmed the decrease in secretion by the transfected cells.  To see 
if this problem could be avoided, a different approach was used. Instead of assaying the 
effect of transfection on the entire monolayer, only the effect on those cells that took up 
the plasmid would be assayed by co-transfecting pIκB-HA with another plasmid that 
expressed a reporter protein when the cells are stimulated by TNFα. 
 
4.8.1  pIκB-HA/pIL8-CAT Co-transfections 
In the first set of co-transfection experiments, the plasmid that expressed IκB-HA 
was co-transfected with a plasmid that expressed the enzyme chloramphenicol acetyl-
transferase (CAT) upon the binding of NFκB to its IL8 promoter (pIL8-CAT).  CAT is 
yet another reporter protein, similar to GFP and luciferase, which has been used 
extensively to study gene transfection (Roche Biochemicals). The amplification and 
purification procedures used to grow up pIL8-CAT can be found in the Appendix. 
 In these experiments, confluent T84 monolayers were electroporated with pIκB-
HA and pIL8-CAT (obtained as a gift from the laboratory of Dr. Andrew Neish), at the 
same time using the high voltage-low voltage pulse protocol described in Section 4.6.4.  
The two plasmids were electroporated in equal amounts (1:1 ratio) into the cells.  The 
following controls were also included in the experiment: a monolayer electroporated with 
no plasmid, an unelectroporated monolayer with pIL8-CAT, a monolayer electroporated 




After electroporation, the monolayers were incubated at 37°C overnight (16-18 
hours) for recovery and to allow expression of IκB-HA. They were then washed with 
warm DMEM and exposed basally to 10 ng/ml TNFα in complete media (2 ml) for 6-8 
hours to stimulate IL-8 production. After TNF stimulation, the monolayers were lysed in 
500 µL of lysis buffer provided in a commercially available CAT ELISA kit (Roche 
Molecular Biochemicals, Germany) and analyzed for CAT expression according to the 
manufacturer’s instructions. The released NF-κB should bind to the promoter of the 
pIL8-CAT plasmid and initiate the expression of CAT. If IκB-HA has been expressed in 
sufficient quantity to inhibit NFκB, CAT expression should be decreased.  
Although pIκB-HA/pIL8-CAT co-transfections were attempted several times, 
CAT levels were always found to be negative (data not shown). One reason for this could 
be that the amount of CAT expressed after IL-8 binding was below the detection limit of 
the assay (50 pg/ml or 10 pg/well). To test that this was the problem, a standard CAT 
reporter plasmid, pCMV-CAT (obtained from Dr. Lauren Collier, a member of Dr. 
Neish’s lab), which did not require the presence of another molecule for expression, was 
electroporated into T84 monolayer and assayed for CAT expression after 48 hours. 
Again, CAT expression assayed by ELISA was negative.  Since the amount of CAT 
being expressed was too low to detect by ELISA, a change was made to use luciferase as 
the reporter.  Luciferase assays are much more sensitive than CAT and other reporter 





4.8.2  pIκB-HA/pNFκB-Luc Co-transfections 
Co-transfection experiments were repeated using pIκB-HA and a plasmid that 
expressed luciferase when free NFκB binds to its promoter (pNFκB-Luc; obtained from 
the laboratory of Dr. Neish).  The two plasmids were electroporated into T84 monolayers 
at a specified ratio using the same pulsing protocol.  For most experiments, the amount of 
pNFκB-Luc was held constant at 15 µg, while the amount of pIκB-HA was varied (see 
Table 4.2).  A standard luciferase reporter plasmid, pCMV-Luc (also obtained from Dr. 
Neish), was electroporated under the same conditions, and at the same ratios with pIκB-
HA, as a control. The plasmids were amplified and purified using standard molecular 
biology techniques (see Appendix). 
 









pNFκB 15 0 
pNFκB/pIκB (1:1) 15 15 
pNFκB/pIκB (1:2) 15 30 
pNFκB/pIκB (1:4) 15 60 
 
 
After electroporation the monolayers were incubated at 37°C and allowed to 
recover overnight.  The old media was removed and the apical volume (2 ml) replaced 
with fresh complete media, while the monolayers were exposed basally to 10 ng/ml 
TNFα in complete media (2 ml) for 6-8 hours to stimulate IκB degradation and NFκB 
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release.  A companion set of monolayers, which were electroporated with the same 
amount of the two plasmids, but were not exposed to TNF was also included as a control.  
The monolayers that were not exposed to TNF should yield very little luciferase 
expression, since there is no trigger for the release of NFκB. The TNF-stimulated 
monolayers should show a significant increase in luciferase expression compared to the 
unstimulated monolayers.  
At the end of the stimulation period, the monolayers were washed twice with PBS 
and then lysed in 200 µL Promega’s Cell Culture Lysis Reagent (CCLR) according to the 
manufacturer’s instructions. The cell lysates were stored at -70°C until ready for analysis 
of luciferase expression, as described in Section 4.6.3, using the Luciferase Assay System 
(Promega) and a plate reading luminometer (LumiCount™). The protein content in each 
of the lysates was determined by the modified Bradford assay so that the amount of light 
produced could be normalized to an approximation of the number of cells present. 
 
 
4.9  Gene Silencing by siRNA Transfection 
4.9.1  Electroporation of siRNA 
These experiments were conducted to test whether electroporation could 
efficiently introduce short, interfering RNA (siRNA) into confluent intestinal epithelial 
monolayers and knockdown the production of a protein of interest by RNA interference 
(RNAi). The nuclear envelope proteins, lamin A and lamin C (lamin A/C), have become 
the standard proteins used to demonstrate the ability of siRNA to mediate gene silencing 




A new electroporation cuvette setup was used for all siRNA transfection 
experiments. The new cuvettes were designed by Dirk Hunt and Brian Babbin, members 
of the laboratory of Dr. Asma Nusrat, especially for use with monolayers grown on 
smaller membrane inserts. These inserts required a much smaller apical electroporation 
volume (100 µl vs. 1.5 ml for the larger cuvettes used in previous experiments).  As a 
result, more experiments could be carried out with much less reagent. 
T84 cells were harvested and seeded as described in Section 4.1 onto collagen-
coated Transwell microporous cell culture inserts in 24-well plates. The inserts had a 
growth area of 0.33 cm2 and a pore size of 0.4 µm (Costar #3470).  The monolayers were 
incubated in a 5% CO2, 37oC environment and maintained in culture for 7-10 days before 
use. Transepithelial electrical resistance (TEER) was monitored to ensure monolayer 
integrity. 
Lamin A/C siRNA was obtained from Qiagen-Xeragon (Germantown, MD) along 
with non-silencing, FITC-labeled siRNA to serve as a control. When the monolayers 
were ready, they were washed twice with DMEM and then an appropriate amount of 
siRNA suspended in 100 µL of HEPES-buffered DMEM was added apically. The 
monolayers were electroporated at a condition of 50V – 20 ms. The amount of lamin 
siRNA and the amount of time allowed for turnover of the protein were varied to identify 
conditions that yielded the greatest silencing effect. Unelectroporated monolayers and 
monolayers that were electroporated with no siRNA present also served as controls. 
Immediately after electroporation, the monolayers were transferred to a 24-well plate 
with 1 ml of warm T84 growth medium in the wells. T84 medium with 12% calf serum 
(100 µL) was then added apically to bring to a total volume of 200 µL with 6% serum. 
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The monolayers were then placed in a 37°C incubator for 24-72 hours (depending on the 
experiment) to allow silencing of the protein of interest.  
 
4.9.2  Analysis of Gene Silencing 
SDS-PAGE and Western blotting were used to confirm whether the siRNA 
electroporated into the T84 monolayers inhibited the production of lamin A/C (see 
Appendix for detailed protocols). At the end of each experiment, the monolayers were 
lysed, on ice, in 50 µL of SDS lysis buffer. In this case, 15 µL of sample were loaded into 
a 4.5% polyacrylamide stacking gel and separated on a 7.5% polyacrylamide gel. Using a 
lower percentage gel put lamin A/C, which have molecular weights of ~70 kDa, in the 
middle of the gel at the end of the run. The proteins were transferred to a nitrocellulose 
membrane blot, which was then blocked and probed with a mouse monoclonal IgG 
antibody to lamin A/C (1:500; type 636; Santa Cruz Biotechnology) followed by a 
peroxidase-conjugated goat antibody to mouse immunoglobulins (1:1000; ICN 
Pharmaceuticals). The blot was placed in ECL ™ for one minute, dried, and then exposed 
to autoradiography film for specific periods of time up to 10 minutes.  
To ensure that any decrease in the amount of lamin A/C observed in the Western 
blot was due to silencing and not to a decrease in the number of cells after 
electroporation, endogenous IκB was used as an internal standard. The membrane blot 
was stripped to remove the lamin A/C primary and secondary antibodies and re-probed 
with the antibodies used to detect IκBα (see Section 4.6.2).  The presence of bands of 




Immunofluorescence staining was used to visualize the lamin proteins (see 
Immunofluorescence Protocol #2 in Appendix). A counterstain for the tight junction 
protein JAM was used to help identify the cell boundaries.  After the monolayers were 
electroporated with lamin siRNA and incubated to allow silencing to take effect, they 
were probed with the 1° antibodies mouse monoclonal anti-lamin A/C (1:200; Santa Cruz 
Biotechnology) and rabbit polyclonal anti-JAM (1:1000; obtained from the laboratory of 
Dr. Charles Parkos, Emory University) and he 2° antibodies, a FITC-labeled (green) anti-
mouse antibody and a TRITC-labeled (red) anti-rabbit antibody (both from Jackson 
Immunochemicals). The membranes on which the monolayers were cultured were 
excised and mounted, cell-side up, in p-phenylenediamine (an anti-fade reagent) on 
microscope slides and then viewed by confocal microscopy. 
 
 
4.10  Statistical Analysis 
 
Unless otherwise stated, each data point represents the average (mean) of at least 
three replicates for all of the graphs presented in this study. Either the standard deviation 
of the mean (SD) or the standard error of the mean (SEM) was calculated and used to 
make the error bars.  When a comparison between two or more means was required, a 
one-way analysis of variance with a 95% level of confidence (ANOVA, α = 0.05) was 
used. Two-way ANOVAs were used to determine the dependence of a population on two 





5.  ELECTROPORATION OF MODEL INTESTINAL EPITHELIUM 
 
5.1  Introduction 
Electroporation is used extensively to deliver molecules such as drugs, proteins, 
and genes to a wide variety of cell types (Chang et al., 1992; Nickoloff, 1995). The 
majority of these experiments have involved placing cells in suspension and then 
electroporating them in a cuvette. Unfortunately, trypsin, the most common method used 
to chemically dissociate adherent cells can affect the cellular membrane (Vogel, 1978).  
In addition, when adherent cells are dissociated, they lose many characteristics they 
would normally have possessed when in their correct geometry (Zheng and Chang, 
1991).  Therefore, the ability to carry out electroporation on adherent cells is necessary to 
ensure a more accurate representation of in vivo conditions. 
A wide variety of methods for electroporating adherent cells have been developed 
over the years.  Some techniques involved plating the cells on glass coverslips or plastic 
tissue culture dishes and electroporating them with electrodes of different geometries, 
e.g., parallel wire (Zheng and Chang, 1991) or concentric ring (Liang et al., 1988; Bright 
et al., 1996) electrodes.  Other techniques involved actually plating the cells on one of the 
electrodes, which could be small pieces of gold-film (Ghosh et al., 1993; Wegener et al., 
2002) or glass slides coated with an electrically conductive material (Raptis et al., 1995a; 
Raptis et al., 1995b; Firth et al., 1997). A counter electrode could then be used to deliver 
the pulses. 
A limitation of these studies is that they all required specially designed electrodes 
and, in some cases, electroporation pulsers. In addition, plating on nonporous glass or 
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plastic would not be ideal for polarized epithelia since these cells only form the desired 
columnar structure when cultured on porous membranes (Madara et al., 1987).  In one 
study conducted by Yang et al. (1995), cells were grown on microporous membranes that 
had been cut into strips.  The strips were then electroporated in a standard cuvette used 
for cell suspensions. The InSitu™ adherent cell electroporation chamber was used in this 
study, which allowed the monolayers to be cultured on a rigid membrane insert and 
remain there during electroporation and the subsequent recovery period. 
To determine if polarized model intestinal epithelial monolayers could be 
electroporated, confluent monolayers of Caco-2 and T84 human colon carcinoma cells 
were subjected to electric pulses while bathed in an apical solution containing either 
calcein, a small molecule (623 Da), or fluorescein-labeled bovine serum albumin, a 
globular protein (BSA; 66,000 Da). Laser scanning confocal microscopy was used to 
image uptake of fluorescent molecules and cell death in monolayers exposed to electric 
pulses expected to cause electroporation. Confocal microscopy allowed us to also 
visualize both the extent and distribution of uptake within cells of the monolayer. 
Histological staining was employed to further determine the effects of electroporation on 
the monolayers. 
 
5.2  Experimental Results 
5.2.1  Intestinal Epithelial Models Take Up Molecules after Electroporation 
Figure 5.1 shows representative confocal micrographs of control and electroporated 
monolayers that were incubated with calcein or BSA. Control monolayers exposed to 
calcein or BSA in the absence of an electric pulse took up essentially no marker  
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Figure 5.1  Confocal images illustrating uptake of calcein and BSA in electroporated Caco-2 and T84 monolayers. While 
unelectroporated monolayers show almost no fluorescence (A-D), uptake of calcein (E,G) and BSA (F,H) is seen in x-y sections of the 
monolayers for both cell types. Cross-sectional (z-section) views further demonstrate intracellular localization of the molecules (I-L). 
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compounds (Figures 5.1A-D), whereas monolayers exposed to a single electroporation 
pulse contain large amounts of intracellular calcein (Figures 5.1E and 5.1G) and BSA 
(Figures 5.1F and 5.1H).  Calcein delivery appears to occur throughout each cell, whereas 
BSA is present throughout the cytosol, but excluded from the nucleus.  
These observations are further supported by images from cross-sectional views of 
monolayers, which show calcein throughout the cell interiors (Figures 5.1I and 5.1K) and 
BSA filling the cytoplasm outlining the nuclei (Figures 5.1J and 5.1L). In addition, when 
monolayers were observed under low power magnification, the distribution of calcein and 
BSA uptake appeared to occur uniformly over the entire monolayer, i.e., there were no 
‘hot spots’ of high fluorescence intensity (data not shown). 
 
5.2.2  Cell Death Results after Electroporation 
Although a significant amount of uptake can take place after electroporation, cell 
death can also occur. For some electroporation conditions, cells began lifting off the 
membrane within 24 hours after treatment, leaving holes in the monolayers (image not 
shown).  Figure 5.2 shows portions of Caco-2 monolayers exposed to electroporation 
after incubation with calcein (A-B) and BSA (C-D). The monolayers were allowed to 
recover for 15 minutes and were then stained with propidium iodide, a vital stain used to 
identify membrane compromised or dead cells.  After electroporation, propidium iodide 
stained cells were observed, either singly or in patches, scattered around the monolayer.  
The number of dead cells present in the monolayer appeared to depend on the strength of 
the electroporation conditions applied, i.e., the stronger the condition, the more dead cells 





Figure 5.2  Confocal images of cell death in Caco-2 monolayers electroporated at 75V – 
10 ms with calcein (A,B) and BSA (C,D).  The nuclei of the dead cells were stained red 







5.2.3  Monolayers Repair Themselves After Electroporation 
In a small set of experiments, T84 and Caco-2 monolayers were electroporated and 
then observed over time as they recovered. Monolayers were fixed and stained using the 
hematoxylin and eosin (H & E) histological staining technique. Hematoxylin stains 
nucleic acids blue, while eosin stains cytoplasmic proteins pink.  Unelectroporated 
monolayers typically showed fully confluent cells with large, tightly packed nuclei 
surrounded by relatively small amounts of cytoplasm, similar to the confocal 
fluorescence image in Figure 5.3. A day after electroporation, holes in the monolayer, 
where dead cells have lifted off, were apparent.  At the edges of these holes, it appeared 
that the adjacent cells began to extend their cytoplasm into the empty area. This indicated 
that these cells may have begun the initial stages of a recovery process that will be 
discussed in more detail in Chapter 7.  
 
 
Figure 5.3  Confocal micrographs of a Caco-2 monolayer with nuclei stained on the left 
by Hoechst 33342 (blue), lipid membranes stained in the middle by FM® 4-64 (red), and 





5.3  Discussion 
Caco-2 and T84 intestinal epithelial cells were electroporated as monolayers to 
determine whether electroporation could be used to uniformly deliver two classes of 
molecules. Confocal microscopy confirmed that electroporation was successful at 
intracellular delivery of both a small, inert molecule (calcein) and a large macromolecular 
protein (BSA). As stated earlier, calcein was found throughout the cell in both the 
cytoplasm and the nucleus, whereas BSA was primarily found only in the nucleus. This 
nuclear exclusion of BSA is probably due to its large molecular size (66,000 Da), which 
would limit its diffusion through nuclear pore complexes (Talcott and Moore, 1999; 
Bagley et al., 2000). 
The nuclear pore complexes (NPC) are 125 MDa structures located on the nucleus 
that regulate the import and export of all molecules across the nuclear membrane (Bagley 
et al., 2000; Adam, 2001). The central channel of the NPC has a diameter of 
approximately 9 nm and is the primary route by which molecules can pass into and out of 
the nucleus. Proteins less than 30 kDa can easily diffuse through the NPC, while those 
greater than 50 kDa or 6 nm can take as long as 24 hours to passively diffuse through 
(Pouton, 1998; Talcott and Moore, 1999; Gasiorowski and Dean, 2003). Large proteins 
and even some small molecules require the presence of a nuclear localization signal 
(NLS), a sequence of amino acids recognized by receptors on the nuclear membrane, in 
order to pass more quickly into the nucleus. 
It should also be noted that the lack of fluorescence in the nucleus suggests that 
there was probably little degradation of BSA by proteolytic enzymes. Small, fluorescein-
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labeled protein fragments would have passed easily through the nuclear pore complex, 
which would have resulted in an image similar to that of calcein.  
If the condition applied is strong enough, the pores that are formed become 
irreversible leading to an influx of extracellular fluid and/or leakage of intracellular 
contents resulting in cell necrosis.  Release of intracellular contents can elicit an 
inflammatory response in adjacent cells (Chopra and May, 1989).  Apoptosis, which is 
another term for programmed cell death or suicide, typically involves individual injured 
cells, which do not lyse, but undergo shrinkage, nuclear condensation, and eventual death 
(Chopra and May, 1989).  It is likely that the individual dead cells observed scattered 
throughout the monolayers after electroporation could be cells in the late stages of 
apoptosis (images not shown). During this stage, the cells have compromised membranes 
and, as a result, can be stained by propidium iodide. The end result of both necrosis and 
apoptosis is that the cells become non-viable and, in the case of adherent cells, are 
released from the monolayer. Histological staining suggested that the viable cells located 
near the exposed areas might be able to repair the wound in the monolayer. In Chapter 7, 
results from experiments in which transepithelial resistance was tracked after 
electroporation indicate that this is a possibility.  Since it appears that cell death is 
dependent on the strength of the electroporation condition applied, it will be useful to try 
to minimize death, while maximizing uptake of the molecule of interest. Quantification of 






5.4  Conclusions 
Two human colon carcinoma cell lines (Caco-2 and T84) that serve as accepted 
models of the intestinal epithelium were electroporated. Calcein (a small fluorescent 
tracer) and fluorescein-labeled bovine serum albumin (a protein) were chosen as marker 
molecules. Electroporation was able to uniformly deliver both molecules intracellularly, 
where calcein localized throughout the entire cell interior and BSA localized primarily in 
the cytoplasm. Cell death occurred after electroporation and was dependent on the 
condition applied. Although dead cells lifted off from the membrane support, as would be 
expected, the remaining cells appeared to attempt to repair the hole left in the monolayer. 
Once it was established that electroporation could deliver molecules to polarized 
intestinal epithelial monolayers, the next step was to quantify molecular uptake and cell 




6.  QUANTIFICATION OF MOLECULAR UPTAKE AND CELL VIABILITY 
 
6.1  Introduction 
Electroporation and its effect on cells have been a topic of interest for many years 
(Neumann et al., 1989; Chang et al., 1992). It is believed that electroporation creates 
transient aqueous pathways in the lipid bilayer of cell membranes, which results in 
enhanced uptake of membrane-impermeant molecules through the resulting pores. 
Because electroporation can be universally applied to almost any cell type, it has proven 
to be a very useful laboratory tool for introducing small molecules, macromolecules, and 
genetic material into cells (Prausnitz et al., 1993; Prausnitz et al., 1994; Bright et al., 
1996; Cataldo et al., 1998; Neumann et al., 1998; Baron et al., 2000; Canatella et al., 
2001; Canatella and Prausnitz, 2001) and has been used to clinically treat some forms of 
cancer (Heller et al., 1999).    
The dependence of molecular uptake and cell viability on electroporation 
parameters such as voltage/field strength, pulse length, and pulse number has been 
explored in many different studies. Most report uptake as the percentage of cells that 
demonstrate the presence of a membrane-impermeant molecule intracellularly after 
electroporation.  This does not provide information about the extent of uptake within each 
cell.  A small number of studies have quantified molecular uptake in this fashion using 
flow cytometry (Bartoletti et al., 1989; Prausnitz et al., 1993; Prausnitz et al., 1994; Gift 




In this set of experiments, we sought to develop methods for electroporation of in 
vitro models of intestinal epithelium and determine if large numbers of small molecules 
and macromolecules could be delivered into epithelial cell monolayers.  Polarized Caco-2 
and T84 epithelial monolayers were exposed to electrical pulses over a range of different 
voltages, pulse lengths, and pulse numbers and then quantified levels of cell viability and 
uptake of two model compounds: calcein, which served as a model for small, membrane-
impermeant drugs, and fluorescein-labeled bovine serum albumin, which modeled 
macromolecular proteins.  The cells were dissociated and analyzed in large numbers 
(20,000 cells) by flow cytometry to determine the molecular uptake (the number of 
molecules taken up by each cell) and cell viability (the percentage of cells still viable 
after electroporation). The dependence of these two outcomes on electrical parameters 




6.2  Experimental Results 
 
6.2.1  Effect of Pulse Voltage and Length on Uptake  
Having established that cells forming a functional epithelial monolayer can be 
uniformly electroporated, flow cytometry was used to quantify the average number of 
calcein and BSA molecules taken up by each cell as a function of pulse voltage and 
length. Figure 6.1 shows that the average number of calcein and BSA molecules taken up 
by each Caco-2 and T84 cell generally increased with increasing applied voltage to an 
apparent plateau or maximum (one-way ANOVA, p < 0.05). Uptake also increased with 
increasing pulse length, which was statistically significant for voltages less than 300 V (p 






Figure 6.1  Dependence of intracellular uptake and cell viability on electroporation 
voltage and pulse length.  Uptake of calcein and BSA by epithelial monolayers increased 
as voltage and pulse length were increased (A-D). Cell viability decreased with voltage 
and pulse length (E,F). Pulse lengths were 1 ms ( ), 5 ms ( ), 10 ms ( ), and 20 ms 

























































































































This analysis also showed that it is possible to transport more than 106 calcein 
molecules per cell and more than 105 BSA molecules per cell into both Caco-2 and T84 
monolayers using electroporation (Figures 6.1A-D).  Moreover, these average uptake 
values represent a homogeneous response of the cells in the monolayer, as shown by the 
approximately Gaussian distribution about the mean uptake level among the 20,000 
viable cells per sample analyzed by flow cytometry (Figure 6.2). This uniform response 
is consistent with previous observations for electroporation of cells in suspension 
(Prausnitz et al., 1993; Canatella et al., 2001).  
 
6.2.2  Effect of Pulse Voltage and Length on Viability 
The above analysis discussed the number of molecules delivered into those cells 
that remained viable after electroporation.  However, electroporation can render cells 
non-viable.  Figures 6.1E and 6.1F show that the viability of electroporated cells 
generally decreased with voltage (p<0.05) and, to a lesser extent, with pulse length. This 
observation indicates that there is a tradeoff between conditions that yield large levels of 
uptake (i.e., long pulses and possibly high voltages) and those that maintain high viability 
(short pulses and low voltages).  The significance of this sometimes large viability loss 
and its possible overestimation by flow cytometry is discussed further in Section 7.3.2. 
 
6.2.3  Effect of Pulse Number on Uptake and Viability 
Additional experiments were performed to determine the effect of multiple pulses 
on calcein uptake and cell viability. Between 1 and 20 pulses were applied over a range 






Figure 6.2  Flow cytometry histograms of calcein fluorescence intensity for Caco-2 
monolayers exposed to (A) no electroporation, (B) moderate electroporation (50V-10ms), 
and (C) strong electroporation conditions (200V-10ms). Histograms are similar to those 


































Figure 6.3  Dependence of intracellular uptake and cell viability on electroporation pulse 
number and pulse length. Calcein uptake increased with increasing pulse number and 
pulse length (A,B).  Cell viability decreased with increasing pulse number and pulse 
length (C,D).  Applied voltage was held constant at 50 V. Pulse lengths were 1 ms ( ), 5 


















































































and 6.3B show that as the number of pulses was increased and as pulse length was 
increased, the amount of uptake increased in both Caco-2 and T84 monolayers (p < 0.05).  
In Figures 6.3C and 6.3D, the viability of the Caco-2 and T84 cells appears to decrease as 
the number of pulses and pulse length were increased (although not always with 
statistical significance; 0 < p < 0.78), thus illustrating the inverse relation between uptake 
and viability.   
Since increasing the number of pulses and increasing the pulse length have similar 
effects (i.e., they both increase the duration of exposure to electroporation), we wanted to 
determine whether single long pulses yielded the same effects as several short pulses 
having the same total exposure time (TET; defined as the product of pulse length and 
number of pulses). Using combinations of pulses having TET of 5 ms, 10 ms, and 20 ms, 
uptake of calcein by both Caco-2 and T84 cells was not found to be statistically different 
at constant TET (Figures 6.4A and 6.4B; one-way ANOVA, p > 0.05 for all TET). 
Similarly, cell viability in both types of monolayers was statistically indistinguishable at 
the same TET (Figures 6.4C and 6.4D; one-way ANOVA, p > 0.05 for all TET). 
 
 
6.3  Discussion 
6.3.1  Dependence of Uptake on Pulse Voltage, Length, and Number 
Caco-2 and T84 epithelial monolayers were electroporated using a range of 
voltages, pulse lengths, and pulse numbers. Quantification of molecular transport and cell 






Figure 6.4  Intracellular uptake of calcein (A,B) and cell viability (C,D) were similar for 
the same total exposure time to electroporation (TET; defined as the product of pulse 
length and number of pulses).  Data are replotted from Figure 5. Pulse lengths were 1 ms 
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increasing voltage and pulse length, reaching levels up to 107 molecules per cell.  It was 
also observed that uptake tends to decrease at higher voltages (> 100 V) and/or longer 
pulses (>10 ms). One possible reason for this could be the low number of cells surviving 
at these conditions (< 20%), which could lower the resulting average uptake in the cells.  
It is also possible that electroporation, which is size dependent, killed off the larger, more 
easily electroporated cells, leaving the more difficult to electroporate small cells. Since 
the smaller cells would not hold as much of the marker molecules, uptake would be 
decreased. 
Multiple pulse experiments indicated that the total ‘on time’ of a pulse determined 
levels of uptake and viability, independent of whether that ‘on time’ was achieved 
through a single long pulse or multiple shorter pulses (Figure 6.4). In contrast, results 
from multiple pulse experiments conducted with prostate cancer cells in suspension 
reported by Canatella et al. (2001) showed more uptake and lower cell viability when 
single long pulses were applied than when several short pulses were applied. This 
difference may be due to differences in cell type, suspension versus monolayer 
configuration, or error bars that may obscure small variations in the measurements. 
 
6.3.2  Sub-equilibrium Uptake of Molecules 
The number of molecules delivered per cell should be thermodynamically limited 
to an intracellular concentration in equilibrium with (i.e., equal to) the extracellular 
concentration, which was 100 µM for calcein and 10 µM for BSA. Based on 
measurements of cell dimensions using multiple x-y sections of 10 cells and 10 nuclei 
chosen randomly from different confocal micrographs, cell volumes were estimated as 
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2500 ± 400 µm3 and 1600 ± 200 µm3 for Caco-2 and T84 cells, respectively, and nuclear 
volumes as 2000 ± 1000 µm3 and 760 ± 200 µm3 for Caco-2 and T84 cells, respectively.  
According to these measurements, the volume of the nucleus makes up a significant 
portion of the cell volume. This result is supported by additional observations of these 
cells in microscopy images collected during the course of these experiments (not shown) 
and in images published by others (Madara et al., 1987; Lu et al., 1996). 
Using these volumes, intracellular concentrations of calcein and BSA were 
calculated.  When the intracellular concentration equals the extracellular concentration, 
maximum calcein uptake (100 µM) should occur at 1.5 x 108 molecules per Caco-2 cell 
and 9.4 x 107 molecules per T84 cell and maximum BSA uptake (10 µM), assuming 
nuclear exclusion, should occur at 3.3 x 106 molecules per Caco-2 cell and 4.9 x 106 
molecules per T84 cell.  Inspection of Figure 6.1 indicates that although large numbers of 
molecules were delivered, uptake of neither calcein nor BSA reached its maximum value. 
Uptake was usually 1-2 orders of magnitude below equilibrium, which is consistent with 
previous quantitative measurements of uptake by cells electroporated in suspension 
(Canatella et al., 2001). 
  
6.3.3  Choosing an Optimal Electroporation Condition 
The choice of an optimal electroporation condition will depend on the application 
for which it is being used.  Most applications will require efficient delivery of a molecule 
of interest while minimizing cell death. Typically, the goal would be to alter or restore 
the functional processes of living cells. In such cases, short, low voltage pulses (e.g., 50 
V, 1-10 ms) should be most effective. If cell death is not a concern, and more extensive 
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uptake by the surviving fraction of cells is needed, then much stronger electroporation 
conditions could be used.   
 
6.4  Conclusions 
 
Electroporation of polarized intestinal epithelial monolayers was demonstrated for 
the first time, showing that intestinal epithelial monolayers can be electroporated to 
induce extensive uptake of extracellular, membrane-impermeant molecules, including 
proteins.  In both Caco-2 and T84 cell lines, uptake increased and cell viability decreased 
with increasing pulse voltage, length, and number.  When total exposure time was kept 
constant, however, neither uptake nor viability changed significantly. The results of these 
experiments suggest the feasibility of using electroporation to deliver drugs, proteins, and 




7.  PHYSICAL AND FUNCTIONAL RECOVERY OF MONOLAYERS AFTER 
ELECTROPORATION 
 
7.1  Introduction 
Electroporation is very proficient at introducing molecules into cells, but it can 
also cause significant cell damage and death.  When working with polarized intestinal 
epithelial monolayers, it is important that the monolayers are confluent so that they 
function like in vivo epithelium. To help maintain this barrier, epithelial monolayers are 
comprised of proliferating cells that can repair small injuries and the possible damage 
caused by electroporation (Lacy, 1988). Transepithelial electrical resistance (TEER), a 
measurement of the epithelial resistance to the flow of current, is regularly used as an 
index of monolayer health and integrity (Shaw, 1996b). In this study, the recovery 
kinetics of transepithelial resistance after electroporation were monitored to determine 
which conditions permitted rapid recovery and which caused long-term injury.   
 
 
7.2  Experimental Results 
7.2.1  Physical Recovery of Intestinal Epithelial Monolayers after Electroporation 
Figures 7.1A and 7.1C show the long-term recovery of Caco-2 monolayer 
resistance after electroporation at a “mild,” “moderate,” or “strong” condition (see 
Section 4.4.1). There was an initial drop in TEER immediately after each pulse, which 




Figure 7.1  Kinetics to restore barrier integrity of monolayers in the first 24 hours (A,B) 
and 14 days (C,D) after electroporation. Caco-2 (A,C) and T84 (B,D) monolayers were 
electroporated under mild ( ), moderate ( ), and strong ( ) electroporation conditions 
(see Materials and Methods section). Monolayer integrity was measured using 
transepithelial electrical resistance (TEER) of the monolayers, which was normalized 
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Mildly electroporated monolayers (uptake ~ 2 x 105 calcein molecules per cell, mpc, 
viability ~ 81%; see Figure 3) were able to recover their original resistance in less than 6 
hours. Moderately electroporated monolayers (uptake ~ 2 x 106 mpc, viability ~ 71%) 
recovered within a day. Finally, strongly electroporated monolayers (uptake ~ 4 x 106 
mpc, viability ~ 44%) did not recover their initial resistance until more than a week later. 
Figures 7.1B and 7.1D show the recovery of electroporated T84 monolayers, 
which behaved similarly to the Caco-2 monolayers. For mild electroporation (uptake ∼ 3 
x 106 calcein mpc, viability ∼ 98%), T84 monolayers recovered their initial resistance in 
24 hours. Monolayers that were moderately electroporated (uptake ∼ 5 x 106 mpc, 
viability ∼ 75%) recovered within a few days, and those that were strongly electroporated 
(uptake ∼ 9 x 106 mpc, viability ∼ 47%) required more than a week to recover. T84 
recovery rates were slower than Caco-2 rates probably because of their longer doubling 
time, i.e., 60 h for T84 cells versus 30 h for Caco-2 cells (Dharmsathaphorn and Madara, 
1990; Gres et al., 1998). Together, these recovery experiments show that on the order of 
106 molecules per cell can be delivered under mild to moderate electroporation conditions 
into monolayers that require hours up to one day to fully recover barrier integrity, which 
is an indicator of good tissue function and health.  
 
7.2.2  Functional Recovery of T84 Monolayers After Electroporation 
Interleukin-8 (IL-8), a pro-inflammatory cytokine, is secreted by injured cells as 
part of the stress response, thus, in a companion study the measurements of the secretion 




Figure 7.2  Electroporation induces a temporary inflammatory response. T84 monolayers 
were exposed to no ( ), mild ( ), moderate ( ), or strong ( ) electroporation. (A) IL-8 
secretion by the monolayers increased with time after electroporation. (B) When 
secretion is plotted as a rate of secretion, the rate increases to maximum at 4 hrs and then 
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monolayers were not included in this study because they secreted IL-8 at levels below the 
detection limit of the assay. Figure 7.2A depicts the concentration of IL-8 secreted after 
electroporation of the monolayers used in the resistance recovery experiments shown in 
Figure 7.1. IL-8 secretion increased after treatment, indicating the presence of necrotic 
cells in the monolayers, which triggered the induction of an inflammatory response in 
neighboring cells.  However, when the data is replotted as the rate of IL-8 secretion 
(Figure 7.2B), the rate of IL-8 secretion increased to a peak at 4 hours after 
electroporation and then decreased over time until the rate reached basal levels 12 hours 
later.  Secretion did not depend on the strength of the electroporation condition applied 
(ANOVA; p = 0.78). 
 
 
7.3  Discussion 
7.3.1  Physical Recovery 
When coupled with the molecular uptake studies discussed in Chapter 6, 
monolayer recovery experiments showed that even under relatively mild electroporation 
conditions (~50 V), monolayers were able to take up many thousands to millions of 
molecules per cell and still recover barrier properties within hours. This ability to take up 
molecules and then recuperate quickly should be useful for laboratory studies of 
gastrointestinal inflammation or other intestinal conditions. For example, one could 
electroporate an experimental drug or protein into an epithelial monolayer, wait 1 - 2 
days and then carry out tests to evaluate the resulting effects on monolayer function. 
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There are also potential clinical applications for electroporation of epithelia, e.g., 
treatment of intestinal disorders by introduction of drugs, proteins, or genes.  Although 
electroporation causes some temporary cell damage, it might still be useful clinically as 
long as the epithelium is able to recover and regain confluence relatively quickly.  When 
superficial wounds to the epithelial lining of the intestinal wall naturally occur in the 
body due to physical injury, microorganisms, or other agents, cells adjacent to the wound 
quickly dedifferentiate and migrate to cover the exposed area as illustrated in Figure 7.3 
(Lacy, 1988; Dignass, 2001).  This frequent and natural healing process, called 
restitution, occurs within minutes to hours in both in vivo epithelium and cultured 
epithelium (Moore et al., 1989; Nusrat et al., 1992; Nusrat et al., 1997) and serves to 
maintain the barrier necessary to protect the body from the external environment. The 
electroporation conditions from which monolayers recovered in less than 24 hours in this 
study may similarly permit rapid resealing of epithelia in vivo.   
 
7.3.2  Underestimation of Cell Viability by Flow Cytometry 
Although measures of cell viability from flow cytometry experiments have been 
provided (e.g., Figures 6.1, 6.3, 6.4), we believe these may overestimate the loss of cell 
viability. For example, fluorescence imaging of intact electroporated monolayers show 
far fewer dead cells (by PI staining) than what is observed by flow cytometry analysis of 
cells dissociated from similarly treated monolayers (images not shown). Moreover, 
monolayer resistance measurements made just after electroporation at mild to moderate 
conditions show drops to at most 50% (Caco-2) or 20% (T84) of pre-electroporation 






Figure 7.3  Illustration of the process of restitution in an intestinal epithelial monolayer. 
When cells are lost due to injury or natural death, nearby cells flatten and migrate into the 
exposed area. They then differentiate back into their original polarized form. 
Physical/chemical






junctions between cells are disrupted (Liu et al., 2000; Ma et al., 2000), and do not 
require killing of large numbers of cells.  If up to 30% of the cells in the monolayer were 
destroyed, as flow cytometry measurements under the same conditions estimated, then 
based on cell doubling times (60 h for T84 cells and 30 h for Caco-2 cells 
(Dharmsathaphorn and Madara, 1990; Gres et al., 1998)), the process of replicating new 
cells to regain confluence should have required more than the 24 hours observed.  
 For these reasons, we believe that cell viability losses calculated using flow 
cytometry are overestimated probably due to monolayer dissociation and artifacts of 
preparing cells for flow cytometry analysis.  Although viabilities were determined by 
comparing to unelectroporated controls, cells that have been electroporated could be 
more fragile and, thus, more likely to be adversely affected by the trypsin and physical 
treatments used to dissociate the monolayers. Since it appears that the cells are better able 
to recover when left in monolayer form, transepithelial resistance may be a more useful 
indicator of monolayer viability than flow cytometry measurements. 
 
7.3.3  Functional Recovery 
Experiments showed that electroporation induces an inflammatory response in T84 
monolayers by causing an increase in IL-8 secretion. This is to be expected since 
electroporation is a form of injury to the cells. Fortunately, the response is temporary and 
the cells appear to return to normal, at least in this respect, within 12 hours.  It is 
understood that IL-8 is only one of many markers that could be used to assay functional 
recovery of the monolayers after electroporation, but it is an especially useful one since it 
relates to our interest in inflammation. In addition, the information about the effect of 
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electroporation alone on IL-8 secretion, aided our interpretation of results from later 
experiments involving the same IL-8 system (Chapter 10). 
 
 
7.4  Conclusions 
Intact intestinal epithelial monolayers electroporated with mild, moderate, and 
strong conditions experienced a loss of resistance and tissue barrier function that 
recovered at different rates depending on the cell line and the strength of the condition 
applied. For some conditions, monolayers were able to recover physically in less than a 
day. Electroporation was found to induce a temporary inflammatory response (increased 
secretion of IL-8), but cells were able recover normal function within 12 hours. These 
experiments will help identify conditions that would be useful for delivering molecules, 




8.  TRANSPORT OF MOLECULES ACROSS MONOLAYERS AFTER 
ELECTROPORATION 
 
8.1  Introduction 
Oral administration is the most common method of drug delivery used today. Drugs 
administered in this fashion must be absorbed across the gastrointestinal barrier before 
entering the systemic circulation and acting on their target (Foye et al., 1995).  While 
many drugs are absorbed fairly easily, others may have poor oral bioavailability because 
of first pass metabolism in the GI tract or poor absorption across the intestinal epithelial 
barrier (Brody et al., 1998). This is especially true for larger molecules, such as proteins. 
To address this problem, many researchers modify the physical characteristics of the 
drug, e.g., charge, polarity, lipid solubility, pH sensitivity, etc., to aid absorption (Langer, 
1998).  
As an alternative to modifying the drug to increase absorption, the barrier function 
of the intestinal epithelium itself could be altered. Experiments conducted to test this 
possibility were conducted by Leonard et al. (2000a) who used an electrically-based 
technique similar to electroporation, called iontophoresis (Banga et al., 1999), to increase 
the paracellular transport of several compounds across intact Caco-2 monolayers. Since 
the Caco-2 line is the most widely used cell line for drug absorption studies (Palm et al., 
1999; Artursson et al., 2001; Krishna et al., 2001) and since transport across these cells 
has been shown to correlate fairly well with in vivo intestinal permeability (Artursson and 
Karlsson, 1991; Rubas et al., 1995; Rubas et al., 1996; Yee, 1997; Yamashita et al., 
2000), it was chosen for our studies. 
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This study was conducted o determine whether, in addition to being able to 
introduce molecules into the cells of the monolayer, electroporation could increase 
transport across the cells. To answer this question, intact Caco-2 monolayers were 
electroporated at various conditions with either the small molecule, calcein, or the 
macromolecular protein, BSA, and monitored for changes in transepithelial permeability.     
 
 
8.2  Experimental Results 
8.2.1  Increase in Epithelial Permeability after Electroporation 
In initial experiments, confluent Caco-2 monolayers were treated with the mild 
(50 V – 1 ms) and moderate (50 V – 10 ms) electroporation conditions used in the 
monolayer recovery experiments described in Chapter 7.  The rate of appearance of 
calcein in the basal compartment was monitored. The inset of Figure 8.1 shows the steady 
increase in calcein accumulation for the first three hours. The main graph in Figure 8.1 
shows that electroporation increases the apparent permeability (Papp) of confluent Caco-2 
monolayers to calcein. Permeability tended to increase with the strength of the 
electroporation condition applied, although not with statistical significance (p = 0.37). 
When compared to the permeability of the unelectroporated monolayers (1.9 ± 0.4 x 10-7 
cm/s), the monolayers electroporated with the mild pulse (2.7 ± 0.7 x 10-7 cm/s) and 
moderate pulse (3.4 ± 1.3 x 10-7 cm/s) had p-values of 0.10 and 0.07, respectively. 




Figure 8.1  Apparent permeability of confluent Caco-2 monolayers to 100 µM calcein 
after treatment with mild (50 V – 1 ms) and moderate (50 V – 10 ms) electroporation 
conditions.  Although permeability appeared to increase with the strength of the condition 
applied, the difference between the two conditions was not statistically significant (p = 
0.37). Monolayers were monitored for 6 hours after electroporation. Unelectroporated 
monolayers served as controls.  Inset: Representative plot of calcein accumulation (nmol) 
in basal compartment for the first 3 h after electroporation. Accumulation was relatively 
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42% and 81% over the controls, respectively.  
 Although the results in Figure 8.1 show that electroporation increases transport 
across the monolayer, this increase was, at most, only twice that of the control.  To 
determine whether a further increase in permeability could be obtained, ten 50 V - 1 ms 
pulses with an interpulse spacing of 15-20 s were applied to each monolayer.  This 
condition has an effect that is essentially the same as the 50 V – 10 ms pulse (see Section 
6.2.3), but allows more time for diffusion of the markers across the cells between pulses. 
When multiple pulses were applied to a new set of Caco-2 monolayers, the permeability 
to calcein increased 6-fold over that of the single pulse condition (Figure 8.2; p = 0.01).  
Comparisons to the unelectroporated monolayers showed that the single pulse condition 
increased permeability almost 2-fold (p = 0.07), while the multiple pulse condition 
increased it 12-fold (p = 0.03).  These results illustrate that, when the total exposure time 
is kept constant, multiple pulses are more efficient than single pulses at increasing 
intestinal epithelial permeability.  
 
8.2.2  Dependence of Epithelial Permeability on Molecular Size 
After determining that electroporation could significantly increase the 
permeability of intestinal epithelial monolayers, the dependence of permeability on the 
size of the molecule being transported was evaluated.  In the next set of experiments, a 
modification was made in the protocol. Initially, unelectroporated monolayers were 
monitored for permeability alongside the treated monolayers. This made it difficult to 
make comparisons between the two sets of monolayers because of the uncertainty about 




Figure 8.2  Transepithelial transport of calcein is significantly higher after treatment with 
multiple pulses versus a single pulse, when total exposure time (TET) is held constant. 
When TET = 10 ms, Caco-2 permeability was 12 times higher than the unelectroporated 
controls (n = 4) after the multiple pulse condition (n = 4; p = 0.03) and only 2 times 
higher after the single pulse condition (n = 6; p = 0.07).  The multiple pulse condition 
was 6 times higher than the single pulse condition (p = 0.01). Monolayers were treated 
with 100 µM calcein and either one 50 V – 10 ms pulse or ten 50 V – 1 ms pulses and 





























those of the controls. To address this issue, each monolayer served as its own control.  
Baseline permeabilities were monitored for three hours prior to electroporation and then 
the monolayer was treated and monitored for an additional three hours.   
Caco-2 monolayers incubated with 10 µM apical solutions of calcein (radius = 0.6 
nm) or FITC-labeled BSA (radius = 3.5 nm) were electroporated with ten 50 V – 1 ms 
pulses and monitored for an increase in permeability.  Table 8.1 and Figure 8.3 shows 
that for both molecules, electroporation induced an increase in permeability over the 
baseline permeability.  For some individual monolayers, permeability increased as much 
as 20-fold for both molecules, but the average increase for all monolayers was 
approximately 8-fold for calcein and 7-fold for BSA (Table 8.1).  Transport across the 
monolayers was found to be size dependent since permeability to calcein was 12 - 13 
times higher than permeability to BSA for both unelectroporated and electroporated 
monolayers (Table 8.1).  
 
 
Table 8.1 Permeabilities of unelectroporated and electroporated confluent Caco-2 
monolayers to calcein and BSA.a   
 














Calcein 623 0.6 3.43 ± 2.10 25.6 ± 14.9 7.5 0.000 
BSA 66,000 3.5 0.28 ± 0.22 1.92 ± 0.83 6.8 0.001 
Calcein:BSA     12.1 13.4   
p-value**   0.002 0.002   
 
a Tabulation of the results from Figure 8.3. 
b Calcein: n = 12; BSA: n = 6 
d Monolayers were electroporated with ten, 50 V – 1 ms pulses. 
* Comparison between unelectroporated and electroporated monolayers. 




Figure 8.3  Comparison of permeability to calcein and BSA for unelectroporated ( ) and 
electroporated ( ) Caco-2 monolayers. For both sets of monolayers, permeability 
increased ~8-fold after electroporation. Permeability to calcein was more than 10-fold 
higher than permeability to BSA. Monolayers were treated with ten 50 V – 1 ms pulses 
and/or 10 µM calcein (radius = 0.6 nm) or 10 µM BSA (radius = 3.5 nm). All 
experiments were carried out at 37°C. Data plotted on a log scale to make the increase in 




























For comparison, the permeabilities of ethanol-fixed monolayers to calcein and 
BSA were measured to establish the highest permeability that could be achieved while 
the cells were still present on the filter support. Figure 8.4 shows that after exposure to 
95% ethanol, which permeabilizes cells and opens tight junctions (Ma et al., 1999), 
permeability to calcein was 1.13 ± 0.06 x 10-5 cm/s, an ~30-fold increase over pre- 
electroporation monolayer permeability (p < 0.0001) and a 4-fold increase over post-
electroporation monolayer permeability (p < 0.0001).  Permeability to BSA after ethanol 
fixation was 1.93 ± 0.07 x 10-6 cm/s, which was about 70-fold higher than pre-
electroporation levels (p < 0.0001) and 10-fold higher than post-electroporation levels (p 
< 0.0001). The difference between calcein and BSA was about 6-fold (p < 0.0001). These 
results show that although electroporation increases transepithelial permeability, it does 
not increase permeability to its fullest extent. 
In another comparison, the experimentally determined permeabilities of empty 
filters and collagen-coated filters to calcein and BSA were measured to aid the analysis of 
the contribution of the different barriers to transport to the permeabilities observed for the 
monolayers (see next section). The results of these experiments are represented in Figure 
8.5 and tabulated in Table 8.2. The permeabilities of unelectroporated, electroporated, 
and ethanol (EtOH) fixed monolayers to the two solutes (previously discussed) have been 
included in the figure and the table for comparison.  It should be noted that permeability 
across collagen-coated filters may not be a true representation of permeability across the 
extracellular matrix, which is synthesized by the cells as they grow in culture and is 





Figure 8.4  Apparent permeability of ethanol-fixed monolayers to calcein and BSA.  
Results from Figure 8.3 have been replotted for comparison. Caco-2 monolayers were 
treated with 95% ethanol (EtOH) for 20 minutes at -20°C and then monitored at 37°C for 
calcein and BSA transport to determine the highest permeability possible with the cells 
still present on the membrane. The resulting permeabilities of the ethanol-fixed 
monolayers to calcein and BSA were approximately 4-fold and 10-fold higher than 
electroporated monolayers, respectively. Data plotted on a log scale to make the 






































Figure 8.5  Calcein and BSA permeability comparisons for different experimental 
configurations.  Permeability across empty and collagen-coated cell culture filter inserts 
with 0.4 µm pores was measured for both marker molecules and will be used to 
determine whether they acted as barriers to transport. Permeability across the collagen-
coated filter was significantly lower than the empty filter, probably because of reduced 
transport of the molecules between the collagen fibers. Permeabilities for the ethanol-
fixed, unelectroporated, and electroporated monolayers have been included for 
































Table 8.2  Solute properties and experimentally measured permeabilities for calcein and 
BSA under different experimental configurations. 
 Solute Properties 
 Calcein BSA 
Solute Radius, nm 0.6 3.5 
Diffusivity (@ 37°C), cm2/s 5.4 x 10-6 9.3 x 10-7 
 Permeability, Papp  
(x 10-6 cm/s) 
Empty filter 34.8 ± 0.92 21.0 ± 1.90 
Collagen-coated filter 24.1 ± 4.41 10.7 ± 1.47 
EtOH fixed monolayer 11.3 ± 0.62 1.93 ± 0.078 
Electroporated monolayer 2.56 ± 1.49 0.19 ± 0.083 
Unelectroporated monolayer 0.34 ± 0.21 0.028 ± 0.022 
  All experiments at 37°C. 
 
 
accurate to carefully remove the cells, leaving the matrix behind, and then measure 
permeability, which could be less than that for filter coated with just collagen. 
 
 
8.2.3  Delineating Barriers to Transport 
The permeability values reported here are termed apparent permeabilities (Papp) 
because they are not just the permeabilities of the monolayer, but also include the 
permeabilities of other barriers to transport. The aqueous boundary layers (ABL), which 
are regions of low mixing adjacent to the apical surface of the monolayer and the basal 
surface of the filter, the collagen matrix used to coat the filter, and the filter support itself 
can all impede transport (Figure 8.6). Thus, it is necessary to determine to what extent 
these additional barriers to transport contribute to the permeabilities obtained. 
If each of the transport barriers are considered to be resistances (R) in series, then 







Figure 8.6 Illustration depicting the various barriers to transport that could affect the 
permeability of calcein and BSA across intestinal epithelial monolayers.  The resistances 
associated with the aqueous boundary layers (ABL), the porous filter of the cell culture 






















+++=  (8.2) 
where Papp is the experimentally measured permeability of the monolayer. To find the 
actual permeability of the monolayer, Pmonolayer, the values of each of the other terms in 
the equation must be determined. 
The permeability of the filter, Pfilter, can be determined based on the physical 
properties of the filter obtained from the manufacturer and is typically calculated using 















π  (8.3) 
where  
N = pore density = 4 x 106 pores/cm2 
R = pore radius = 0.2 µm 
hf = filter thickness = 10 µm 
r = solute radius  
D = diffusivity of the solute (cm2/s) 
 
 F(r/R) is the Renkin function, a molecular sieving function for cylindrical channels 














































rF  (8.4) 
For r<<R, which is the case for both calcein and BSA, F(r/R) ≈ 1. The diffusivity of the 








=  (8.5) 
where at 37°C 
k = Boltzmann’s constant, 1.38 x 10-16 erg/K 
T = absolute temperature = 310 K 
µ = solvent (water) viscosity = 0.007 poise 
r = solute radius [=] cm 
 
 
Using this equation, the diffusivities of calcein (r = 0.6 nm) and BSA (r = 3.5 nm) were 
calculated to be 5.4 x 10-6 cm2/s and 9.3 x 10-7 cm2/s, respectively. Inserting these 
diffusivity values into Eq. 8.3 yielded theoretical permeabilities of 2.72 x 10-5 cm/s and 
4.67 x 10-6 cm/s across empty filters with 0.4 µm pores for calcein and BSA, 
respectively.  
 Although the monolayers were kept on an orbital shaker during the course of each 
experiment to minimize the effect of the ABL, it is possible that there may be small 
effects on filer permeability that would need to be accounted for.  To determine the 













since, in the case of the empty filter, only the filter and the ABL should contribute to the 
permeability. Pfilter+ABL, the total apparent permeability of the empty filter, was 
experimentally measured to be 3.48 ± 0.09 x 10-5 cm/s for calcein and 2.10 ± 0.19 x 10-5 
cm/s for BSA. These values were significantly higher than the filter permeabilities (Pfilter) 
calculated using Eq. 8.3, Pfilter = 2.72 x 10-5 cm/s for calcein and 4.67 x 10-6 cm/s for 
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BSA. Consequently, calculation of the permeability of the ABL, PABL, was made difficult 
since negative values were obtained.  While the shaking may have increased permeability 
by decreasing the ABL resistance, it is also possible that there was some convective flux 
of the calcein and BSA solutions through the pores of the filter.  
When the filters were coated with collagen, the measured permeability to calcein 
(2.41 ± 0.04 x 10-5 cm/s) and BSA (1.07 ± 0.15 x 10-5 cm/s) dropped by 30% and 50%, 
respectively, when compared to the empty filter (Figure 8.5; Table 8.2). The decrease is 
probably due to the collagen fibers, which would impede diffusion of the molecules 
across the filters. The permeability across the collagen matrix alone, Pcollagen, can be 













Instead of using the Pfilter determined with Eq. 8.3, which resulted in a negative 
collagen permeability value for BSA, the measured permeabilities of the empty filters for 
both calcein and BSA were used in Eq. 8.7. Using the appropriate values, the 
permeability of the collagen alone, Pcollagen, was calculated to be 7.84 x 10-5 cm/s for 
calcein and 2.17 x 10-5 cm/s for BSA.  When the resistance of the collagen (1/Pcollagen,) 
was divided by the total resistance of the collagen coated filter (1/Pcollagen+filter), the 
collagen matrix was found to account for 30% of the resistance to calcein transport and 
50% of the resistance to BSA transport across the coated filter.  This means in cell-free, 
collagen-coated filters, the filter is the most important barrier to transport of calcein and 
for BSA, the filter and collagen contribute equally to resistance. 
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 The permeability of unelectroporated and electroporated monolayers to calcein 











−−=  (8.8) 
 
where Papp is the experimentally measured total permeability of the Caco-2 monolayers to 
calcein and BSA (see Table 8.2), Pcollagen is the permeability of the collagen matrix to 
calcein (7.84 x 10-5 cm/s) and BSA (2.17 x 10-5 cm/s), and Pfilter is assumed to be the 
same as the measured permeability across the empty filter (3.48 ± 0.09 x 10-5 cm/s for 
calcein and 2.10 ± 0.19 x 10-5 cm/s for BSA). Using Eq. 8.8, the permeabilities of the 
unelectroporated monolayers, Pmonolayer, were calculated to be 3.48 x 10-7 cm/s for calcein 
and 2.84 x 10-8 cm/s for BSA.  For the electroporated monolayers, Pmonolayer was 
calculated to be 2.87 x 10-6 cm/s for calcein and 1.95 x 10-7 cm/s for BSA.   
In each case, the true permeability of the monolayer was slightly higher than the 
total permeability that was experimentally measured, which indicated that the filter and 
collagen matrix may have provided some resistance to transport. To determine the extent 
each barrier contributed to the permeabilities of unelectroporated and electroporated 
monolayers, the resistance (1/P) of each barrier, e.g., filter, collagen, monolayer, was 
divided by the total resistance (1/Papp).  Table 8.3 shows the results of these comparisons. 
For the unelectroporated monolayers, the filter support and collagen provided very little 
resistance to calcein (≤ 1%) and BSA transport (0.1%), while the monolayer resistance 
accounted for ~99% of the resistance to transport. When the monolayers were 
electroporated, the resistance contribution of the filter and collagen coating increased for 
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both calcein (7% and 3%) and BSA (~1%) but, again, the monolayer was the dominant 
barrier to transport.  
 
Table 8.3 Delineation of permeabilities across unelectroporated and electroporated Caco-
2 monolayers and the contribution of each barrier to transport to overall permeability.  
 
  Calcein  BSA 
  Permeability % Resistancea Permeability 
% 
Resistancea 
Unelectroporated Papp* 0.343 (0.21)  0.0283 (0.022)  
 Pcollagen 78.4 0.4 21.7 0.1 
 Pfilter* 34.8 (0.92) 1.0 21.0 (1.90) 0.1 
 Pmonolayer 0.348 98.6 0.0284 99.6 
Electroporated Papp* 2.56 (1.49)  0.192 (0.083)  
 Pcollagen 78.4 7.4 21.7 0.9 
 Pfilter* 34.8 (0.92) 3.3 21.0 (1.90) 0.9 
 Pmonolayer 2.87 89.2 0.195 98.5 
All permeability values have units of 10-6 cm/s. Where applicable, standard deviations are in parentheses. 
a % Resistance values may not add up to 100% because of rounding. 
* Experimentally measured 
 
 
8.2.4  Monitoring TEER of Monolayers during Permeability Studies 
Since transepithelial permeability is directly related to the integrity of the 
monolayers, the transepithelial electrical resistances (TEER) of all monolayers were 
monitored during the course of each permeability experiment. Figure 8.7 shows the 
TEER of Caco-2 monolayers, which were measured each hour for the three hours prior to 
and after electroporation.  During the 3 hour period when baseline permeability was 
measured for the unelectroporated monolayers, TEER was initially ~700 Ω-cm2 and then 
dropped to a constant level of about 500 Ω-cm2 over the next three hours.  TEER values 




Figure 8.7  Monitoring transepithelial electrical resistance (TEER) of confluent Caco-2 
monolayers during permeability studies. Resistance was measured each hour for three 
hours before and three hours after electroporation Post-electroporation resistance was 
approximately 60% lower than pre-electroporation resistance and remained relatively 
constant (p > 0.05). Resistance measurements at t = 0 hr, which were made immediately 
before and after electroporation, are elevated because of the dependence on temperature 
(see text). If measurements had been taken for a longer period time after electroporation, 



































The resistance was initially high because of its dependence on temperature. 
Although monolayers were incubated at 37°C prior to starting the experiment, the pre-
electroporation measurements made at t = 0 hr were usually made after the fluorescent 
marker solution had been added, by which time the monolayers had cooled to room 
temperature. This resulted in elevated resistance values. Subsequent measurements made 
after the monolayers were returned to the incubator are more indicative of the true 
resistances of the monolayers.  
Just after electroporation, the resistance was initially a little over 500 Ω-cm2 and 
then dropped and maintained levels ranging from about 300 to 350 Ω cm2 in the three 
hours after electroporation. Again, the initial post-electroporation resistances were higher 
than subsequent measurements because the monolayers cooled to room temperature 
during the electroporation procedure. For the measurements taken 1 – 3 hours after 
electroporation, the resistances were not statistically different from each other (p = 0.62).   
When the post-electroporation resistances were compared to the pre-
electroporation resistances, the former were found to be about 60% - 75% of the latter (p 
< 0.0001). This indicated that the monolayers did not completely recover their initial 
TEER values, which would explain why permeability did not ultimately decrease with 
time. Based on our previous experience with monolayer recovery after electroporation 
(Chapter 7), it is likely that an increase in resistance, coupled with a decrease in 
permeability, would have been observed if measurements had been taken for longer than 




8.2.5  Modulating Paracellular Permeability of Caco-2 Monolayers 
For most hydrophilic molecules, transport across the intestinal epithelium occurs 
in the paracellular space between the cells and is regulated by the tight junctions.  Since 
increased paracellular transport may contribute to the increase in permeability observed 
after electroporation, experiments were conducted to determine how much transport 
occurs when the tight junctions are opened.  The role of extracellular calcium in the 
formation and maintenance of tight junctions has been well-documented (Gonzalez-
Mariscal et al., 1990; Ma et al., 2000).  Incubation of epithelial monolayers in a calcium 
free solution has been found to cause a decrease in epithelial resistance and an increase in 
permeability. The increase in permeability was due to contraction of the cytoskeletal 
network and subsequent opening of the tight junctions (Gonzalez-Mariscal et al., 1990; 
Ma et al., 2000). 
In this set of experiments, Caco-2 monolayers were incubated in HBSS without 
Ca2+ and Mg2+ (HBSS-) for the period of time required for the transepithelial resistance 
to drop to approximately half of initial values. At this point, the monolayers were 
switched to calcium supplemented HBSS (HBSS+) and allowed to recover for at least 30 
minutes.  During both time periods, the permeability of calcein across the monolayers 
was monitored. Control monolayers were incubated in HBSS+ for the duration of the 
experiment.   
Figure 8.8 shows the results from two independent experiments conducted to monitor the 
paracellular permeability of calcein across monolayers with opened tight junctions. In 
Experiment #1 (Figure 8.8A), the permeabilities of monolayers in HBSS-  
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Figure 8.8  Effect of extracellular calcium depletion and addition on Caco-2 paracellular 
permeability of calcein.  Two independent experiments were conducted to evaluate 
permeability. Treated Caco-2 monolayers were placed in Ca2+-free HBSS (HBSS-) and 
monitored for up to 20 min (A) or 40 min (B).  They were then switched to Ca2+ 
supplemented HBSS (HBSS+) and monitored further for calcein permeability. Control 
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were initially low (2.35 ± 0.76 x 10-7 cm/s) and only slightly higher than the permeability 
of the control monolayer. After incubation in HBSS- for 20 minutes, the permeability 
increased to a maximum of 3.72 ± 0.004 x 10-6 cm/s, which was a 12-fold increase over 
the permeability of the HBSS+ incubated control monolayer.   At this point, the treated 
monolayers were switched to HBSS+ and within 30 minutes, the permeability returned to 
a level comparable to that of the control monolayer (6.15 ± 2.59 x 10-7 cm/s vs. 8.02 x 10-
7 cm/s).   
In Experiment #2 (Figure 8.8B), a similar trend was observed in that permeability 
of the HBSS- incubated monolayers increased to a maximum of 2.52 ± 0.89 x 10-6 cm/s, 
which was about 4 times higher than that of the HBSS+ incubated control monolayers 
(6.05 ± 0.79 x 10-7 cm/s; p = 0.046).  The time required to reach this maximum, however, 
was twice as long as that observed in the first experiment (40 min vs. 20 min). When the 
treated monolayers were switched to HBSS+, permeability decreased, but, even after 40 
minutes, was still twice as high as the controls (1.69 ± 0.66 x 10-6 cm/s vs. 6.88 ± 1.83 x 
10-7 cm/s; p = 0.11).  Although there is some variability in the results of these 
experiments, averaging the two gives an estimated paracellular permeability of 3.12 ± 
0.85 x 10-6 cm/s for calcein. 
 In a companion study, simultaneous measurements of the transepithelial 
resistance of the Caco-2 monolayers were made during the paracellular permeability 
experiments.  Figure 8.9 shows the changes in TEER that occurred while the monolayers 
were incubated in HBSS- and HBSS+.  In Experiment #1, the TEER for control 
monolayers incubated in HBSS+ remained relatively constant at about 600 Ω-cm2. The 
TEER for control monolayers in Experiment #2 ranged between 500 and 600 Ω-cm2.  In
 
 120
Figure 8.9 Transepithelial resistances of Caco-2 monolayers measured during 
extracellular calcium depletion experiments. Resistances for calcium depleted 
monolayers in both Experiment #1 (A) and Experiment #2 (B) dropped to less than half 
of the control monolayers, which remained in calcium-supplemented HBSS+. Upon 
switching to HBSS+, resistances of monolayers in both experiments increased to within 














































both experiments, the TEER for monolayers incubated in HBSS- dropped to almost 200 
Ω-cm2.  When these monolayers were switched to HBSS+, TEER began to increase 
almost immediately (the rate of increase was slightly faster for Experiment #1) until they 
were ~70 - 80% of control resistances. 
 
8.2.6  Discrepancies in Mole Balances for Permeability Experiments  
When mole balances were performed on the monolayers to ensure that the number of 
moles lost from the apical solution was equal to the number of moles transported into 
and/or across the cells, inconsistencies in the results were found. For some experiments, 
the decrease in the amount of calcein in the donor solution during the course of the 
experiment was higher than the total amount of calcein that accumulated in the receiver 
solution.  This was true for both unelectroporated and electroporated monolayers.  Even 
when electroporated monolayers were analyzed for calcein uptake by flow cytometry, the 
total amount of calcein did not add up. In a few cases, the amount of calcein calculated to 
be in the donor solution at the end of the experiment was higher than the amount of 
calcein present at the beginning of the experiment, but this can probably be attributed to 
the variability associated with having to dilute the apical samples.  
Another factor that could have affected the mole balances of the electroporated 
monolayers could be the cells themselves. Caco-2 cells are known to have efflux 
mechanisms which actively pump foreign material out of the cell and play a role in the 
low absorption of some drugs (Feller et al., 1995; Hidalgo and Li, 1996).  In fact, 
researchers have found that Caco-2 cells pre-loaded with calcein, rapidly transported the 
marker from the cytoplasm (Feller et al., 1995; Fujita et al., 1997). It is also possible that 
 
 122
there could be some type of metabolism of the markers within the cell, especially in the 
case of BSA, which would be prone to degradation by proteases.  
 
8.3  Discussion 
The results presented in this chapter show that electroporation does increase the 
permeability of intestinal epithelial monolayers. However, the mechanism by which 
permeability increases is not easily determined.  As Figure 8.10 illustrates, there are three 
potential pathways via which transport can occur after electroporation. Paracellular 
transport, which occurs between the cells, is the primary route of transport of molecules 
across intact epithelium in vitro and in vivo.  Transcellular transport across the cells is not 
a common route of transport for hydrophilic molecules, but could potentially be enhanced 
by electroporation, which permeabilizes cell membranes.  Finally, since electroporation 
can cause cell death, cells could lift off the membrane and leave gaps through which 
transport could occur (transmonolayer transport). Any, or all, of these pathways could 
play a role in the increased permeability observed after electroporation. 
 
8.3.1  Paracellular Transport 
In Section 8.2.5, when Caco-2 monolayers were incubated in calcium-free HBSS to 
open the tight junctions, the paracellular permeability of the monolayers, Pparacellular, to 
calcein increased to 3.12 ± 0.85 x 10-6 cm/s.  In comparison, the total permeability of 
electroporated Caco-2 monolayers to calcein, Pelectroporation, was determined to be 2.56 ± 








Figure 8.10 Illustration of the various pathways that could play a role in the increase in 
transport observed after electroporation.  Paracellular (between cells), transcellular 
(across cells), and transmonolayer (through holes in monolayer) transport could each 





statistical difference between the two values (t-test; p = 0.60). This means that if 
electroporation disrupted the tight junctions, then paracellular transport could very well 
contribute a great deal to the observed increase in permeability.  
In two separate studies, Ma et al. examined the effects of extracellular calcium 
depletion (2000) and low concentrations of ethanol (1999) on the tight junction barrier of 
Caco-2 monolayers. They observed that the transepithelial resistance of the monolayers 
dropped to 20% of initial values within 10 minutes after calcium removal and to less than 
half of initial values within an hour after ethanol addition. When the monolayers were 
returned to their normal medium, barrier function was completely restored within 2 
hours. In both studies, a concurrent increase in the flux of mannitol, a common 
paracellular tracer molecule, was observed during the period of low resistance, followed 
by a rapid decrease in flux as resistance returned to normal. Leonard et al.  
Leonard et al. (2000a) found that iontophoresis, the application of low level 
currents to transport molecules by electrophoresis, resulted in increased paracellular 
transport of dextrans ranging in size from 4 kDa to 20 kDa and increased TEER.  Within 
40 minutes after the current had been turned off, both permeability and TEER returned to 
pre-treatment values. These, and the findings of Ma et al., are in good agreement with the 
permeability and resistance results obtained in our experiments with extracellular calcium 
depletion (Figures 8.8-8.9), where we saw an increase in Caco-2 permeability to calcein 
20-40 minutes after calcium removal and a subsequent decrease in permeability back to 
control levels in as little as 30 minutes after calcium addition.   
As will be discussed in Section 8.3.3, when calcein and BSA transport was 
monitored after electroporation, the rate of transport for the two markers showed no sign 
 
 125
of decreasing, even after three hours.  In addition, resistance of the electroporated 
monolayers remained slightly lower than controls for the duration of the experiments 
(Fig. 8.7).   Unless electroporation damages the cells or tight junctions in such a way that 
long-term opening of junctions results, which cannot be determined based on existing 
results, the evidence suggests that another pathway may also be involved in enhancing 
the permeability of the monolayers.  
 
8.3.2  Transcellular Transport 
Transcellular transport, which occurs across the cells, would likely be most evident 
immediately after electroporation. Because of the direction of the electric field and the 
orientation of the cells, electroporation causes the formation of pores at the apical and 
basal membranes of the cells. Ten 1-ms pulses were applied to each monolayer and, 
because of a limitation of the pulsing machine, the spacing between each pulse was about 
15 s.  This means that transport could be driven by electrophoresis during the pulses and 
by diffusion between the pulses.  If transport occurred during electroporation through the 
porated apical membrane, across the cell, and then out of the basal membrane, then some 
amount of the marker molecule would be present in the basal chamber of the cuvette 
immediately after pulsing.  
To determine whether this could be the case, the fluorescence intensities of 
samples collected from the basal compartment immediately after electroporation (within 
30 sec of last pulse)  were compared to basal samples of unelectroporated control 
monolayers at time t = 0 for both calcein and BSA (Figure 8.11). Although calcein 





Figure 8.11 Fluorescence intensities of basal samples collected from unelectroporated 
and electroporated monolayers immediately after treatment (t = 0 min) and 30 minutes 
after treatment. Transcellular transport of calcein and BSA after electroporation was 
assumed to be negligible since there was no significant difference in the basal sample 
fluorescence of control and electroporated monolayers (p > 0.05; n = 6-12). Additionally, 
the relatively short lifetime of electropores (1 or 2 minutes) precludes their involvement 
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higher than the controls, it was not statistically significant (p = 0.08). The difference 
between the basal sample intensities for the control monolayers and treated monolayers 
was not significant for BSA as well (p = 0.08). In addition, the fluorescence intensities 
increased by two orders of magnitude for calcein and by an order of magnitude for BSA 
during the 30 minute period following electroporation. This increase in fluorescence 
cannot be explained by transport through pores formed after electroporation, since 
electropores do not stay open longer than a minute or so (Chang et al., 1992). Based on 
these results, transcellular transport of calcein and BSA after electroporation was 
assumed to be negligible.  
 
8.3.3  Transmonolayer Transport 
Transmonolayer transport, or transport through holes left by shedding cells,  is 
more difficult to quantify. If dead cells lift off during the course of the permeability 
experiment, estimating the size and number of gaps in the monolayer is not an easy task, 
especially if only one or two cells lift off randomly around the monolayer. Nevertheless, 
some of the unelectroporated and electroporated monolayers were checked at the end of a 
full permeability experiment for any obvious holes or gaps. The monolayers were washed 
and fixed with ethanol and then treated with the nuclear stain propidium iodide to aid 
identification of the cells.  
Figure 8.12 shows two sets of representative control monolayers (A-B) and 
electroporated monolayers (D-E) at the end of a permeability experiment.  Each 
monolayer was visually scanned in its entirety and imaged at the lowest magnification so 





Figure 8.12 Propidium iodide staining of fixed unelectroporated (A-B) and electroporated 
(C-D) Caco-2 monolayers at the end of permeability studies. To determine whether there 
were large holes present in the monolayers that could result in transmonolayer transport 
of calcein, cells were fixed with ethanol and then incubated with 10 µg/ml of propidium 
iodide to stain all nuclei and aid identification of cells.  Small holes, or gaps, (identified 
by white arrows) were evident in both control monolayers and electroporated 





and electroporated monolayers, which indicates that there was not a significant amount of 
cell death. There were small dark areas that could represent locations where cells had 
lifted off. However, these gaps (indicated by white arrows) were found in control and 
electroporated monolayers, which makes it difficult to say whether there were actual 
holes in the monolayer or just regions where the nuclei were more widely spaced.  
There is some additional supporting evidence that cells may have detached from 
the monolayer. Figure 8.13 shows the results of four independent experiments in which 
the transport of calcein and BSA across three Caco-2 monolayers was monitored over 
time before and after electroporation. Before electroporation occurred at time t = 0 h, the 
accumulation of calcein and BSA in the basal compartment was relatively low. After 
electroporation, the rate of accumulation increased significantly, indicating increased 
permeability of the monolayers to the two markers. In two experiments, accumulation 
was relatively linear for both calcein (Fig. 8.13A) and BSA (Fig. 8.13B) after 
electroporation. In another set of experiments, however, a sudden increase in the 
transport was observed for both calcein and BSA (Figs. 8.13C,D). This increase could be 
the result of the detachment of dead cells from the monolayers. 
For calcein, a large increase occurred in the first 30 minutes after electroporation in 
Monolayer C, corresponding to a permeability of 1.1 x 10-5 cm/s, followed by slower 
transport (P = 2.4 x 10-6 cm/s) for the rest of the experiment (Fig. 8.13C). The transport of 
BSA was relatively low for the first hour after electroporation and then two of the three 
monolayers had a large increase in transport (Fig. 8.13D). The permeability before the 





Figure 8.13 Calcein (A,C) and BSA (B,D) accumulation over time before and after 
electroporation from four independent experiments. Electroporation took place at time t = 
0 h.  Calcein and BSA transport was linear with time for most monolayers (A,B); 
however, in a few monolayers there were sudden increases in transport that could perhaps 














































































































respectively. After the jump, the permeabilities of these two monolayers increased to 5.4 
x 10-7 cm/s and 1.5 x 10-7 cm/s, respectively. Monolayer C maintained a post-
electroporation permeability of 1.1 x 10-7 cm/s for the duration of the experiment. 
The fact that the accumulation of marker molecules in the basal compartment did 
not level off after three hours (Figure 8.13) and that the resistances of the electroporated 
monolayers remained consistently lower than the control monolayers (Figure 8.7) 
suggests that there may have been some cell loss after electroporation. If this was the 
case, then transmonolayer transport may have contributed to the increase in permeability 
seen after electroporation. Unfortunately, there is not enough information to be able to 
quantify and correlate the loss of a few cells to changes in the overall permeability.  
 
8.4  Conclusions 
Electroporation increased the permeability of confluent Caco-2 monolayers to 
calcein and bovine serum albumin.  The increase in permeability was size dependent and 
was enhanced by the application of multiple pulses (when total exposure time was held 
constant).  When the various barriers to transport were evaluated, the monolayer was 
found to be the primary barrier. The route by which permeability was increased could be 
a combination of paracellular and transmonolayer transport, but it is likely that 
transmonolayer transport was the major contributor. The results of these experiments 
demonstrate that electroporation could be useful for increasing the permeability of intact 




9.  NUCLEIC ACID DELIVERY TO MONOLAYERS BY ELECTROPORATION 
 
9.1  Introduction 
Since the first demonstration of electroporation-mediated gene transfer and 
expression over twenty years ago (Neumann et al., 1982), electroporation has rapidly 
become a common laboratory tool for in vitro transfection of bacterial, plant, and 
mammalian cells (Neumann et al., 1989; Chang et al., 1992).   Electroporation has also 
proven to be very useful for in vivo gene delivery in animal models as evidenced by 
published accounts of successful gene delivery to corneal epithelium (Oshima et al., 
1998), murine melanoma (Rols et al., 1998), skeletal muscle (Mir et al., 1999), and other 
tissues (Jaroszeski et al., 1999; Jaroszeski et al., 2000; Trezise, 2002). 
The majority of in vitro gene transfection protocols for adherent cells call for 
removal of cells from their substrate and/or the use of subconfluent cells for increased 
expression (Ravid and Freshney, 1998; Sambrook and Russell, 2001). However, many 
types of epithelial cells only exhibit the characteristics of in vivo epithelium when they 
are cultured to full confluence and are allowed to differentiate into mature epithelium. 
Unfortunately, many methods of transfection, including lipofection, work much less 
efficiently on differentiated cells, as described by Uduehi et al. and Matsui et al., who 
monitored cationic lipid-mediated transfection in two types of epithelia, Caco-2 intestinal 
epithelial cells (Uduehi et al., 1999) and airway (bronchial and tracheal) epithelial cells 
(Matsui et al., 1997).  In both studies, a common theme was observed: increased 
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resistance to transfection with cationic lipids as the cells became more differentiated, e.g., 
the formation of tight junctions and apical features such as microvilli or cilia.  
Many protocols for gene transfection have been published that show that the 
determination of optimal electroporation parameters for successful transfection of DNA 
is largely empirical (Nickoloff, 1995; Lynch and Davey, 1996; Cataldo et al., 1998).  
Some researchers have found that the application of combinations of short, high voltage 
pulses (which porate the cells) and long, low voltage pulses (which electrophoretically 
drive the DNA into the cells) yielded good results in in vitro (Sukharev et al., 1992) and 
in vivo transfection experiments (Bureau et al., 2000; Satkauskas et al., 2002). A variation 
of this approach was used in these experiments. 
This study will evaluate the ability of electroporation to effectively transfect well-
differentiated T84 intestinal epithelial monolayers with reporter plasmid DNA to express 
luciferase or green fluorescent protein.  The resulting DNA uptake and protein expression 
were compared with uptake and expression after lipid-mediated transfections to 
determine whether electroporation could transfect these cells more efficiently. 
 
9.2  Experimental Results 
9.2.1   Luciferase Expression in Confluent T84 Monolayers after Lipofection 
Figure 9.1 shows the expression of luciferase after transfection with a range of 
LipoTAXI® lipid concentrations (0 mM – 0.1 mM) and amounts of gWiz™-Luc plasmid 





Figure 9.1 Luciferase expression over a range of lipid concentrations and DNA amounts 
after transfection of confluent T84 monolayers with the cationic lipid LipoTAXI. 
Transfection with 5 µg of DNA and either 0.08 mM or 0.1 mM of lipid yielded the 
highest levels of expression.  Although expression appears to vary with lipid 
concentration and DNA amount, statistical analysis by two-way ANOVA showed no 
dependence of luciferase expression on the two variables (p=0.09 and 0.42, respectively). 





























5 µg 10 µg 20 µg 30 µg
 
 135
luminometer and is reported as the number of relative light units expressed per milligram 
of cellular protein (RLU/mg protein).   
At all but the lowest lipid concentration, transfection with 5 µg of plasmid yielded 
the highest amount of luciferase expression (up to 6 x 105 RLU/mg protein), while 
transfection at the other conditions resulted in expression that ranged from about 0.7 – 3.5  
x  105 RLU/mg protein.  Luciferase expression appeared to increase to a plateau as the 
lipid concentration increased and decrease as the DNA amount increased. Statistical 
analysis by two-way ANOVA, however, showed that there was no significant difference 
in luciferase expression when the lipid concentration was changed (p = 0.09) or when the 
DNA amount was changed (p = 0.42).  Despite this, 0.08 mM LipoTAXI was the highest 
concentration used to treat monolayers because of the potential for toxicity at high lipid 
concentrations. 
 
9.2.2 Combining High and Low Voltage Pulses for Transfection by Electroporation 
As described in Section 4.5.4, a combination of short, high voltage pulses and 
long, low voltage pulses were used to introduce plasmid DNA into confluent T84 
monolayers.  Prior to performing the actual transfections, the high voltage (HV), 300 V – 
300 µs, pulse and the low voltage (LV), 25 V – 20 ms, pulse were tested on the 
monolayers to check calcein uptake and cell viability. The results, which were obtained 
by flow cytometry, helped identify potential conditions that could be used for later 
transfections. 
Figure 9.2A shows the uptake of calcein by confluent T84 monolayers after 
electroporation with high and low voltage pulses or with combinations of the two. Again,  
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Figure 9.2 Determining an optimal electroporation condition for transfection 
experiments. (A) Calcein uptake by T84 monolayers after electroporation with 
combinations of short, high voltage pulses and long, low voltage pulses, increased with 
the strength of the condition applied (p < 0.001). (B) Cell viability dropped after 
electroporation, but showed a weak dependence on electroporation conditions (p=0.06).  
The HV + 3LV condition was chosen for use in future transfection experiments (see text) 
The extracellular concentration of calcein was 10 µM. [n = 3; HV = 300V – 300 µs; LV = 

















































electroporated monolayers show a significant increase in calcein uptake over 
unelectroporated control monolayers. Uptake increased as the strength of the 
electroporation conditions increased (p < 0.001).  The single low voltage pulse (LV) 
resulted in uptake that was six times that of the single high voltage pulse (HV). However, 
there was little difference in uptake between the LV, HV + 1LV, and HV + 2LV 
conditions (p = 0.22). Electroporation with an additional low voltage pulse (HV + 3LV) 
increased calcein uptake almost 2-fold above the HV + 2LV condition, while the HV + 
4LV condition did not significantly increase uptake above the adjacent condition (p = 
0.43). 
The viability of the T84 monolayers decreased after electroporation (Figure 9.2B), 
but the dependence was not statistically significant (p = 0.06). Comparisons of the 
viabilities for all of the treated monolayers showed an even weaker dependence on the 
electroporation conditions (p =0.85). Since the viabilities were all similar, calcein uptake 
became the determining factor for choosing a transfection condition, which meant that 
the HV + 3LV or HV + 4LV condition could be used. Although the viabilities at the HV 
+ 3LV and HV + 4LV conditions were not significantly different, resistance recovery 
experiments showed that the monolayers electroporated with the former condition 
recovered their original resistance more rapidly (12 hrs vs. 24 hrs).  Since future 
experiments with these monolayers will require the monolayers to be used in less than 24 




9.2.3 Luciferase Expression in Confluent T84 Monolayers after Electroporation 
After identifying a promising electroporation condition, confluent T84 
monolayers were electroporated with the gWiz™-Luciferase reporter plasmid to 
determine the levels of luciferase expression that could be achieved.  In the next set of 
experiments, monolayers were treated with combinations of short, high voltage pulses 
and long, low voltage pulses and with increasing amounts of DNA for comparison with 
the expression obtained after lipofection. 
 
  9.2.3.1 Dependence of Expression on Electroporation Conditions 
To ensure that the HV + 3LV condition identified in the previous experiments 
with calcein also yielded the most expression, several combinations of the high and/or 
low voltage pulses were also tried. A plasmid amount of 30 µg was used to evaluate 
luciferase expression after treatment.     
Figure 9.3 shows that, luciferase expression tended to increase as the strength of 
the condition or the number of pulses applied increased (p = 0.0003). A relatively low 
amount of expression (< 2 x 105 RLU/mg protein) resulted when either a single high 
voltage pulse (HV) or a single low voltage pulse (LV) was applied. When the two were 
applied in combination (HV + LV), an additive effect on expression was observed. 
Applying three high voltage pulses (3HV) in succession increased expression only 2-fold 
over the single high voltage pulse.  Statistical analysis showed no significant difference 







Figure 9.3 Luciferase expression tends to increase as the strength and/or number of 
electroporation pulses applied increase. Combinations of short, high voltage pulses and 
long, low voltage pulses were applied to confluent T84 monolayers.  The HV+3LV and 
3LV conditions yielded the most expression, indicating that the HV pulse may not be 
necessary.  DNA amount was held constant at 30 µg of gWiz™-Luciferase expression 
































When the single, high voltage pulse followed by one or more long, low voltage 
pulse protocol was applied, expression appeared to increase as each additional pulse was 
applied (p = 0.10).  For the strongest condition, HV + 3LV, expression reached 9.3 x 105 
RLU/mg protein. However, when expression at this condition was compared to 
expression at the 3LV condition (8.8 x 105 RLU/mg protein), the difference between the 
two was not statistically significant (p = 0.85). This suggests that the single short high 
voltage pulse may not be necessary to permeabilize the cells.  This is in contrast to in vivo 
studies of electroporation-mediated gene transfer to skeletal muscle in which expression 
was highest when a high voltage pulse was combined with the low voltage pulse(s) 
(Bureau et al., 2000; Satkauskas et al., 2002). Since the additional short high voltage 
pulse did not appear to affect cell viability (Figure 9.2B), the HV+3LV was still used as 
the electroporation pulse protocol for subsequent transfections. 
 
9.2.3.2 Dependence of Expression on Amount of DNA 
Figure 9.4 shows that when confluent T84 monolayers were electroporated with 
the HV+3LV condition, luciferase expression depended strongly on the amount of 
gWiz™-Luc plasmid present, which ranged from 5 µg to 60 µg (ANOVA; p < 0.001).  
Expression increased steadily and reached a maximum level of 3 x 106 RLU/mg protein, 
which was five times better than the maximum expression obtained after lipofection (6 x 
105 RLU/mg protein).  Electroporation with DNA amounts ranging from 10µg to 20 µg 
resulted in statistically similar levels of luciferase expression of about 5 x 105 RLU/mg 
protein (p > 0.05).  Monolayers electroporated with 5 µg of plasmid expressed about 2 x 






Figure 9.4 Luciferase expression after electroporation increases with DNA amount. The 
amount of DNA present during electroporation was increased from 5 µg to 60 µg.  
Confluent T84 monolayers were electroporated with the HV + 3LV condition using the 
specified amounts of gWiz™-Luciferase expression plasmid. [n = 3; HV = 300 V – 300 






























lipofection at this concentration (6 x 105 RLU/mg protein).  However, for DNA amounts 
greater than 5 µg, electroporation consistently yielded more luciferase expression than 
lipofection. In addition, for the DNA amounts studied, luciferase expression after 
electroporation did not saturate with increasing amounts of DNA as it did after 
lipofection (Figure 9.1). 
  
9.2.4 GFP Expression in Confluent T84 Monolayers after Lipofection  
Using reporter plasmids that expressed green fluorescent protein (GFP), the 
abilities of lipofection and electroporation to efficiently transfect and express GFP in 
confluent intestinal epithelial monolayers were again compared.  Confluent T84 
monolayers were treated with either pEGFP-N1 or gWiz™-GFP and the cationic lipid 
LipoTAXI and then imaged 24 h later using epifluorescence microscopy.  
Figures 9.5 and 9.6 show that there was very little GFP expression in confluent 
monolayers after lipofection.  In the image fields shown, only 1 – 3 GFP positive cells 
were visible for monolayers treated with 10 µg of pEGFP-N1 plasmid and either 0.03 
mM (Figure 9.5A) or 0.05 mM (Figure 9.5B) of LipoTAXI. When the T84 monolayers 
were transfected with 5 µg gWiz™-GFP expression plasmid and 0.08 mM of LipoTAXI, 
GFP expression was again very low (Fig. 9.6A), even though this condition yielded the 
most luciferase expression in previous experiments with lipofection (Fig. 9.1).  
Transfection with 10 µg of the gWiz plasmid at the same lipid concentration also 
produced very little GFP expression (Fig. 9.6B).  These results illustrate the difficulty 






Figure 9.5 Transfection of confluent T84 monolayers with LipoTAXI resulted in very 
little GFP expression. Monolayers were transfected with either (A) 0.03 mM or (B) 0.05 
mM of LipoTAXI and 10 µg pEGFP-N1. Monolayers were imaged by epifluorescence 







Figure 9.6  GFP expression in confluent T84 monolayers after lipofection is significantly 
less than after electroporation.  Lipid-treated monolayers were transfected with 0.08 mM 
of LipoTAXI and either 5 µg (A) or 10 µg (B) of gWiz™-GFP expression plasmid.  The 
5 µg condition was found to be optimal for luciferase expression in previous experiments 
(Fig. 9.1). (C) Expression in monolayers electroporated with 10 µg of the same plasmid 
using the HV + 3LV condition had higher levels of GFP expression. [HV = 300 V – 300 






9.2.5  GFP Expression in Confluent T84 Monolayers after Electroporation 
Using the HV+3LV electroporation condition, confluent T84 monolayers were 
electroporated with either the pEGFP-N1 or gWiz™-GFP reporter plasmids and analyzed 
24 h later for GFP expression by standard epifluorescence microscopy.  Where stated, 
estimates of the density of cells expressing GFP were made by counting the number of 
GFP positive cells in each field of view using the image acquisition/analysis software 
ImagePro Plus (Media Cybernetics) as described earlier (Section 4.5.2). 
In referring back to Figure 9.6, which shows a comparison of GFP expression in 
confluent T84 monolayers after lipofection and electroporation, expression after 
electroporation (Figure 9.6C) was significantly higher than expression after lipofection 
(Figure 9.6B), when the same amount of gWiz™-GFP plasmid was used (10 µg). Results 
from experiments with the second plasmid, pEGFP-N1, were very similar. Figure 9.7 
shows expression in confluent T84 monolayers after electroporation with 20 µg (Figure 
9.7A,B) and 30 µg (Figure 9.7C,D) of pEGFP-N1. Two additional images of the same 
monolayers, taken at a higher magnification were included in the figure for a closer view 
of expression (Figures 9.7B, D). 
Estimates of the density of GFP expression in the images in Figure 9.7 were made 
by counting the number of GFP positive cells and dividing by the field area. The 
monolayers transfected with 20 µg of plasmid had densities of approximately 1300 ± 340 
cells/cm2 (n = 2), while monolayers electroporated with 30 µg of plasmid had densities of 
about 2900 ± 1300 cells/cm2 (n = 2). Control monolayers, which were not electroporated, 




Figure 9.7 GFP expression in confluent T84 monolayers 24 h after electroporation.  
Monolayers were electroporated with either 20 µg (A,B) or 30 µg (C,D) of pEGFP-N1 
using the HV + 3LV pulsing protocol. Unelectroporated monolayers incubated with DNA 
served as controls and showed little to no expression (not shown). Images B and D are 
higher magnifications of images A and C, respectively.  [HV = 300 V – 300 µs; LV = 25 





In a replicate experiment carried out under the same conditions with 20 µg of 
pEGFP-N1 plasmid, electroporation yielded a density of about 8700 cell/cm2 in confluent 
monolayers (Figure 9.8A), which is again higher than expression observed after 
lipofection.  Just for comparison, monolayers were electroporated with 20 µg of pEGFP-
N1 using the milder HV + 2LV condition (Figure 9.8B).  Expression was lower (~3400 
cells/cm2), which supported the results obtained with calcein (Figure 9.2). 
A rough approximation of the percentage of cells expressing GFP can be made by 
dividing the number of GFP-positive cells in the entire monolayer by the number of all 
cells in the monolayer.  Multiplying the density of GFP positive cells calculated from the 
fluorescence micrographs by the growth area of the membrane (4.7 cm2) gives an 
estimate of the total number of cells expressing GFP in the monolayer.  The number of all 
cells in the monolayer was determined by dissociating the cells from the monolayer by 
trypsinization and performing a cell count using a Coulter Counter. The total number of 
T84 cells in a monolayer seeded on a 4.7 cm2 membrane was found to be 1.26 ± 0.15 x 
106 cells (n = 4). Based on these calculations, the highest percentage of cells in a 
confluent monolayer demonstrating expression of GFP after electroporation was ~ 3% 
(for a density of 8700 cell/cm2). Although relatively low, this result was still better than 






Figure 9.8  GFP expression in confluent T84 monolayers increased as the electroporation 
condition strength increased.  Monolayers electroporated with 20 µg of pEGFP-N1 using 
the HV + 3LV (A) condition showed higher numbers of GFP positive cells than those 






9.2.6  DNA Uptake after Lipofection and Electroporation 
When reporter plasmid expression was evaluated, results showed that 
electroporation was as good, if not better, than a cationic lipid at successfully treating 
polarized, confluent intestinal epithelial monolayers.  However, in both cases, the amount 
of expression was rather low.  The following experiments were conducted to help 
determine whether the low expression levels could be due to low uptake of the plasmid 
DNA itself. 
To study DNA uptake, the gWiz™-GFP plasmid was fluorescently labeled using 
the DNA intercalating dye YOYO-1 at a 100:1 DNA to dye molar ratio and transfected 
into confluent T84 monolayers by lipofection or electroporation.  The uptake results after 
transfection with 0.08 mM LipoTAXI were compared to those from electroporation with 
the HV+3LV pulse protocol. The monolayers were incubated for 3–4 hours after 
treatment and then imaged by epifluorescence microscopy.   
Uptake of stained DNA complexed with lipid by confluent T84 monolayers after 
lipofection is shown in the images presented in Figure 9.9.  If the overall fluorescence of 
the monolayers is used as a measure of uptake of the lipid-DNA complexes, then the 
control monolayer had very little uptake, as indicated by the lack of green fluorescence 
(Figure 9.9A). A decrease in lipid-DNA uptake was observed as the amount of DNA 
present during lipofection increased from 5 µg to 30 µg. Uptake was highest in the 
monolayers transfected with 5 µg of DNA (Figure 9.9B), which correlates with the 
results obtained after luciferase transfections (Figure 9.1) and could indicate an optimal 
lipid:DNA ratio. At higher concentrations of DNA, fluorescence (and therefore uptake)  
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Figure 9.9 Lipid-mediated uptake of fluorescently labeled DNA by confluent T84 monolayers decreases with increasing DNA 
concentration.  gWiz™-GFP expression plasmid was labeled with the DNA intercalating dye YOYO-1 at a molar ratio of 100:1 base 
pairs to dye molecules.  Treated monolayers were transfected with 0.08 mM LipoTAXI and (B) 5 µg, (C) 10 µg, (D) 20 µg, and (E) 30 
µg of DNA. The control monolayer incubated with just 20 µg of DNA from Figure 9.10 has been included for comparison (A). 






dropped significantly (Figure 9.9C-E), which again correlates with the luciferase 
transfection results.  
Delivery of the stained DNA by electroporation into confluent T84 monolayers 
resulted in high levels of uptake, when compared to the unelectroporated control 
monolayer (Figure 9.10A).  In contrast to lipofection, uptake increased as the amount of 
DNA present during electroporation increased from 5 µg to 30 µg (Figure 9.10B-E). 
Again, this correlates with the results observed after transfection with the luciferase 
expression plasmid (Figure 9.4) and the GFP expression plasmid (Figure 9.7). In 
addition, since all of the images in Figures 9.9 and 9.10 were taken using the same 
exposure time, it can be inferred, based on the overall fluorescence intensity of the 
images, that electroporation appears to deliver more DNA into the cells than lipofection. 
According to these results, the inability to introduce DNA into the confluent 
intestinal epithelial monolayers does not appear to be a limitation of electroporation or, 
for low DNA amounts, of lipofection.  Electroporation, in particular, caused a significant 
amount of uptake of DNA. However, when the extent and distribution of DNA uptake in 
the monolayers are compared to the amount of GFP expression presented earlier in this 
chapter, it is evident that the DNA uptake was significantly higher than the GFP 
expression.  Potential reasons for this disparity will be discussed in more detail in the 
discussion section of this chapter.  
A final observation made while analyzing the DNA uptake images was evidence 
of the difference in the uptake mechanism after lipofection versus electroporation.  After 
lipofection, uptake of the labeled DNA appeared in the image as punctate spots of 
fluorescence.  These spots could indicate uptake of the lipid-DNA complexes by  
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Figure 9.10 Electroporation-mediated uptake of fluorescently labeled DNA by confluent T84 monolayers increases with increasing 
DNA concentration.  The gWiz™-GFP plasmid was labeled with the DNA intercalating dye YOYO-1 at a molar ratio of 100:1 base 
pairs to dye molecules. (A) The unelectroporated control monolayer was incubated with 20 µg of DNA. Treated monolayers were 
transfected using the HV + 3LV pulsing protocol and (B) 5 µg, (C) 10 µg, (D) 20 µg, and (E) 30 µg of DNA.  Fluorescence imaging 






endocytosis, the hypothesized mechanism by which complexes are taken into cells 
(Bichko, 1998). Uptake after electroporation, on the other hand, appeared more diffuse, 
which would be expected if holes are being made in the cell membrane through which 
DNA would be transported directly into the  cell interior (Xie et al., 1990; Klenchin et al., 
1991; Sukharev et al., 1992). 
 
9.3 Discussion 
Polarized T84 intestinal epithelial monolayers were treated with either 
electroporation or with lipofection using LipoTAXI to evaluate the transfection and 
resulting expression of two reporter plasmids. When compared to lipofection, 
electroporation resulted in more luciferase and GFP expression in confluent T84 
monolayers under almost all conditions tested.  
The one condition at which luciferase expression was higher after lipofection was 
for 5 µg of plasmid and 0.08 mM – 0.1 mM LipoTAXI (Figures 9.1). This condition also 
resulted in the most DNA uptake for lipofection (Figure 9.9B) and could indicate an 
optimal lipid to DNA molar ratio (~5:1).  Since GFP expression under these conditions 
was very low however (Figure 9.5-9.6), it is possible that only a few cells were 
successfully transfected and those cells expressed large amounts of luciferase.   
When the images of GFP expression and DNA uptake after electroporation were 
compared (Figures 9.6-9.8 vs. Figure 9.10), it became obvious that high levels of uptake 
did not translate into high numbers of cells with expression. In electroporation 
experiments, only 3% of cells, at most, were positive for GFP expression. This could be 
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an indication of some type of inefficiency in the processing of the DNA after it enters the 
cell. 
It is well known that it is difficult to obtain high levels of expression in polarized, 
confluent epithelial monolayers using conventional methods of transfection like cationic 
lipids. The steps involved in lipofection, i.e., endocytosis of the lipid-DNA complexes 
into the cells, release of the complexes from the endosome, dissociation of the DNA from 
the lipid, and DNA transport into the nucleus, are all barriers to expression, with nuclear 
import being the most rate limiting barrier (Zabner et al., 1995).  As a result, it is 
common practice to use  cells in the mid-log phase of growth to take advantage of the 
breakdown of the nuclear membrane during cell division (Tseng et al., 1999; Sambrook 
and Russell, 2001).  When this approach is taken, very high levels of expression can be 
obtained in these cells, as we found when we transfected subconfluent Caco-2 and T84 
monolayers with the pEGFP–N1 reporter using the cationic lipid Lipofectin®. 
Figure 9.11 shows the expression of green fluorescence protein (GFP) over time in 
subconfluent Caco-2 monolayers and for different concentrations of DNA in monolayers 
after transfection with Lipofectin. For both cell lines, a significant amount of GFP 
expression, which occurred over the entire membrane growth area, was evident 1 day 
after transfection (Figure 9.11B, E, F) and lasted for at least 4 days, although it 
diminished as new cells replaced old ones (Figure 9.11D). Subconfluent T84 monolayers 
transfected in the same manner showed similar levels of GFP expression after treatment 
with either 5 µg (Figure 9.11E) or 10 µg (Figure 9.11F).  Expression in the T84 cells also 
lasted at least 96 hours (not shown). Control monolayers, which were incubated with 





Figure 9.11 GFP expression is very high after lipid-mediated transfection of subconfluent 
Caco-2 (B-D) and T84 (E-F) monolayers. Expression of GFP reached very high levels 
within 1 day of transfection and lasted for at least 4 days.  Transfected monolayers were 
treated with the posted amount of pEGFP-N1 and 60 µg of Lipofectin. The control 
monolayer (A) was treated with DNA alone. Caco-2 monolayers were used 2 days after 
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When the transfected subconfluent Caco-2 monolayers were observed at higher 
magnification, colonies or “islands” of cells were observed. In many epithelial cell lines, 
the cells on the perimeter of these islands are typically proliferating, undifferentiated 
cells, which do not exhibit the characteristics of mature epithelium that cells located in  
the center of the islands do (Matsui et al., 1997).  Figure 9.12A is a fluorescence 
microscopy image of subconfluent Caco-2 cells with cells expressing GFP indicated by 
white arrows.  When coupled with a bright field microscopy image of the same field 
(Figure 9.12B), with the white arrows placed in the same locations, the images show that 
GFP expression took place almost exclusively in the proliferative, undifferentiated cells 
located at the edges of these islands. Expression was rare in the cells located in the 
centers of the colonies. 
The cells located in the center of the islands are most like the confluent epithelial 
monolayers used in the transfection experiments discussed in this chapter.  While there is 
some proliferation in confluent monolayers, the majority of cells are at rest, which would 
make diffusion of DNA into the nucleus difficult. It was interesting to note that even 
though most of the monolayers treated with lipofection showed relatively little expression 
(Figures 9.5, 9.6), some confluent monolayers treated with the lipid showed large 
amounts of DNA uptake (Figure 9.9). This could mean that the cells are taking up the 
complexes, but once inside, either the steps involved in lipofection (release of complex 
from endosomes, dissociation of lipid and DNA) are being hindered or the DNA, once 




Figure 9.12 GFP expression in subconfluent Caco-2 monolayers occurred primarily in 
cells located at the edges of cell islands.  (A) The fluorescence microscopy image shows 
the GFP expression 24 h after treatment with Lipofectin. (B) The bright field microscopy 
image (w/ fluorescence overlay) shows that the location of these GFP positive cells 
(indicated by white arrows) is almost exclusively at the edges of cell “islands”. Typically, 






Just as for lipofection, the nuclear membrane may also be a significant barrier 
against achieving high numbers of cells with expression after electroporation. 
Susceptibility of the naked DNA to degradation by cytoplasmic nucleases  could also be a 
potential problem (Lechardeur et al., 1999). Despite this, electroporation was still able to 
achieve more expression than lipofection. Comparisons of the fluorescence intensities of 
the images made in the DNA uptake studies indicate that electroporation may deliver 
more DNA into the cells than lipofection as well (Figure 9.9 vs. Figure 9.10). It is 
possible that the more DNA that is loaded into the cells, the higher the probability that 
some DNA will bypass barriers to transfection, and the better the chances that expression 
will occur.  
 
9.3  Conclusions 
 
Polarized intestinal epithelial monolayers were transfected with two reporter 
plasmids using electroporation and lipofection. When compared to lipofection, luciferase 
and GFP expression were found to be higher after electroporation, especially at higher 
concentrations of DNA. DNA uptake studies showed that both electroporation and 
lipofection (under certain conditions) can deliver relatively large amounts of DNA into 
the cells, but it appears that intracellular barriers to transfection limit the amount of 
expression achieved. Electroporation appears to be able to bypass these barriers, to some 









10.1  Introduction 
The epithelial cells that line the mucosal surface of the intestine serve as a 
protective barrier to prevent harmful agents from gaining access to the interior and 
adversely affecting the body. When in the presence of “threat” stimuli such as bacteria, 
viruses, inflammatory cytokines, or physical stress, these cells initiate a proinflammatory 
signal transduction pathway regulated by the family of transcription factor proteins 
known as NFκB (Thanos and Maniatis, 1995).  This cascade of events is known to play a 
role in inflammatory syndromes or diseases such as asthma (Yamamoto and Gaynor, 
2001), rheumatoid arthritis (Makarov, 2000), and inflammatory bowel disease (IBD) 
(Schreiber et al., 1998; Schmid and Adler, 2000), and also in cancer (Schwartz et al., 
1999; Yamamoto and Gaynor, 2001). 
Several approaches for inhibiting the NFκB-mediated inflammatory pathway have 
been studied. Most involve blocking the activity of one or more of the intermediate 
components of the pathway to prevent activation of NFκB.  As stated in Chapter 2, many 
of the drugs used to treat IBD have been shown to inhibit the activation of NFκB. The 
mechanisms of action for these drugs include inhibiting the activities of the proteins that 
phosphorylate, ubiquitinate, or degrade IκB and inducing the synthesis of new IκB, which 
binds and sequesters free NFκB in the cytoplasm (Yamamoto and Gaynor, 2001). 
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In addition to drug therapy, researchers have also studied the potential of gene 
therapy for treatment of diseases that involve this pathway.  Various methods of delivery 
were employed to introduce nucleic acids both in vivo and in vitro.  One study involved 
the intravenous and rectal administration of antisense oligonucleotides directed against 
NFκB to diminish experimental colitis in rats (Neurath et al., 1996).  In another study, 
successful intranasal delivery of a plasmid that expressed a protein to treat experimental 
colitis in rats was reported (Jobin and Sartor, 2000).  Finally, viral delivery of a plasmid 
vector that expressed a mutated form of IκB, called the IκBα super-repressor, 
successfully inhibited NFκB activation in mammalian cells in vitro (Elewaut et al., 1999). 
The mutated protein is modified at its sites of phosphorylation to prevent it from being 
targeted for degradation, which leads to continued retention of NFκB in the cytoplasm.  
In this study, electroporation was evaluated for in vitro gene delivery into intestinal 
epithelial cell monolayers.  A plasmid that expressed hemagglutinin (HA) –tagged IκBα 
was electroporated alone and in combination with other plasmids into these cells to try to 
inhibit TNFα-mediated activation of NFκB.  Secretion of the cytokine IL-8 was used 
initially as a marker of inflammation. In later experiments, expression of the reporter 
protein, luciferase, was used to measure inhibition of NFκB. 
 
10.2  Experimental Results 
10.2.1  Delivery of IκBα Expression Plasmid 
Confluent T84 monolayers were electroporated with 20 µg/ml (30 µg) of a 
plasmid that expressed hemagluttinin-tagged IκBα (pIκB-HA) to determine whether the 





Figure 10.1  Electroporation-induced IL-8 secretion by confluent T84 monolayers may be 
temporarily inhibited after electroporation with an IκB-expression plasmid. Secretion by 
monolayers electroporated with pIκB-HA was monitored for 24 h and compared to 
unelectroporated monolayers with and without the plasmid, and monolayers 
electroporated with and without the control plasmid, pEGFP-N1. Samples of the basal 




































the secretion of IL-8 during the first 12 hours of the 24-hour recovery period after 
electroporation. As expected, unelectroporated monolayers, with and without the IκB 
plasmid present, secreted very little IL-8 (final basal concentration reached ~ 0.1 ng/ml).  
Monolayers that were electroporated with the control plasmid, pEGFP-N1, or with our 
plasmid of interest, pIκB-HA, showed a significant increase in IL-8 secretion within 4 
hours after electroporation. The final basal concentration was approximately 17 times that 
of the unelectroporated monolayers. The monolayers electroporated with pIκB-HA 
appeared to have lower levels of IL-8 secretion than the pEGFP electroporated 
monolayers in the first four hours after treatment. Statistically, however, only the 
difference between IL-8 secretion at 2 hours and 12 hours for the monolayers transfected 
with pIκB-HA proved to be significant (Student’s t-test: p = 0.02 < 0.05). 
After recovery, some of the monolayers were exposed to TNFα (10 ng/ml) for 6 
to 8 hours to further stimulate IL-8 secretion. This would allow us to determine whether 
any IκB expressed during the recovery period would inhibit the secretion of IL-8 in 
response to TNF.  Two fresh T84 monolayers, one stimulated and one left unstimulated, 
were included as controls.  Figure 10.2, which illustrates the secretion of IL-8 after TNF 
stimulation, shows that the unelectroporated control monolayers (No DNA and pIκB) had 
similar amounts of IL-8 secretion that were comparable to secretion by the TNF 
stimulated control monolayer.  The unstimulated monolayer showed no IL-8 secretion.  
The important finding, however, is that IL-8 secretion by monolayers electroporated with 




 Figure 10.2  IL-8 secretion by T84 monolayers electroporated with pIκB-HA after 
stimulation by TNFα for 6-8 h.  Monolayers electroporated with the IκB expression 
plasmid showed no decrease in IL-8 secretion when compared to unelectroporated 


































expressed IκB did not inhibit IL-8 secretion or that there was not enough IκB expressed 
to suppress secretion by the entire monolayer.  
To determine which possibility was true, new T84 monolayers were 
electroporated with pIκB-HA and lysed at various time points for up to 24 hours after 
transfection. Depending on the experiment, various controls were included for 
comparison.  All monolayers were analyzed for IκB expression by SDS-PAGE and 
Western blotting. The Western blot in Figure 10.3A shows that expression of IκB-HA 
occurred within 4 hours after electroporation and was present for at least 24 hours. The 
amount of protein expressed appeared to decrease over time, which could indicate 
possible degradation of the protein.  The control monolayers, including the monolayer 
transfected with LipoTAXI, show no IκB-HA expression.  
Although the Western blot confirms expression of IκB-HA, when a visual 
comparison is made between the size and intensity of these bands and those of 
endogenous IκBα (Figure 10.3B), the amount of IκB-HA being expressed is very small. 
The average intensity of the endogenous IκBα bands, as determined by densitometry, was 
approximately 5 times higher than that of the darkest band of IκB-HA (the 4 h time 
point).  The fact that the samples used for the IκBα blot were diluted 1:2 (to decrease 
endogenous IκBα band intensity and make it easier to see any expressed IκB-HA) further 
underscores the low amount of expression. 
IL-8 secretion was also monitored during the recovery period to determine 
whether the expressed IκB-HA would inhibit electroporation-induced secretion. Figure 
10.3C shows that IL-8 secretion increased with time for the electroporated monolayers as 
observed in previous experiments. However, the presence of IκB-HA appeared to have no 
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Figure 10.3 Monitoring IκB-HA expression over time in T84 monolayers after 
electroporation. (A) Western blot showing IκB-HA expression over time after 
electroporation with the HV + 3LV condition.  (B) Western blot of endogenous IκBα for 
the same samples.  IκB-HA and endogenous IκBα were detected with anti-HA and anti-
IκBα antibodies, and the exposure time for their blots were 30 min and 30 s, respectively.  
Samples for IκBα blot were diluted 1:2. (C) IL-8 secretion by these monolayers was 
monitored and was found to be unaffected by the expressed IκB-HA. [n=1-4; IκB-HA 


























































































































































































effect on IL-8 secretion. In fact, the monolayers electroporated with pIκB-HA showed 
slightly higher levels of IL-8 secretion than the monolayer electroporated with no DNA.  
Since it is possible that the presence of the DNA, which can be toxic to cells, 
could affect IL-8 secretion, the experiment was repeated and a monolayer electroporated 
with gWiz™-Luc as a control plasmid was included. The results of this experiment are 
shown in Figure 10.4.  Again, some expression of IκB-HA after electroporation with 
pIκB-HA (Figure 10.4A) was evident, but this time the amount of protein expressed was 
even less than what was observed in the first experiment.  Expression appeared to peak at 
about 8 hours versus the 4 hours seen in the first experiment. A comparison with 
endogenous IκBα (samples diluted 1:10) yielded a 3-fold average difference in band 
intensities (Figure 10.4B). Monitoring of IL-8 again showed no decrease in secretion with 
IκB present (Figure 10.4C). Secretion by these monolayers was still greater than secretion 
by those electroporated with no DNA or with gWiz™-Luc. 
 
10.2.2  Co-transfection of IκB Expression Plasmid with Reporter Plasmids 
When it appeared that the amount of IκB expressed after transfection by 
electroporation was insufficient to inhibit the secretion of IL-8 by the entire monolayer, a 
different approach (described in Section 4.8) was tried.  The monolayers were 
electroporated with both the plasmid that expressed IκB-HA and a plasmid that expressed 
a reporter protein when the cells were stimulated with TNFα. As stated in Section 4.8.1, 
efforts to electroporate pIκB-HA with a plasmid that expressed the reporter protein 




Figure 10.4 Second Western blot showing IκB-HA expression over time after 
electroporation with the HV + 3LV condition (A).  Western blot of endogenous IκBα for 
the same samples (diluted 1:10) (B).  IκB-HA and endogenous IκBα were detected with 
their respective antibodies and the blots exposed for 30 min and 30 s, respectively.  IL-8 
secretion by these monolayers was monitored and was again found to be unaffected by 
the expressed IκB-HA (C).  [n=1-4; IκB-HA molecular weight ~42 kDa; endogenous 

































































































































































































































unsuccessful because the amount of CAT expressed was below the detection limit of the 
assay used for detection.   
Since luciferase assays can be 10,000 times more sensitive than the CAT assays, a 
plasmid that expressed luciferase when free NFκB binds to its promoter (pNFκB-Luc) 
was chosen as an alternative. The two plasmids, pIκB-HA and pNFκB-Luc, were 
electroporated into confluent T84 monolayers at specified ratios, while keeping the 
amount of pNFκB-Luc constant at 15 µg. Monolayers exposed to TNFα, which triggers 
the release of NFκB, were expected to have increased levels of luciferase expression. A 
standard luciferase plasmid with a CMV promoter (pCMV-Luc) was used as a control.  
Figure 10.5 shows the expression of luciferase by TNF stimulated and 
unstimulated monolayers co-transfected with pIκB-HA and pNFκB-Luc and by 
monolayers co-transfected with pIκB-HA and the control plasmid pCMV-Luc.  There 
was no significant difference between the expression by pCMV-Luc alone or co-
transfected with increasing amounts of pIκB-HA (one-way ANOVA, p = 0.76). The 
NFκB-Luc treated monolayers that were not stimulated with TNFα had relatively low 
levels of luciferase expression (< 9000 RLU/mg protein). When treated monolayers were 
stimulated with TNFα, luciferase expression increased significantly.  Depending on the 
individual experiment, expression by TNF-stimulated monolayers ranged from 7 to 30 
times that of the unstimulated monolayers.  
According to these results, which are an average of four different experiments, 
luciferase expression did not decrease as the amount of pIκB-HA was increased. 






Figure 10.5 Luciferase expression results from pIκB-HA/NFκB-Luc plasmid co-
transfection experiments.  Using the HV + 3LV pulsing protocol, monolayers were 
electroporated with either pNFκB-Luc alone or at the specified ratio with pIκB-HA. 
TNF-stimulation triggered an average 18-fold increase in luciferase expression over 
unstimulated monolayers. Increasing amounts of pIκB-HA did not inhibit NFκB 
activation, resulting in similar levels of luciferase expression for all conditions. [n=4] 


















pNFκB-Luc transfected alone or with varying amounts of pIκB-HA (ANOVA, p = 0.65 > 
0.05). However, when the results from the TNF stimulated monolayers in Figure 10.5 are  
replotted to show each individual experiment, the results are not as clear (Figure 10.6). In 
two experiments (#1 and #3), luciferase expression tended to decrease as the amount of 
IκB-HA present was increased, while in the other two experiments (#2 and #4), luciferase 
expression increased with increasing amounts of IκB-HA. 
To confirm whether IκB-HA was expressed, the cell lysate used to assay luciferase 
expression was also analyzed by SDS-PAGE and Western blot analysis.  The protein was 
detected with an anti-HA antibody.  Figure 10.7 shows the expression of IκB-HA for 
each of the samples from the four experiments plotted in Figure 10.6. There was some 
expression of the protein, but it was so low, the radiography film had to be exposed to the 
blot for one hour before the bands could be seen clearly. The intensity of the bands 
correlates well with the amount of the plasmid pIκB-HA present during electroporation, 
but does not correlate with the results of each experiment. Although all of the 
experiments exhibit some IκB-HA expression, only experiments 1 and 3 showed 
decreased luciferase expression as the amount of pIκB-HA was increased. 
 
 
10.3  Discussion 
10.3.1  IκB Expression Plasmid Delivery 
Confluent T84 monolayers were electroporated with 20 µg/ml of pIκB-HA in an 
effort to inhibit IL-8 secretion. In an initial experiment, the expressed IκB appeared to 




Figure 10.6  Luciferase expression by TNF-stimulated T84 monolayers from individual 
pIκB-HA/pNFκB-Luc co-transfection experiments.  Data from Figure 10.5 were replotted 
to show results from each replicate. Experiments 1 and 3 demonstrated the anticipated 
decrease in luciferase expression as the amount of pIκB-HA was increased. Experiments 






















Figure 10.7  Western blot analysis showing evidence of IκB-HA expression from pIκB-
HA/pNFκB-Luc co-transfection experiments.  The protein, which was detected with an 
anti-HA antibody, was expressed in very low quantities.  The blots had to be exposed for 


































































































































































































































































































































































































































same monolayers were exposed to TNF, production of IL-8 remained undiminished 
(Figure 10.2).  Monitoring of IκB-HA expression over time showed the appearance of the 
protein within 4 hours of transfection and then a decrease in the amount of protein over 
the next 20 hours (Figure 10.3.A).  A similar result was obtained, but with a peak in 
expression at 8 hours, when this experiment was repeated (Figure 10.4.A).  
As reported in Chapter 9, transfection efficiencies in confluent monolayers after 
electroporation are relatively low (~3%). This was evident in the size and intensity of the 
bands in both Western blots, which indicate that there was relatively little IκB-HA being 
expressed in the monolayers, especially when compared to the bands for endogenous 
IκBα (Figures 10.3.B & 10.4.B). Other indications of the low transfection efficiency were 
the antibody dilutions and radiography film exposure times used to detect the bands. The 
blots for IκB-HA expression had to be incubated in a higher antibody concentration than 
usual (1:250 dilution instead of 1:1000) and had to be exposed for 30 minutes and longer 
in order to see the bands clearly.  In comparison, a 1:1000 dilution of antibody and 1 min 
exposure time for the endogenous IκB blots was more than sufficient to detect the bands.  
Based on these results, and the fact that IL-8 secretion in these experiments was 
unaffected by the IκB-HA expressed (Figures 10.3.C & 10.4.C.), we surmised that there 
was not enough IκB being expressed to inhibit IL-8 secretion by the entire monolayer. 
Although it is possible that much of the IκB-HA in the cells was degraded by the end of 
the TNF stimulation period, it is more likely that there were too few cells expressing IκB-
HA. As a result, the IL-8 secretion by the untransfected cells may have swamped out the 




10.3.2 pIκB-HA/pNFκB-Luc Co-transfection Experiments 
Experiments to co-transfect pIκB-HA with pNFκB-Luc were conducted to bypass 
the problem of low transfection efficiency.  The principle behind this approach was that 
cells taking up the plasmid, pNFκB-Luc, would express luciferase when stimulated by 
TNFα.  TNF causes the degradation of endogenous IκB and the subsequent release of 
NFκB. The free NFκB then binds to the promoter of pNFκB-Luc and initiates the 
expression of luciferase.  When the cells take up both plasmids, the expressed IκB-HA 
was expected to bind the NFκB freed by TNF stimulation, prevent its binding to the 
promoter, and ultimately prevent luciferase expression. 
An initial concern with using the co-transfection approach was the possibility of 
pIκB-HA physically interfering with the transport of pNFκB-Luc into the cells, especially 
at higher concentrations of the plasmid.  The standard reporter plasmid, pCMV-Luc, was 
used as a control plasmid to evaluate this possibility.  Figure 10.5 showed that there was 
no significant difference between luciferase expression by pCMV-Luc alone or with 
pIκB-HA (p = 0.76). This indicates that presence of the other plasmid did not impede the 
ability of pCMV-Luc to enter the cell and express luciferase. It also demonstrated that 
measurable levels of luciferase expression could be achieved, even with relatively low 
transfection efficiencies. 
When pIκB-HA and pNFκB-Luc were transfected together into the monolayers, 
the difference in luciferase expression by the unstimulated monolayers versus the 
stimulated monolayers was as expected (Figure 10.5). The unstimulated monolayers had 
relatively low levels of luciferase expression. The little that was expressed is probably a 
result of the minor inflammatory response electroporation triggers in these cells. The 
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stimulated monolayers had luciferase expression levels that were, on average, over 12 
times that of the unstimulated monolayers. This means that TNF successfully triggered 
the release of NFκB and its subsequent binding to the plasmid promoter. 
The ability of the IκB-HA expressed after co-transfection to inhibit this 
expression of luciferase was not so easily determined.  Even though Western blot analysis 
showed expression of IκB-HA in each of the four experiments performed (Figure 10.7), 
luciferase expression was inhibited in only two experiments (Figure 10.6). It is unclear 
why this was the case, but two possible reasons will be discussed. First, just as with the 
transfection of pIκB-HA alone, it is possible that there was not enough IκB-HA expressed 
to prevent the binding of NFκB to the promoter of pNFκB-Luc.  Since NFκB is normally 
found bound to endogenous IκB, it is reasonable to assume that it would be found in the 
same large quantities observed for IκB (Figures 10.3 and 10.4). As a result, even if the 
expressed IκB did bind some NFκB, there may have been a significant amount of free 
NFκB left to initiate luciferase expression.   
A change in the electroporation apparatus might yield better expression results.  
When T84 monolayers grown on 0.33 cm2 inserts were electroporated with pIκB-HA 
using the smaller cuvette designed for the siRNA experiments, higher levels of protein 
expression were achieved, when using comparable amounts of DNA per unit area,  than 
what was observed using the 4.7 cm2 ring and the InSitu™ system (Figure 10.8). When 
the samples were analyzed by Western, small IκB-HA bands were clearly visible after 
only a 5 min exposure (vs. 1 h for bands in Figure 10.7) 








Figure 10.8  IκB-HA expression in T84 monolayers electroporated using the smaller 
cuvette design. Monolayers were grown on 0.33 cm2 inserts and electroporated with the 
specified amount of DNA using two 50 V – 20 ms pulses. Significantly more expression 
was observed using this apparatus when compared to expression using the InSitu™ 
system shown in Figure 10.7. Blot was exposed for 5 min. [IκB-HA molecular weight 
~42 kDa; endogenous IκBα molecular weight ~37 kDa] 
Electroporation
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A second potential reason the co-transfections did not always work could involve 
degradation of the expressed IκB-HA, especially in the case of monolayers stimulated 
with TNF. With the exception of the HA tag, the expressed IκB is essentially the same as 
endogenous IκBα, including the serine residues at which phosphorylation occurs.  This 
means that when the cells were stimulated with TNFα, IκB-HA could have been 
phosphorylated and targeted for subsequent degradation. If this was the case, then 
degradation was obviously not complete, since some expression of the protein was still 
visible, but the ability of expressed IκB to inhibit activation of NFκB could have still 
been affected. One way to avoid degradation could involve electroporating a plasmid that 
expressed the IκBα super-repressor. This protein, which can also be tagged with HA, is 
mutated at the serine residues that play a role in phosphorylation, thus making the protein 
resistant to degradation and able to inhibit NFκB activation. 
Although inhibition of NFκB activation by plasmid delivery did not work as well as 
we would have liked, other means of inhibiting this pathway may prove to be more 
successful. Even if efficient inhibition of NFκB activation is achieved, the issue of how to 
inhibit the transcription factor without affecting the other essential functions it regulates 
(e.g., cell growth, adhesion, apoptosis) would still be a concern. Several studies have 
shown that complete inhibition of NFκB in animal models can lead to serious side effects 
(Baldwin, 1996; Schmid and Adler, 2000). Therefore, additional research is needed to 





10.4  Conclusions 
Confluent T84 monolayers were electroporated with plasmids that were meant to 
inhibit NFκB activation after stimulation with TNFα.  Delivery of a plasmid that 
expressed IκB-HA showed no effect on IL-8 secretion, probably because of low 
transfection efficiency. Results from co-transfection experiments with the IκB-expression 
plasmid and a plasmid that expressed luciferase upon binding of NFκB to its promoter 
were inconclusive since NFκB was inhibited in some experiments, but not in others. A 
common problem with both sets of experiments appeared to be low levels of IκB protein 
expression. Although results from one experiment indicated that a change in 
electroporation apparatus might provide better results, other methods of inhibition, such 
gene silencing by siRNA transfection (which will be discussed in the next chapter), may 








11.1  Introduction 
The previous two chapters demonstrated that gene expression in confluent 
intestinal epithelial monolayers by electroporation can be relatively inefficient, when 
compared to the large amounts of DNA that can be loaded into the cells. Poor trafficking 
of the plasmid DNA into the nucleus could one reason for this problem.  If one is 
interested in inhibiting the function of a particular cellular process by introducing a 
genetic molecule, one alternative to plasmid DNA is the use of short-interfering RNAs, 
or siRNAs. These molecules, which are typically only 21-23 base pairs long, mediate a 
process called RNA interference (RNAi) and have received much attention in recent 
years because of the highly specific manner in which they can inhibit, or silence, a 
particular gene (Hannon, 2002).   
RNAi is the inhibition of gene expression through the introduction of double-
stranded RNAs that are homologous to the gene of interest (Zamore, 2002).  In the 
cytoplasm, the dsRNAs are cleaved by an enzyme called Dicer into short-interfering 
RNAs (siRNAs), which in turn bind to a ribonuclease enzyme called RNA-induced 
silencing complex (RISC).  The siRNA guides the RISC to its complementary target 
mRNA, which is then degraded by the ribonuclease, thereby preventing (silencing) 
expression of the gene. This phenomenon, thought to be a defense mechanism against 
viral infection, was originally observed in plants, fungi, and worms (Baulcombe, 2002), 
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but when dsRNAs longer than 30 bp were introduced into mammalian cells, they 
triggered a shut down of all protein synthesis in the cells (Shi, 2003).  It wasn’t until 
Elbashir et al. (Elbashir et al., 2001a) demonstrated that introduction of shorter RNAs (21 
– 22 bp) into mammalian cells resulted in highly specific gene silencing, that this field of 
research really began to grow. Because of the specificity and efficiency with which 
siRNAs target a gene for silencing, they have generated a significant amount of interest 
in their use as a tool for studying gene function (Harborth et al., 2001; Elbashir et al., 
2002) and as a potential therapeutic (Shuey et al., 2002; Check, 2003). 
Since gene expression was relatively low in confluent monolayers after plasmid 
transfection, siRNA transfection was evaluated as a possible alternative.  Of particular 
interest, was the fact that the site of action for these molecules is in the cytoplasm and not 
the nucleus.  Also, because siRNAs are much smaller than plasmids, we surmised that 
there should be less difficulty to introduce them into intestinal epithelial monolayers. 
These experiments were conducted to determine whether electroporation could be used to 
transfect intact monolayers with siRNAs to initiate silencing of lamin A and lamin C, 
intermediate filament-type proteins found on the nuclear envelope. 
 
 
11.2  Experimental Results 
Confluent T84 monolayers were electroporated using a modified cuvette designed 
for use with smaller cell culture inserts with 0.33 cm2 growth areas (see Section 4.9).  
siRNA directed against the nuclear envelope proteins lamin A (70 kDa) and lamin C (65 
kDa) was chosen to test the ability of electroporation to knock down production of a 








Figure 11.1 Immunofluorescence staining of lamin A/C (red; right), the tight junction 
protein JAM (green; middle). The lamins are intermediate filament-like proteins located 
on the inner side of the nuclear envelope. Lamin C is a variant of lamin A and has an 





a T84 monolayers that has been stained by immunofluorescence for lamin A/C and the 
tight junction protein JAM (to distinguish cell boundaries).  Inhibition of lamin A/C has 
become a standard control protocol for evaluating siRNA transfection (Elbashir et al., 
2001a). The amount of siRNA and the time at which the monolayers were lysed were 
varied to determine any dependence of inhibition on time and siRNA concentration.  A 
single 50 V – 20 ms pulse was applied to introduce the siRNA because of its success at 
delivering the protein, BSA, into these cells. Transepithelial resistance returned to initial 
values within 24 hours after pulsing with this condition (personal observations). 
The first step in this study was to conduct an experiment to determine at what point 
after transfection there would be the most knockdown of the lamins. Three separate 
monolayers were electroporated with 100 nM of lamin A/C siRNA and lysed at 24 h, 48 
h, and 72 h.  An unelectroporated monolayer incubated with 100 nM of the siRNA for 72 
h was included as a control. The Western blot in Figure 11.2 shows that there was a 
significant decrease in the amount of lamin A/C present 24 hours after transfection. When 
a comparison was made between the intensities of the bands, siRNA knocked down lamin 
A and C to 50% and 58% of control levels, respectively. As time passed, lamin 
production recovered so that between 48 and 72 h, lamin A/C returned to 85 - 90% of the 
control. After detecting the lamins, the blot was stripped and re-probed with an antibody 
to IκBα, which served as an internal control and confirmed equal loading of protein in the 
gel. The similarity in size of the IκBα bands in this companion blot indicates that the 






Figure 11.2 siRNA directed against lamin A/C temporarily knocks down production of 
the nuclear envelope proteins. Confluent T84 monolayers were electroporated with 100 
nM lamin A/C siRNA using a single 50 V – 20 ms pulse. Monolayers were lysed at the 
specified times after transfection and analyzed by SDS-PAGE and Western blotting. 
After detection of the lamins with their respective antibodies, the blot was stripped and 
re-probed for IκBα, which served as an internal control, and confirmed equal loading of 
protein in the gels. Blots were exposed for 30 s. [Molecular weights: Lamin A = 70 kDa; 








After observing that most inhibition occurred 24 h after siRNA transfection, the 
extracellular concentration of the lamin siRNA was then varied to check for a 
dependence on the amount of siRNA.  The monolayers were electroporated with a 50 V – 
20 ms pulse using concentrations of lamin siRNA ranging from 10 nM to 1 µM. The 
resulting decrease in lamin production was analyzed 24 h later.  Inhibition of lamin A/C 
tended to increase as the concentration of lamin siRNA increased, although there were a 
couple of concentrations at which there was no discernable change (100 nM and 200 nM) 
(Figure 11.3A). At the lowest concentration used, 10 nM, there was no reduction of lamin 
A/C, which could be an indication of a threshold for inhibition. An approximately 15 - 
20% reduction in lamin A/C was observed after transfection with 20 nM and 50 nM 
siRNA. At 500 nM, lamin A/C was reduced by 50%. The highest extracellular siRNA 
concentration, 1 µM, siRNA caused a 90% reduction in lamin A/C. The IκB band for the 
1 µM siRNA condition was slightly smaller than the other bands, which could indicate 
some loss of cellular material, but the decrease was not enough to account for the almost 
complete loss of lamin. 
Several other controls were included to ensure that any inhibition observed was 
due to the lamin siRNA alone. To show that electroporation did not have an effect on 
lamin A/C, a confluent T84 monolayer treated with a 50 V – 20 ms pulse and no siRNA 
was compared to an unelectroporated monolayer. The bands for both monolayers were 
similar in size and intensity and showed no reduction in lamin A/C (Figure 11.3B). As an 
added control, non-silencing siRNA was introduced by electroporation at two 
concentrations, 200 nM and 2 µM. This control siRNA did not have an effect on lamin 





Figure 11.3  (A) Western blots showing the dependence of gene silencing on lamin A/C 
siRNA concentration. Confluent T84 monolayers were electroporated with a 50 V – 20 
ms pulse using siRNA amounts ranging from 10 nM to 1 µM. Monolayers were 
harvested 24 h after transfection.  (B) Included for comparison were an unelectroporated 
monolayer with no siRNA, a monolayer electroporated with no siRNA, and two 
monolayers electroporated with 200 nM or 2 µM of non-silencing siRNA (ns-siRNA). 
The two ns-siRNA controls demonstrate the specificity of the lamin A/C siRNA.  All 
blots were stripped and reprobed for IκBα to confirm equal loading of protein. 





















It was not clear why no effect was observed at the 100 nM and 200 nM 
concentrations, especially since the 100 nM concentration was successful in Figure 11.2. 
It could be that the band for the “no electroporation + 100 nM siRNA” control monolayer 
was not as heavy as previous controls and as a result the band for the treated monolayer 
appeared darker than the control. It is also possible that the electroporation pulse was not 
delivered as efficiently.  During the course of experiments, it was observed that the 
aluminum electrode became pitted and worn very easily, and as a result, should have 
been replaced more frequently. 
A replicate experiment was performed to retest inhibition of lamin A/C in T84 
monolayers at siRNA concentrations of 100 nM, 500 nM, and 1 µM.   The dependence of 
inhibition on time was also re-evaluated after finding that other studies involving lamin 
A/C siRNA transfection by both polyfection and electroporation, saw inhibition up to 48 
hours after transfection (Elbashir et al., 2001a; Jiang et al., 2003).  Figure 11.4 shows the 
reduction of lamin A/C 24 h and 48 h after lamin siRNA transfection at three different 
concentrations. When compared to an unelectroporated control monolayer, levels of 
lamin A and lamin C 24 hours after transfection were both about 60% of the control at 
100 nM, 75% and 65%, respectively, at 500 nM, and 36% at 1 µM.  At 48 hours after 
transfection, inhibition was still evident, with lamin A and lamin C levels that had 
decreased to approximately 56% of the control at 100 nM, 59% and 50%, respectively, at 
500 nM, and 32% and 23%, respectively, at 1 µM. 
 
11.3 Discussion 






Figure 11.4  Western blot replicate showing inhibition of lamin A/C after siRNA 
transfection. Monolayers were electroporated with a 50 V – 20 ms pulse using siRNA 
concentrations of 100 nM, 500 nM, or 1 µM and then lysed at either 24 h or 48 h after 
transfection.  Inhibition lasted for at least 48 hours in this experiment.  No siRNA and 
unelectroporated and controls showed no inhibition of the lamins. Blot was stripped and 
reprobed for IκBα to show equal loading of protein. [Molecular weights: Lamin A = 70 














plasmid DNA.  The site of action of these molecules is the cytoplasm, where they bind 
and target messenger RNA (mRNA) for degradation (Elbashir et al., 2001b; Baulcombe, 
2002; Zamore, 2002). This means that transport into the nucleus, where the transcription 
and translation processes necessary for protein expression after plasmid transfection, is 
not necessary.  In addition, the size of these small molecules (~22 bp) is significantly less 
than the size of standard plasmids (~5000 bp), which makes them much easier to deliver.  
Most studies of siRNA have used the proprietary formulation Oligofectamine™ or 
cationic lipids to transfect subconfluent adherent cells (Elbashir et al., 2001a; Yu et al., 
2002). A few have used electroporation to transfect fibroblast, adipocytes, stem cells, and 
hepatocytes in suspension (Jiang et al., 2003; Oliveira and Goodell, 2003; Wilson et al., 
2003). To the best of our knowledge, there have no published reports of siRNA 
transfection into polarized, confluent intestinal epithelial monolayers using 
electroporation or other methods of delivery, although transfection of subconfluent Caco-
2 cells with Oligofectamine™ has been reported (Balamurugan et al., 2003).   
Although expression after lipofection was quite low in our studies with confluent 
T84 monolayers (see Chapter 9), the DNA uptake results showed that lipid-mediated 
uptake of plasmid DNA by these monolayers can be relatively high under certain 
conditions (Figure 9.9).  This suggests that siRNA transfection with lipids should be 
more successful than plasmid transfection, since nuclear transport is not necessary to 
have an effect.  However, when lipid-mediated transfection of confluent T84 monolayers 
with siRNA was attempted by researchers in Dr. Asma Nusrat’s laboratory at Emory 
University, they were not able to obtain satisfactory gene silencing (personal 
communication). After our success with electroporating epithelial monolayers, Dr. 
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Nusrat’s group has since begun evaluating electroporation as a method of siRNA delivery 
into these cells.  
The results of our experiments with siRNA transfection are very promising. The 
fact that monolayer integrity recovered in 24 hours and that silencing also occurred in 
that time could prove to be useful in protocols where monolayers can be treated, allowed 
to recover, and be ready for use the next day.  The trend of increasing lamin A/C 
silencing as the siRNA concentration increased, is consistent with trends reported by 
others (Elbashir et al., 2002; Jiang et al., 2003). The minimum amount of siRNA required 
to see silencing in our experiments is higher than what was observed in the study by 
Elbashir, et al. ( 20 nM vs. 2 pM), but this could possibly be because of the many 
differences between the two experiments, e.g., cell type, cell confluence, transfection 
method, etc. Despite this, the results obtained provide a good foundation for future 
experiments with siRNA-mediated gene silencing in intestinal epithelial monolayers. 
 
 
11.4  Conclusions 
Successful transfection of siRNA, which bypasses the need for nuclear import and 
subsequent transcriptional and translational processing, was demonstrated for the first 
time in polarized intestinal epithelium.  The extent of silencing of the nuclear envelope 
proteins lamin A/C occurred within 24 hours of transfection and increased with 
increasing siRNA concentration. These results demonstrate the potential for modification 
of intestinal epithelial function by electroporation-mediated siRNA transfection and open 





12.  CONCLUSIONS 
 
 
The ability to introduce exogenous drugs, proteins, or genes into intact, intestinal 
epithelium could greatly facilitate the study, and potential treatment, of various intestinal 
disorders. In this study, electroporation of two cell lines that model the intestinal 
epithelium resulted in extensive, uniform uptake of calcein, a small fluorescent tracer, 
and fluorescein-labeled bovine serum albumin (a protein). In both cell lines, molecular 
uptake, which reached on the order of 106 calcein molecules per cell and 105 BSA 
molecules per cell, increased with increasing pulse strength, length, and number. Cell 
viability decreased as the parameters were increased indicating a trade off. When total 
exposure time was kept constant, however, neither uptake nor viability changed 
significantly.  
Intestinal epithelial monolayers electroporated with a range of conditions 
experienced a loss of resistance and tissue barrier function that recovered at different 
rates depending on the cell line and the strength of the condition applied. For some 
conditions, monolayers were able to recover physically in less than a day. In addition to 
causing a temporary loss of barrier function, electroporation also induced a temporary 
inflammatory response (increased secretion of IL-8), but monolayers were able to recover 
normal function within 12 hours.  
The permeability of confluent Caco-2 monolayers to calcein and bovine serum 
albumin was significantly enhanced by electroporation and was found to be size 
dependent.  When the various barriers to transport were evaluated, i.e., the monolayer, 
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the aqueous boundary layers, collagen matrix, and filter, the monolayer was found to be 
the primary barrier. Transmonolayer transport, i.e., through small holes in the monolayer, 
is the most likely route by which permeability enhanced; although paracellular (between 
cells) transport may also contribute. Transcellular (across cells) transport was found to be 
negligible.   
Electroporation’s ability to transfect confluent T84 monolayers, which are refractory 
to conventional methods of transfection, with plasmid DNA was initially evaluated using 
luciferase and GFP reporter plasmids. A combination of an optional single, short high 
voltage pulse and three long, low voltage pulses was found to yield the most luciferase 
expression. For the most part, electroporation was more successful at transfecting 
confluent intestinal epithelial monolayers than lipofection. Despite high levels of DNA 
uptake after both lipofection and electroporation, however, the overall transfection 
efficiency was essentially zero for the former and only ~3% for the latter.  
When confluent T84 monolayers were electroporated with plasmids that would 
inhibit activation of the NFκB-mediated inflammatory pathway, results were not 
consistent. In a few cases, activation was inhibited, but, more often, no change in 
activation was observed. The most likely reason is low expression of the inhibitory 
protein, IκBα, as observed for the reporter plasmids.  
The fact that expression after plasmid transfection was not high led to an interesting 
addition to the research. Electroporation of short interfering RNAs (siRNAs) into 
confluent T84 monolayers was found to be very efficient at silencing the nuclear 
envelope proteins, lamin A and lamin C in as little as 24 hours. Unlike plasmids, the site 
of action of these small nucleic acid fragments is the cytoplasm, not the nucleus, and, as a 
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result, they do not require transcriptional and translational processing.  To our 
knowledge, this is the first time successful transfection of siRNA into polarized intestinal 
epithelium was demonstrated. The use of siRNAs could prove to be a useful alternative to 
plasmids for inhibiting or modifying intestinal cell function in vitro and, perhaps in vivo.   
We have demonstrated that electroporation can be used to efficiently deliver a wide 
range of molecules, from small tracers to large nucleic acids, into polarized, intestinal 
epithelial monolayers.  These results could lead to improved models of the intestinal 
epithelium by providing researchers a relatively simple and easy way to introduce 
exogenous molecules into these monolayers and modify cellular function, and could form 




13.  RECOMMENDATIONS 
 
 
I would recommend that the following experiments be performed. Since flow 
cytometry appears to underestimate the cell viability of the monolayers after 
electroporation (Section 7.3.2), a method of quantifying the viability in situ would be 
useful. Although transepithelial electrical resistance (TEER) gives a qualitative measure 
of cell viability, by providing information about how quickly the cells recover barrier 
function, quantitative numbers about the percentage of cells that survive electroporation 
could also be useful.   
As stated in Section 4.2.4, the voltage experienced by the monolayers during 
electroporation is less than the voltage applied to the cuvette. Unfortunately, we were 
unable to determine this actual voltage with our equipment. It is possible that a more 
sophisticated oscilloscope, with a higher sampling rate that would allow us to view 
minute changes in the voltage and current traces, would have aided our efforts. Also, 
since changes in cuvette geometry could also affect the voltages and currents, it may be 
necessary to develop a new cuvette design. The adherent cell cuvettes obtained from 
EquiBio, Ltd. were not as rigid as the cuvettes used for suspension cells and, as a result, 
deformations in the plastic could, for example, affect the electrode spacing, which would, 
in turn, affect the voltage delivered to the cells. 
Development of a new cuvette design could also aid plasmid delivery experiments, 
as illustrated in Figure 10.8 where IκBα-HA expression was higher after using the 
alternative cuvette. It is possible that the smaller design, which required a much lower 
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electroporation volume, also resulted in a shorter distance for the DNA to travel to the 
cells, which led to the increased expression. A similar cuvette could be designed for the 
larger culture inserts with rigid electrodes of fixed spacing that are situated in such a way 
that the amount of medium necessary for electroporation is minimized. 
The results reported in this thesis demonstrate that electroporation will be a useful 
tool for manipulating cell culture models of the intestinal epithelium.  Future experiments 
with the technique, however, could involve moving to a more complex geometry such as 
excised intestinal tissue. In ex vivo experiments, similar to skin electroporation, either the 
innermost layers or the full thickness of the intestinal wall could be initially 
electroporated with fluorescent marker molecules. Confocal microscopy could then be 
used to determine how deeply marker molecules can be delivered. Permeability studies 
could be conducted to evaluate whether electroporation can similarly increase transport 
across epithelial tissue as it did across epithelial monolayers. Experiments with 
biologically active molecules, such as proteins or nucleic acids, could also be performed.  
Electroporation of both ex vivo and in vivo epithelium is not expected to be as 
straightforward as treatment of the in vitro monolayers since monolayers have a 2-
dimensional geometry and epithelial tissue has a 3-dimensional structure. This more 
complex structure would have implications on both the electrode design and on the 
resulting uptake of molecules by the cells.   
In ex vivo experiments, the tissue could be mounted so that the electrodes can be 
placed on the mucosal and serosal sides of the intestinal tissue, thus allowing the electric 
field to pass directly across the entire wall thickness. This set-up would not be possible in 
vivo, since the electrodes cannot be placed on either side of the intestinal wall. They 
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would have to be introduced rectally in an endoscopic-like manner and the electric field 
applied with both electrodes on the mucosal side of the intestine.  In addition, the area to 
be treated would have to be cleansed (to prevent the electroporation of potentially 
dangerous luminal contents from entering the cells or crossing the epithelial barrier) and, 
perhaps, bathed in a saline solution (to facilitate electroporation).   
The effect of the electric field on the cells is another issue that will have to be taken 
into consideration when electroporating intestinal tissue.  In contrast to in vitro models, 
the epithelial lining of the intestine consists of different types of cells of various sizes and 
shapes.  In addition, the location of these cells on structures such as the villi and 
microvilli means the cells will have different orientations with respect to the electrodes. 
All of these could result in non-uniform effects of the electric field on the cells and 












A.1 Toxic Effect of Cationic Lipids on Intestinal Epithelial Cells 
In Figure A.1, two sets of bright field microscopy pictures of Caco-2 monolayers 
are presented.  The cells in Figure A.1A are control cells that were exposed to plasmid 
DNA (pEGFP-N1) only, while the cells in Figures A.1B,C were exposed to Lipofectin 
and transfected with pEGFP-N1. These monolayers were imaged 4 days after seeding, 
which was 2 days after transfection for the treated cells.  At the time of imaging, control 
cells appeared almost 100% confluent, with very few gaps appearing only at the edges of 
the monolayer near the membrane edge. The transfected cells, on the other hand, still had 
not formed a confluent monolayer after four days. Islands of cells were still very 
prevalent, which could indicate that the cationic lipids had an inhibitory effect on the 
growth of these cells. By 6 days after seeding (4 days after transfection), the cells finally 
filled in to form an intact monolayer, although rings of potentially still dividing cells 





Figure A.1  Cell growth was slowed when Caco-2 cells were transfected with the cationic 
lipid. Four days after-seeding, or 48 h after transfection, the monolayers exposed to the 
lipid appeared very patchy and were not confluent (B, C). The control monolayer, which 
was not exposed to lipid, was almost fully confluent by this time (A). The lipid 
transfected monolayers did not fill in until eight days after seeding, although areas where 






A.2 Comparison of LipoTAXI and Lipofectin Cationic Lipid Formulations 
Although Lipofectin worked well in initial experiments, a switch was made to the 
cationic lipid mixture, LipoTAXI (Stratagene), because it was readily available in our 
laboratory. To ensure that similar results would be achieved with this lipid, subconfluent 
T84 monolayers were transfected one day after seeding with 10 µg of pEGFP-N1 and 
either 0.05 mM LipoTAXI or 60µg/ml Lipofectin.  The LipoTAXI concentration was 
chosen based on the manufacturer’s recommended range of lipid quantity.  GFP 
expression by subconfluent monolayers treated with LipoTAXI was comparable to that 
observed in monolayers treated with Lipofectin (Figure A.2). The density of GFP positive 
cells after exposure to LipoTAXI and Lipofectin were estimated to be 2,000 cells/cm2, 
and 1500 cells/cm2, respectively. Although expression was lower than previously 
observed (perhaps because the cells were more confluent than usual), based on the 
similarity in results, LipoTAXI was concluded to be acceptable for use as the lipofection 






Figure A.2  The cationic lipid formulations, LipoTAXI (A) and. Lipofectin (B), yielded 
similar levels of GFP expression in subconfluent T84 monolayers. Monolayers were 
treated with either 0.05 mM LipoTAXI or 60 µg/ml of Lipofectin and 10 µg pEGFP-N1 






A.3 Recombinant IκB Protein Delivery Results 
A few experiments were conducted to determine whether electroporation could be 
used to deliver a protein to inhibit NFκB activation. The protein to be delivered was 
recombinant IκBα, which was obtained as a gift from Dr. Neish. The protein contained a 
His•Tag sequence (a series of consecutive histidine residues), which made it possible to 
distinguish it from endogenous IκB by size. Based on the results of experiments with 
electroporating FITC-labeled BSA, a condition of 50V-5ms was chosen for 
electroporating the IκB protein into T84 monolayers. This condition resulted in the 
uptake of about 105 BSA molecules per cell and a viability of approximately 90% (see 
Chapter 7) and was expected to produce similar results for delivery of IκB protein 
molecules.  
 
Electroporation of Recombinant IκBα 
Confluent T84 monolayers were electroporated with 50 µg/ml of recombinant 
IκBα in HEPES-buffered DMEM added apically and then allowed to recover for one 
hour at 37°C. In addition to having an unelectroporated monolayer incubated with IκBα 
for an hour, several other controls were also included. Two monolayers (unelectroporated 
and electroporated) incubated with no protein and two monolayers (unelectroporated and 
electroporated) incubated with 50 µg/ml of FITC-labeled BSA served as controls to 
ensure that any change in the inflammatory response is specific to the presence of IκBα. 
Another set of samples consisting of replicates of the monolayer conditions just described 
were added for comparison. 
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After the one hour incubation, one set of monolayers was washed twice with 
warm DMEM and then exposed basally to 10 ng/ml TNFα in complete medium for 8 
hours.  The replicate set of monolayers was placed in just complete medium for those 8 
hours. During this time, 200 µL samples of the basal medium were collected at 0, 2, 4, 6, 
and 8 hrs to test for the secretion of IL-8. Equal volumes of fresh medium were added 
after each sampling time. Following TNF stimulation, the monolayers were lysed, on ice, 
in 400 µL of cold SDS lysis buffer and stored at -70°C until later analysis by SDS-PAGE 
and Western blotting. 
 
Analysis of IL-8 Secretion and Protein Delivery 
To determine whether the introduction of IκBα protein inhibited IL-8 secretion, the 
samples of the basal medium collected during TNF stimulation were analyzed for the 
presence of IL-8 by sandwich ELISA. The same ELISA protocol used during the 
functional recovery experiments described in Section 4.4.2 was used to calculate the 
amount of IL-8 secreted in response to TNFα (See Appendix B for detailed protocol). 
The cell lysates were analyzed for the presence of endogenous and recombinant 
IκBα by SDS-PAGE and Western blotting using the protocols described in Appendix B, 
Section VII.  A 12.5% polyacrylamide separating gel was used to separate the protein, 
which was probed with the same anti-IκBα primary antibody (1:1000) and horseradish 
peroxidase-labeled secondary antibody (1:1000) used in the pIκBα-HA transfection 
experiments Section 4.6.2.  Since the recombinant IκBα protein contained the His•Tag 




Immunofluorescence staining was used to visualize the localization of the 
recombinant IκB protein within the cells. One hour after electroporation, the monolayers 
were washed 3 times in HBSS+, fixed in 3.7% paraformaldehyde for 20 minutes at room 
temperature, and then stained according to Immunofluorescence Protocol #1 detailed in 
Appendix B, Section VIIE. 
 
Negative Results for Recombinant IκBα Delivery Experiments 
 Unfortunately, the results of these experiments were not successful. First, when 
IL-8 secretion by T84 monolayers electroporated with recombinant IκBα was monitored 
after TNFα stimulation a decrease in secretion was observed (Figure A.3). TNF 
stimulated monolayers without IκB showed the same amount of, if not lower, IL-8 as the 
monolayers treated with the protein. Replicate monolayers with that were not stimulated 
with TNF had close to basal levels of secretion (not shown). When the lysates of the 
monolayers were analyzed by Western blot (Figure A.4) and immunofluorescence 
(Figure A.5) to check that recombinant IκB was delivered intracellularly, both the 
unelectroporated and electroporated monolayers showed the presence of the protein. This 
made it impossible to determine whether the protein was delivered to the cells.  It is 
likely that the extracellular protein was not sufficiently washed from the monolayers 
(despite repeated attempts to do so), which would have contaminated the 
unelectroporated control samples during the lysing required for the Western and the 







Figure A.3  IL-8 secretion by T84 monolayers after TNF stimulation was not inhibited by 




Figure A.4 Western blot analysis showed recombinant IκB present in the lysates of both 















































































































Figure A.5 Immunofluorescence staining for the His-Tag sequence also showed the 
presence of the protein in both (B) unelectroporated and (C) electroporated monolayers. 
(A) Monolayers that were not exposed to the protein and probed with an antibody to His-
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I. RECIPES FOR FLUORESCENT SOLUTIONS 
 
A. Calcein (1 mM stock solution) 
 
Supplies: 
• Small vial of high purity calcein (Molecular Probes) 
• Phosphate Buffered Saline (PBS) 
 
Procedure: 
1. To make 14 ml of 1 mM stock solution of calcein, measure out exactly 0.0087 g 
of calcein using a small weigh boat and spatula. 
2. Carefully pour the calcein powder into a 15 ml conical centrifuge tube. (Keep the 
weigh boat) 
3. Using the electric Pipet-Aid, add 5 ml of PBS to the calcein while also rinsing the 
weigh boat into the centrifuge tube.  
4. Wrap the centrifuge tube with aluminum foil (to protect the calcein from light). 
5. Vortex the solution for several minutes or until the calcein is dissolved. 
6. Add another 9 ml of PBS to the calcein solution. 
7. Vortex for another minute. 
8. Label the centrifuge tube with the date, the solution concentration, and your 
initials. 
9. Keep in refrigerator. 
 
 
B. FITC-labeled BSA (100 µM stock solution) 
 
Supplies: 
• Lyophilized FITC-labeled BSA (Molecular Probes – 25 mg vials or Sigma 
Chemical – 50 mg vials) 
• Hanks Balanced Saline Solution (HBSS) or Phosphate Buffered Saline (PBS) 
 
Procedure: 
1. To make 3 ml of 100 µM stock solution using the BSA from Molecular Probes, 
measure out exactly 19.8 mg of BSA using a small weigh boat and spatula. 
2. Carefully pour the BSA powder into a 15 ml conical centrifuge tube. (Keep the 
weigh boat) 
3. Using a manual pipet, add 1 ml of PBS or HBSS at a time to the BSA while also 
rinsing the weigh boat into the centrifuge tube.  
4. Pipet the solution up and down to dissolve the BSA. 
5. For the BSA from Sigma, add 7.6 ml of HBSS to the 50 mg vial of BSA.  
6. Mix well and aliquot into amber microcentrifuge tubes. 
7. Wrap the centrifuge tube with aluminum foil (to protect the BSA from light). 
8. Label the centrifuge tube with the date, the solution concentration, and your 
initials. 





C. Fluorescent Microspheres Solution 
 
Supplies: 
• 100% fluorescent intensity fluorescent microspheres from the LinearFlow™ 
Green Flow Cytometry Intensity Calibration Kit (use the most recently received 
kit) 
• Phosphate Buffered Saline (PBS) 
 
Procedure: 
1. Get a small test tube and place 1 ml of PBS into it. 
2. Vortex the bottle of microspheres to ensure that they’re well mixed 
3. Using the 10 µL pipettor and tip, insert the tip into the hole, turn the bottle up-side 
down and draw out 10 µL of beads. 
4. Add the beads to the PBS. 
5. Vortex.  
6. Write ‘µspheres’, the date, and your initials on the test tube and then wrap it in 
foil. 
7. Keep in refrigerator. 
 
 
D. MESF Bead Solution 
 
Supplies: 
• Package of 5 green-striped bottles of fluorescent calibration beads (in refrigerator 
door; made by Flow Cytometry Standards Corporation) 
• Phosphate Buffered Saline (PBS) 
 
Procedure: 
1. Get a small test tube and place 1 ml of PBS into it. 
2. Take the four bottles which have intensity values on the label and add about 5 
drops from each bottle to the PBS. 
3. Vortex.  
4. Write ‘MESF’, the date, and your initials on the test tube and wrap it in foil. 




II. RECIPIES FOR SALINE SOLUTIONS AND CELL CULTURE MEDIA 
 
A. Phosphate Buffered Saline (PBS) – 1X Solution  
 
Supplies: 
• 500 ml of filtered H2O (from the U.S. Filter tap by the sink) 
• 50 ml of 10X  PBS made by GibcoBRL (in the refrigerator) 
 
Procedure: 
1. Put the filtered water into one of the empty 500 ml media bottles on the shelf 
above the 37oC oven. 
2. Add the 10x PBS to the water. 
3. Using lab tape, label the bottle as follows: 1X PBS, nonsterile/sterile, date, 
initials. 
4. Keep in refrigerator. 
 




B. Hanks Buffered Saline Solutions (HBSS)  
 
Supplies: 
• 1 bottle of Hanks Balanced Salts (‘+’ or ‘-‘) - (located in the refrigerator) 
‘+’ = contains calcium and magnesium 
‘-‘ = does not contain calcium or magnesium 
• 10 ml HEPES solution (from Mediatech) 
• Filtered water 
 
Procedure: 
1. Obtain a 1000 ml graduated cylinder and fill it with 900 ml of filtered water. 
2. Pour the Hanks powder into the water. 
3. Add 10 ml of HEPES. 
4. Place stirring bar into solution and mix on stirring plate until Hanks is dissolved. 
5. Take cylinder of solution to the pH meter in the next lab and place on stirring 
plate. 
6. Check pH. 
7. Adjust pH as necessary to 7.4.  Use HCl to lower pH and NaOH to increase pH.  
(You should only need a few drops of either). 
8. Top off solution with filtered water to a final volume of 1000 ml.  
9. Check pH again. 
10. Sterily filter the HBSS (+) into two 500 ml containers using a 500 ml Steritop 
filter (has top only). 
11. Use lab tape to label the two containers as follows: HBSS (+/-), nonsterile/sterile, 
date, initials. 




C. DMEM Medium w/ antibiotics 
 
Supplies: 
• 500 ml Dulbecco’s Modified Eagle’s Medium (DMEM)  
• 5 ml Antibiotics (penicillin/streptomycin) 
 
Procedure: 
1. Add the antibiotics to the DMEM. (Use a pipettor to retrieve all of the antibiotic 
solution) 
2. Write ‘P/S’, the date, non-sterile, and your initials on the label. 




D. Electroporation Medium  - DMEM w/ 25 mM HEPES  
 
Supplies: 
• 500 ml Dulbecco’s Modified Eagle’s Medium (DMEM)  
• 12.5 ml 1M HEPES 
 
Procedure: 
1. Remove 12.5 ml of DMEM.  
2. Add HEPES to the DMEM.  
3. Write ‘DMEM + 25mM HEPES’, the date, sterile/nonsterile, and your initials on 
the label.  




E. Caco-2 Cell Culture Medium [STERILE!] 
 
Supplies: 
• 500 ml sterile Dulbecco’s Modified Eagle’s Medium (DMEM) – Denise’s 
refrigerator 
• 50 ml heat-inactivated Fetal Bovine Serum (FBS) - freezer 
• 5 ml antibiotics (penicillin/streptomycin) - freezer 
• 5 ml L-glutamine – freezer 
• 5 ml sterile HEPES - refrigerator 
• 5 ml sterile MEM nonessential amino acids – refrigerator 
 
You will have to work in the laminar flow hood for to make this media.  Don’t forget 
to work as far back in the hood as is comfortable.  Also, don’t leave any containers 






1. Thaw FBS, antibiotics, and glutamine in the 37oC water bath. 
2. Load all of the above, a Stericup filter assembly (has top and bottom), ethanol,  
paper towels, and marker onto a cart and take them to the hood. 
3. Lift hood door and turn on the blower. 
4. Spray hood down with ethanol and wipe with paper towel. 
5. Spray all bottles and filter assembly with ethanol and place them in the hood.  
6. Loosen the caps of the media bottles and the centrifuge tubes. 
7. Add the FBS, antibiotics, glutamine, HEPES, and MEM to the DMEM media 
bottle.  Make sure you get all of the antibiotics and glutamine. 
8. Cover the DMEM bottle. 
9. Open the Stericup filter assembly package in the hood. 
10. Lift the lid off the upper container and pour in the DMEM solution. 
11. Put the lid back onto the upper container.  Tape it down to help maintain sterility. 
12. Bring the entire assembly back to the lab bench. 
13. Hook up the filter assembly to the vacuum aspirator and turn on the vacuum. 
14. When the media solution has finished filtering into the bottom container, take the 
filter assembly back to the hood.  Spray it with ethanol before putting it into the 
hood. 
15. Unscrew the upper chamber and close the bottom container using the cap 
provided.  
16. Take the label from the original DMEM bottle (try not to tear it) and place it on 
the new container of DMEM complete media. 
17. Write ‘Caco-2 medium, STERILE, the date, and your initials on the label. 
18. Throw empty centrifuge tubes and empty DMEM bottle into biohazard box in our 
lab. 
19. Spray hood down with ethanol. 
20. Turn of blower and close hood. (If hood and blower were already open and on 
when you started, then leave them open and on). 
21. Keep media in refrigerator. Store no longer than 3 weeks. 
 
 
F. T84 Cell Culture Medium [STERILE!] 
 
Supplies: 
• 500 ml sterile DMEM/F12 medium  w/ 15 mM HEPES - refrigerator 
• 30 ml heat-inactivated newborn calf serum (NCS) - freezer 
• 5 ml antibiotics (penicillin/streptomycin) – freezer 
• (All reagents from Gibco, now Invitrogen) 
 
See instructions for making Caco-2 media. Follow the same procedure to make the 
T84 media. Label the bottle ‘T84 medium’, STERILE, the date, and your initials. 





III. SEEDING AND MAINTENANCE PROTOCOLS FOR CACO-2 AND T84 
MONOLAYERS 
 
Seeding protocols obtained from Dr. Susan Voss (cell culture technician) 
 
A. T84 Cells – cells seeded onto collagen-coated inserts 
 
1. Trypsinize cells from T-162 cm2 tissue culture flask, when cells are 
approximately 90% confluent (~1 week of culture). 
 
2. Resuspend cells in 20 ml of complete medium 
 
3. For flask culture – split 1:2 
a. Add 10 ml of cell suspension to each of 2 new culture flasks 
b. Add an additional 15-20 ml of complete medium to flasks 
 
4. For insert culture 
a. 0.33 cm2 insert: add 162 µl of cell suspension to each insert 
b. 4.7 cm2 insert: add 2 ml of cell suspension to each insert 
c. Place either 1 ml (for 0.33 inserts) or 2 ml (for 4.7 inserts) of warmed 
complete medium in wells. 
 
 
B. Caco-2 Cells – cells seeded onto collagen-coated inserts 
 
1. Trypsinize cells from T-75 cm2 tissue culture flask, when cells are approximately 
90% confluent (~1 week of culture). 
 
2. Resuspend cells in 10 ml of complete medium 
 
3. For flask culture – split 1:10 
a. Add 1 ml of cell suspension to new culture flasks 
b. Add an additional 12 ml of complete medium to flasks 
c. Feed cells once a week by completely replacing spent medium with fresh 
d. Split cells 3-4 days after feeding 
 
4. For insert culture 
a. 0.33 cm2 insert:  
i. Dilute the 10 ml cell suspension to 20 ml 
ii. Add 80 µl of diluted cell suspension to insert 
b. 4.7 cm2 insert:  
i. Add 150 µl of undiluted cell suspension to each insert 
ii. Bring up apical volume to 2 ml 
c. Place either 1 ml (for 0.33 inserts) or 2 ml (for 4.7 inserts) of warmed 
complete medium in wells. 
  
For monolayer feeding, wait 3-4 days after initial seeding to change medium. Change 
medium every 48 hrs for all subsequent feedings. Use a fresh pipet for each plate of 
inserts to minimize potential for contamination. 
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IV. MONOLAYER ELECTROPORATION PROTOCOL 
 
A. Setting Up 
 
1. Place two 50 ml conical centrifuge tubes of DMEM into the water bath. 
2. Place bottles of HBSS (+) and the non-sterile DMEM into the water bath. 
3. Rack and number microcentrifuge tubes, flow test tubes, and 15 ml conical 
centrifuge tubes. 
4. Get a tray full of ice. 
5. Take ____ 6-well plates and fill each well with 2 ml of the non-sterile DMEM. 
6. Make sure each plate is labeled and numbered. 
7. Cover each plate with foil and place half of them on ice and the other half in the 
37oC oven.  
 
 
B. Monolayer Electroporation 
 
1. Washing the Monolayers – for the removal of old media and dead cells 
 
Supplies:  
• warmed HBSS(+) solution 
• warmed DMEM 
• 200 ml beaker 
• forceps/tweezers 
• small plastic container (for waste) 
• 1000 ml glass beaker (for waste)  
 
Procedure: 
1. Fill the beaker about 1/3 full with warm HBSS (+). 
2. Holding the filter with the tweezers, carefully aspirate the old media from the top 
of the monolayer and from the bottom well. 
3. Gently dip the filter/monolayer into the HBSS. 
4. Slowly swirl the HBSS over the monolayer and pour it out into a waste container. 
(Be careful with this step.  If the HBSS is swirled too hard the monolayer could 
breakup). 
5. Repeat washing twice more. (When the HBSS becomes slightly pink, pour it into 
the waste container and replace it with fresh solution.) 
6. Pipet 2 ml of the warm DMEM into the bottom well. 
7. Place the filter back into the well.  Be careful not to create any air bubbles around 
the filter.  (If air bubbles do form, use the fine tip transfer pipet to remove them.) 
8. Gently place 2 ml of the warm DMEM on top of the monolayer. (Again be careful 
not to breakup the monolayer). 
9. Repeat steps 2 through 7 for each monolayer. 





2. TEER Measurements – to check monolayer integrity. 
 
Voltage Clamp System – see first lab notebook 
 
Millicell ERS – Test the Millicell apparatus using the ‘Test’ button and make sure the 
readout is 1000 and 1.00 for the 2000Ω and 2kΩ settings, respectively. Measure the 
resistance of a small amount of media in a 50 ml conical tube and make sure it reads 
around 12Ω. To measure the resistance of the monolayers, insert the chopstick 
electrodes into each of the three access ports located around the insert. Average the 
readings and subtract the resistance value for a cell-free insert. Multiply this value by 
the area of the insert (4.7 cm2) to obtain the TEER for the monolayer. 
 
 
3. Monolayer Preparation – for electroporation 
 
From this point forward, the monolayers have to be kept in the same order. 
 
Supplies: 
• non-sterile DMEM    
• 1 mM calcein stock solution 
• HBSS (+) 
• InSitu™ adherent cell electroporation chamber  
  
Procedure: 
1. Take a filter with tweezers and pour off the DMEM. 
2. Aspirate any remaining DMEM off the monolayer and the bottom of the filter. 
3. For Costar filters: Place 1.35 ml (1350 µl) of DMEM and 0.15 ml (150 µl) of 
calcein on top of the monolayer. 
4. For Millipore filters: Place 2.25 ml (2250 µl) of DMEM and 0.25 ml (250 µl) of 
calcein on top of the monolayer. 
5. Cover the plate with foil and allow the cells to incubate in calcein for about 3 
minutes. 
6. Meanwhile, place the bottom electrode of the cuvette into the InSitu 
electroporation chamber and put 3 ml of DMEM into it. 
7. Take the filter with the monolayer in calcein and put it into the bottom electrode. 
(Don’t make any air bubbles) 
8. Place upper electrode of the cuvette on top of the monolayer.  Make sure the 
upper electrode is in contact with the media. 










4. Electroporation – to introduce calcein or BSA into the cells 
 
Equipment: 
• BTX exponential-decay electroporator 
• HP 10:1 voltage probe 




1. Connect the BTX pulser, oscilloscope, and, if necessary, the current monitor as 
illustrated in the Figure on the next page. 
2. Set the voltage, capacitance, and resistance electroporation conditions on the BTX 
machine. 
3. Set up the oscilloscope for the desired voltage and pulse length. 
4. Pulse the cells. 
5. Record the peak voltage and pulse length values from the oscilloscope. (If you 
can’t get a reading from the oscilloscope, take these values from the BTX 
machine and make a note of it.) 
6. Place electroporated filter in the plate of warm media in the 37oC oven. (This 
helps the pores to reseal.) 
7. Record the time. 
8. Pour the 3 ml of DMEM in the bottom electrode into the waste container.  Rinse 
the bottom electrode with HBSS and dry it with a Kimwipe. 
9. Repeat the above for each monolayer. 
 
NOTE:  When finished electroporating, put trypsin in the 37oC water bath and make 
sure you have one or two 50 ml conical tubes of DMEM complete on hand. 
 
 
5. Washing the Monolayers – to remove excess calcein 
 
Supplies: 
• cold HBSS (+) solution 
 
Procedure: 
1. Dip the filter into cold HBSS (+) to rinse off calcein and pour it into the waste 
container. 
2. Check the monolayer after each dipping to make sure none of the cells have 
started to lift off.  If cells begin to lift off, stop washing.  
3. Repeat the washing step about 5 times for each monolayer or until cells start 
lifting off. 
4. Remove any excess HBSS (+) using a fine tip transfer pipet. 
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C. Dissociation of Monolayers for Flow Cytometry Analysis 
 
1. Trypsinization – to lift the cells off the filter membranes 
 
Supplies: 
• Warm (37oC) trypsin (to break up monolayer and lift off cells) 
• Complete medium w/ serum (to inactivate the trypsin) 
 
Procedure: 
1. Add 1 ml of warm trypsin to each filter and put plate into the 37oC oven (trypsin 
is most active at this temperature). 
2. NOTE: if most of the cells lift off at this point, add 3 ml of DMEM complete. 
3. Wait 5 minutes. 
4. Take a fine tip transfer pipet and gently squirt the trypsin onto the monolayer to 
check if any cells are lifting off.   
5. If most of the cells lift off then quickly add 3 ml of DMEM complete. 
6. If most of the cells are still adherent, put the filter back into the 37oC oven for 
another 5 minutes. 
7. Repeat as necessary. 
8. For the monolayers that have been lifted off, use transfer pipets to remove the 
media + trypsin + cells and put them into their corresponding 15 ml centrifuge 
tube.  Use a different pipet for each filter. 
9. Keep the tubes on ice. 
10. Take the centrifuge tubes to the large centrifuge and spin them down at 4oC and 
3200 rpm for 6 minutes. 
11. While the cells are spinning, put ice in the tray holding the microcentrifuge tubes 
and flow test tubes. 
12. When the cells are finished spinning, check for a pellet and then put the tubes 




2. Washing Cell Suspensions – to resuspend the cell suspensions in clear PBS. 
 
Supplies: 
• Cold PBS (w/o Ca2+ and Mg2+) 
 
Procedure: 
1. Pour the supernatant in the centrifuge tubes into the waste container.  Remove any 
excess supernatant. 
2. Add 1 ml of cold PBS to each tube. 
3. Gently pipet up and down to break up the cell pellet and put the resuspended cells 
into their corresponding microcentrifuge tube.  Use a different pipet tip for each 
sample. 
4. Spin the microcentrifuge tubes down in the Eppendorf microcentrifuge for 3 
minutes at 3200 rpm. 
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5. Check for pellet. 
6. Pour off PBS supernatant. 
7. Add 0.5 ml of cold PBS. 
8. Pipet up and down with transfer pipet. 
9. Spin the cells down again at the same settings. 
10. During the spinning down steps, put 5 µL of propidium iodide and 50 µL of well-
vortexed microsphere solution into each flow test tube.   
11. Repeat steps 5 through 9 three more times.   
12. Pour off PBS. 
13. Use transfer pipet to remove all remaining PBS (be careful of the pellet). 
14. Add exactly 0.5 ml of PBS and thoroughly resuspend the pellet into single cells. 
15. Transfer the cells to the flow test tubes. 
16. Keep the test tubes on ice. 




V. ANALYSIS OF SAMPLES USING THE BD LSR FLOW CYTOMETER 
 
1. Check sheath fluid tank and waste tank. 
a. Sheath fluid tank - release vacuum to open; Fill to rim if level is low. 
b. Waste tank - Empty if more than half full and add 400 ml of bleach 
 
2. Turn on power strip behind monitors and computer. 
 
3. Allow computer to boot and bypass the login prompt. 
 
4. Turn on the cytometer. If first user, allow cytometer to warm-up for 30-45 minutes. 
 
5. Make sure to do the following before running samples: 
a. Purge cytometer with bleach 
b. Set cytometer to Run and run bleach on Hi for 5 minutes. 
c. After running bleach, Run water for 5 minutes. 
 
6. Briefly vortex each sample before running 
 
7. Open "DigiFACS" software and stretch to fill screen. 
 
8. Double click to open the "Esi-Caco2" experiment. This may take a little while. The 
last run experiment and data will open on the screen. 
 
9. Click "Worksheet" on the menu bar and choose "New Worksheet". 
 
10. Click inside the empty space of the new worksheet and go to the new panel on the far 
right. Do the following: 
a. Rename the worksheet with today's date - (mmddyy) 
b. Put today's date in the "data collected" field - (mmddyy) 
c. Set number of horizontal pages to 2 
d. Check show page breaks and page number 
 
11. Go back to the experiment list on the far left panel, right-click "Esi-Caco2", and 
choose "New Specimen". 
 
12. Click on the new specimen ("Specimen_001 ") and rename it with today's date in the 
"Collected" field on far right panel. - (mmddyy) 
 
13. Delete the "Tube_001" that has been created automatically in the specimen folder.  
 
14. Open a previous specimen folder using similar conditions to the current experiment, 
right-lick on "Tube_001" of that experiment, and copy the tube. 
 
15. Re-open today's specimen folder, right-click the folder, and select "Paste" to insert the 
tube information. This will bring up blank plots already set up with gates as well as 





Plot #1 – SSC vs. FSC (w/ P1 = cells) 
Plot #2 – PerCP vs. FSC (gated on P1, regions P2 = viable and P3 = dead) 
Plot #3 – PE vs. FSC (gated on P1) 
Plot #4 – FITC vs. FSC (region P4 = beads) 
Plot #5 – Histogram of FITC (gated on P2) 
 
16. Make sure the small arrow next to the new tube is green so that the new data will be 
saved here. 
 
17. Check the Acquisition Rules under the Acquisition Tab and specify the following:  
a. # Events = 20,000 
b. Stopping: P2 
c. Storage: All Events 
 
18. Use the following commands to perform the following actions while running 
samples: 
a. To run sample without saving: click Acquire 
b. To run sample and save data: click Acquire then Record 
c. To restart collection while acquiring: click Restart 
d. To stop collection: click Acquire again 
 
19. When sample has finished collecting, click "Next" to create a new tube and set up 
system for the next sample. 
 
20. After running all samples: 
a. Run bleach for 5 minutes 
b. Run water for 5 minutes 
c. Set cytometer to Standby 
 
21. To save Data: 
a. Select today's specimen 
b. Select File, then Export 
c. Specify FACS 2.0 and click Next 
d. Specify export location (D:\export) and click details to make sure all tubes 
were exported 
 
22. To Shutdown cytometer: 
a. Close DigiFACS Software 
b. Shutdown computer 
c. Turn off cytometer 
d. Turn off power supply 
 
NOTE: These instructions were used for the original DigiFACS software. The system has 
since been upgraded. See Johnafel Crowe for instruction on how to use the new software. 
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VI. ANALYSIS OF FLOW CYTOMETRY DATA WITH WINMDI SOFTWARE 
 
1. Double click on ‘WinMDI 2.8’ icon. 
2. Select Density Plot and then click OK 
3. Go to folder  where flow data is located (I name folders by date and individual flow 
files either by date or Tube #) 
4. Open  flow file with extension *.001 (e.g., MMDDYY.001 or Tube.001) 
5. Set the X-axis to ‘FSC-H’ and the Y-axis to ‘SSC-H’.   PLOT A 
6. Change ‘Smooth’ to 2, uncheck ‘Calculate Colors’ and Click OK 
7. Select ‘Display’ from the menu at the top, then select ‘Density Plot’. 
8. Select the first flow file in the group again. 
9. Set X-axis to FSC-H and Y-axis to FL3 (PerCP channel) and Click OK.  PLOT B 
(NOTE:  can also use FL2 (PE channel)  
10. Select Display-Density Plot 
11. Select the first flow file in the group again. 
12. Set the X-axis to FL1-H and the Y-axis to FL3.    PLOT C 
13. Activate SSC-FSC graph (click on) 
14. Click left mouse button-Regions 
15. Create R1 
16. Click buttons to create region R1 (as shown below) 
17. Click left mouse button-Regions 
18. Create R2 (as shown below) 
**The graph should look like the plot A located below on the left.** 
19. Click on the line in the upper right hand corner of box to minimize 
20. Activate FL3-FSC graph (click on) 
21. Click Left Mouse button-Gates, set R1 to OR [+] 
22. Click left mouse button-Regions 
23. Create R3 (as shown below) 
24. Click buttons to define region R3 
25. Click left mouse button-Regions 
26. Create R4 (as shown below) 






28. Click left mouse button-‘Stats’ on PLOT #2; Format box so the following columns 
are showing (not necessarily the same numbers): 
 
File: **.001 
Sample ID:  
Gated Events 9294 
FSC-Height (1) vs FL3-H (5) 
Region   X-Mean  Y-Mean  Events  
R0         404.5    246.7    9294   
R1         404.5    556.5    9294   
R2          0.0      0.0        0    
R3         412.9    15.9     8147   [No. of viable cells] 
R4         338.9   1956.3    1080 [No. of dead cells] 
 
29. Click on the line in the upper right hand corner of graph to minimize. 
30. Activate Plot #3, the  FL3 vs. FL1 graph (click on) 
31. Click Left Mouse button-Gates, set R2 to OR [+] 
32. Click left mouse button-Regions 
33. Create R5 (as shown below) 




**The graph should look like this one.  If there appear to be no beads, ALT-PAGE 
DOWN to a sample that does have beads and make a gate around that. Then ALT-PAGE 









35. Click left mouse button-Stats; Format box so the following is showing: 
File: 072299.001 
Sample ID:  
Gated Events 9294 
FL1-Height (1) vs FL3-H (5) 
Region   X-Mean  Y-Mean  Events  
R0         404.5    246.7    9294   
R1         404.5    556.5    9294   
R2          0.0      0.0        0    
R3         412.9    15.9     0   
R4         338.9   1956.3    10 
R5  222.3  222.1  3333  [No. of beads] 
 
36. Click on the line in the upper right hand corner of graph box to minimize 
**You should now have only two text boxes open and three graphs minimized** 
 
 
37. Select the ‘Display’ function from the menu, then select ‘Histogram’. 
38. Open (***.001), the first flow file of the group. 
39. Change the read parameter to FL1 and Click Read 
40. Click/Drag on corner of box to make bigger 
41. Click left mouse button-Gates, gate on  R1 and R3 by clicking AND [*] for both 
42. Click OK 
43. Click left mouse button-Stats (Click Format button and make sure % GATED, 
MARKERS, EVENTS, MEAN/CV, MEDIAN are checked.) 
44. Click left mouse button-Marker 
45. Set Marker 1 from 1-1023, click OK 
46. Set Marker 2 from 1 to a number that makes the % gated value for M3 equal 97% of 
the percent gated value in M1. 
 
**You are now ready to begin collecting data; write down the values in a table**  
 
47. Record total EVENTS for R3 (Viable) and R4 (Dead) from the FL3 vs. FSC plot stats 
48. Record total EVENTS for R5 (Beads) from the FL1vs. FL3 plot stats  
49. Record total %GATED, MEDIAN, MEAN, CV from M3 from the FL1 histogram 
stats  
50. For each new sample (ALT-PG DOWN), adjust M3 such that the value is 97% of that 
in M1 
 
**Once finished, need to obtain data from calibration beads (usually the last sample in 








51. Open new copy of the WinMDI Flow Cytometry Program. 
52. Create Density Plot (Y-axis = FL1; X-axis = FSC)  
53. Left mouse button-Region 
54. Define Region 1 as follows below so that all four bead populations are included. 
 
 
55. Display-Histogram (FL1) 
50. Gate on R1 [+] 
51. Create Markers around each peak 




Sample ID:  
Gates: +R6 
Gated Events: 14468 
Param name M  Low,High Events %Total  %Gated  Mean CV Peak,Value 
Calcein 0 0,1023 14468 80.80   100.00 14.53 1507.08  2685,1 
 1 19, 118 4851 27.09   33.53  1.94 3721.02  173,1.91095
 2 118, 218 2676 14.94   18.50  4.45 3626.40  107,4.41094
 3 222, 372 2014 11.25   13.92 12.56 2134.91  131,12.2983
 4 375, 594 2220 12.40 15.34 72.04 559.17    152,70.4136
 
               
**Now you are ready to enter values into the spreadsheet** 
**Save all values, R3, R4, R5 for each sample, Marker 3 - Median, Mean, CV for each 
sample and MESF calibration bead values in  a separate spreadsheet ** 
 
53. Don’t forget to save and exit!!!! 
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VII. MOLECULAR BIOLOGY PROTCOLS 
A. IL-8 ELISA – Protocol was obtained from Dr. Lauren Collier-Hyams in Dr. Neish’s Lab. It has been modified to show 
more detail.  
 
Supplies: 
• Hanks Balanced Saline Solution (HBSS) – w/ calcium and magnesium 
• 0.1 M NaHCO3 (pH 9.6) 
• 10X Wash Buffer – 25 ml aliquots stored at -70°C 
(5% Goat Serum + 1% Tween-20 in HBSS or PBS) 
• 96-well plates w/ covers (Linbro®/Titertek®, ICN Pharmaceuticals, Aurora, OH) 
• Antibodies: 
o Anti-human IL-8 capture antibody (R&D Systems) 
o Anti-human IL-8 antibody from rabbit (Endogen) 
o Peroxidase-labeled anti-rabbit antibody (KPL) 
• TMB Microwell Peroxidase Substrate (KPL) 
• Recombinant human IL-8 protein standard (R&D Systems) 
 
Dilution Scheme for IL-8 Standards (Conc. Ranging from 0.0195 to 20 ng/ml): 
Standards made by 10 serial dilutions (in the same buffer as the samples) of a 20 
ng/ml solution of IL-8. 20 ng/ml solution is made by diluting 2 µL of 10 µg/ml IL-8 
stock in 1 ml of buffer. 
 
Vol. Transferred: 0.5 ml 0.5 ml 0.5 ml 0.5 ml 
 
 
Vol. in Tube: 1 ml     0.5 ml 0.5 ml 0.5 ml 0.5 ml  et c. 
IL-8 Conc. 20 ng/ml 10 ng/ml 5 ng/ml 2.5 ng/ml 1.25 ng/ml 
  
Procedure: 
1. Coat 96-well plate with 100 µL R&D Systems anti-human IL-8 capture antibody.  
Dissolve 40 µL aliquot of antibody in 5 ml of bicarbonate buffer (need 10 ml for a 
whole plate) for a final concentration of 8 µg/ml. Cover plate and incubate 
overnight at 4°C. 
2. Pour off capture antibody solution. Wash plate 4 times with wash buffer. Pat 
overturned plate on a stack of paper towel to remove excess liquid. 
3. Add IL-8 containing samples and standards (100 µL per well) and incubate plate 
1 hour at 37°C to allow IL-8 to bind capture antibody. Do two replicates of 
standards. 
4. Pour off samples and standards. Wash plate 4 times with wash buffer. 
5. Add Endogen anti-human IL-8 antibody (100 µL per well) to sandwich bound IL-
8. Dissolve 40 µL aliquot in 5 ml of wash buffer (need 10 ml for whole plate).  
Incubate plate 1 hour at 37°C. 
6. Pour off Endogen antibody. Wash plate 4 times with wash buffer. 
7. Add peroxidase-conjugated anti-rabbit antibody (100 µL per well) to bind the 
primary antibody and allow detection of IL-8. Dilute the antibody 1:7000 in wash 
buffer (1.43 µL in 10 ml). Incubate plate 1 hour at 37°C. 
8. Pour off detecting antibody. Wash plate 4 times with wash buffer. 
9. Add KPL peroxidase substrate (100 µL per well). Gently shake plate and wait 5 - 
10 min to allow color develop.  
10. Read plate on absorbance spectrophotometer at wavelength of 650 nm. 
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B. Plasmid Amplification and Purification5 – Protocols written up by Amelia Tomlinson of Dr. Neish’s  
  Laboratory. More detail has been added when necessary. 
 
The following series of steps should be taken whenever any new plasmid is prepared or 
received.  Though many little steps are involved, you will save yourself a great amount of 
time and effort in the long run.  Detailed protocols for each of these steps follow. 
 
1. Transform bacteria with your new plasmid. 
 
2. Streak out a single colony of the bacteria on an agar plate with the appropriate 
antibiotic(s) for selection of plasmid-carrying bacteria. 
 
3. Grow a small culture of the plasmid-carrying bacteria from a single colony, in 
media with the appropriate antibiotic(s).  Make a small preparation (mini- or 
midi-prep) of the plasmid. 
 
4. Conduct the appropriate restriction digests for your plasmid. 
 
5. Assess the plasmid construction by agarose gel electrophoresis. 
 
6. If plasmid is properly constructed, store the remaining sample at -20°C.  Never 
use this aliquot for transfections, etc.  It should be saved as a “sacred” stock to be 
used ONLY for future transformations, in the unfortunate scenario that they may 
be necessary.  
 
7. Making a larger batch of plasmid for use in transfection experiments. 
a) Grow a large culture of bacteria and make a large-scale prep of the plasmid.   
b) Check this batch of plasmid by digest and electrophoresis.   
c) Quantify yield by spectrophotometry.  This batch will serve as your 
working stock.   
d) Store at -20°C.   
 
8. Make a glycerol stock of the transformed bacteria, and store at -80°C.  Future 
cultures of the bacteria for plasmid preparations may be started directly from 
these frozen stocks. 
                                                 
5 Many of the protocols in this section can be found in the popular protocol book,  Molecular Cloning:  A 
Laboratory Manual (2001), by Sambrook, Fritsch and Maniatis. 
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1. Bacterial Transformation 
 
Bacterial transformations should be conducted according to the manufacturer’s 
protocol.  We’ve had good results with commercially available E. coli bacterial 
strains such as:  Stratagene’s XL1-Blue Subcloning Grade Competent (catalog# 
200130) or SoloPack™ Gold SuperCompetent (catalog# 230350-41) Cells and 
Invitrogen’s Subcloning Efficiency (catalog# 18265-017) or MAX Efficiency (catalog# 
18258-012) DH5α Competent Cells.   
 
1. You can transform as little as 0.5 µl of pure plasmid DNA into 50 µl of competent 
cells. (I usually transformed 1 to 3 ng of DNA into cells.) There is no need to use 
more than 50 µl cells per transformation unless the plasmid concentration is 
extremely low (>0.001 µg/µl). Include a tube of cells with no plasmid DNA as a 
control.   
 
2. The next steps should be performed under a Bunsen burner to maintain sterility. 
 
3. When spreading the transformed cells, dilute the cells 1:10 in 150 µl of LB 
(recipe below), which was placed in the center of a pre-warmed LB-agar plate 
containing the appropriate selective antibiotic (the manufacturer will provide 
information about the antibiotic concentration). The cells should be spread with a 
sterilized metal spreader, until the liquid is absorbed. 
 
4. Cover the plates and incubate them agar side up (to prevent condensation on the 
agar) overnight at 37°C. The plate with the transformed cells should have several 
colonies of bacteria, while the control plate should be colony-free because of the 
lack of resistance to the selective antibiotic. Plates should only incubate O/N up to 
~24 hrs or they will begin to overgrow and the colonies will no longer be isolated. 
Seal the plates with parafilm and store at 4°C until needed. 
 
Luria-Bertani Broth Recipe 
Manuf.: EM Science 
Cat.#: 1.00547.0500 
Composition:  10g/L peptone for casein 
   5 g/L yeast extract 
   5 g/L sodium chloride 
 
Preparation: 
a. Suspend 20 g of LB powder in 1 L (1000 ml) of purified water. Adjust the 
amount of powder and volume of water as necessary. 
b. Autoclave (15 min @ 121°C) 








2. Streaking Out a Single Colony of Bacteria 
 
After transforming bacteria and spreading on the appropriate plates, you will 
hopefully yield isolated colonies of bacteria.  It is important to streak a single colony 
of bacteria onto a fresh plate, in order to have a pure culture from which to start 
cultures for purification of plasmid DNA. 
 
1. A single colony from the plate of transformed bacteria should be “picked” using a 
flame sterilized platinum wire loop or a sterile toothpick. 
2. Streak the bacteria on a new pre-warmed LB + selective antibiotic agar plate.   
3. Incubate the plate at 37°C overnight.  
4. Seal plate with parafilm and store at 4°C until needed. 
 
 
3. Small Plasmid Prep to Check Transformation 
 
Pick another colony to inoculate 5 ml of liquid LB + selective antibiotics. Incubate 
the cells in a 37°C shaker (~250 rpm) (Innova™ 4430, New Brunswick Scientific, 
Edison, NJ) for 8 hours or overnight to allow the bacteria to grow. This liquid culture 
will be used to isolate a small amount of plasmid to check that the transformation was 
successful. The Qiaprep Spin Miniprep Kit (Qiagen, Valencia, CA), which has an 
expected yield of 20 µg of plasmid, works well for isolation and purification of the 
plasmid. Just follow the manufacturer’s instructions. 
 
 
4. Restriction Digests of Plasmids 
 
Digests (or cutting) of the plasmids are performed to confirm the construction of your 
plasmid. Digests are performed using restriction enzymes, which cut at specific 
locations in the plasmid DNA sequence. The sites of restriction must be identified 
using the plasmid map, which can be obtained from the manufacturer. 
 
1. Choose 1 or 2 enzymes that will cleave the plasmid to yield 2-3 detectable size 
fragments (>500 bp). If you choose 2 enzymes, set up 3 digests – 1 with each 
enzyme separately and 1 with both enzymes. Try to use common cheap enzymes 
for this purpose (EcoRI, HindIII, SalI, PstI, BglII, KpnI, etc.). Remove enzymes 
just before you are about to use them. Since, the enzymes are easily denatured at 
room temperature, keep them cold while they are out of the freezer. 
 
2. The restriction buffer you use will depend on the enzymes you choose. Check the 
catalog of the company that made your enzymes, to determine which buffers to 








3. Digest reactions are usually set up in the following manner. 
 
Reaction: xx µl ddH2O 
    x µl plasmid DNA 
    x µl 10X restriction buffer 
    x µl enzyme 1 
    x µl enzyme 2 (if necessary)  
  xx µl total volume     
 
Typically, only 1 or 2 µg of DNA is digested with 1 µl of each enzyme. The 
volume of restriction buffer should be 10-fold less than the total volume. Use the 
water to bring up the reaction volume. The total reaction volume can range from 
25 µl – 50 µl. Add all reagents in the order listed and mix by flicking the tubes. 
Spin down in a centrifuge to get all liquid in the bottom of the tube.  
 
4. Allow reactions to digest for 2-3 hrs in a water bath at the appropriate temperature 
(usually 37°C) in a foam/plastic floater. Make sure to check what temperature the 
enzyme works best at by looking in a New England Biolabs or Promega catalog. 
A given enzyme will always function at the same temperature and in the same 
buffer, no matter what company it was purchased from. 
 
For more information about performing restriction digests, check the manufacturer’s 
catalog or website. New England Biolabs has a particularly good website. 
 
 
5. Agarose Gel Electrophoresis 
 
Sourced from Chapter 6 of: Molecular Cloning:  A Laboratory Manual, Sambrook, 




50X TAE Stock Solution 
121 g Tris Base 
28.55 ml glacial acetic acid 
50 ml 0.5M EDTA, pH 8.0 
 
Dissolve tris base in just under 400 ml mqH2O.  Add glacial acetic acid and EDTA 
solution. Bring to a final volume of 500 ml. 
 
0.5M EDTA, pH 8.0 
Dissolve 9.3 g EDTA in nearly 500 ml mqH2O.  Adjust pH to 8.0 with NaOH 






Preparation of 1% Agarose/TAE Gel 
Agarose gels are used to separate DNA (and RNA) fragments, so that information 
about the size and construction of the molecule can be obtained. 
 
For small gel apparatus (Easy-Cast Electrophoresis System #B1A, Owl Scientific, 
Portsmouth, NH)  
0.5 g agarose         
50 ml 1X TAE        
2 µl - 5 µl ethidium bromide 
 
1. Melt agarose in TAE in microwave for 30 s in 250 ml glass Erlenmeyer flask. 
Swirl flask to mix. Microwave in additional 10 sec increments until agarose is 
completely melted. Swirl between each heating period. Do not allow solution 
to boil over.  
 
2. Let agarose solution cool on bench until it is warm to the touch. Add ethidium 
bromide, a DNA dye that fluoresces under UV light, and pour into gel caster. 
Immediately pull any bubble to the side of the gel using a fine pipet tip.  
 
3. Gel takes ~45 min. to set. Place gel and caster in electrophoresis chamber (gel 
box) and pour TAE buffer until gel is just covered (~1 mm above gel). 
 
 
Preparation of DNA Samples for Agarose Gel  
 
1. Start with approximately 100-500 ng DNA. I usually took 10 µl of solution 
from the restriction digest reactions. If checking plasmid directly from a 
plasmid prep, take appropriate amount of plasmid and dilute to 10 µl with 
mgH2O. 
2. Add 2 µl 6X gel loading dye (Blue/Orange Loading Dye, Promega). 
3. Mix well. 
 
 
Running the Gel 
 
1. Load 10 µl of your samples per lane. 
2. Load ~10 µl of a 1 kb DNA ladder (New England BioLabs) containing DNA 
standard fragments of known size (1 kb ladder or Lambda/HindIII ladder 
should be fine for most purposes; use 100 bp ladder only when looking at very 
small fragments <400 bp) 
3. Run gel at a constant 90 volts (PowerPac 300, Bio-Rad, Hercules, CA) using 
1X TAE as the running buffer. 
4. After the gel finishes running (orange dye front is ¾ of the way to the end of 
the gel) turn off power to the gel box.  
5. Remove the gel on the tray from the apparatus and check it on a UV light box 
(Transilluminator, VWR Scientific, West Chester, PA) to make sure there is 
enough separation between the fragments.  
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6. I  photographed the gel using the AlphaImager™ 2200 Documentation and 
Analysis System (Alpha Innotech Corp., San Leandro, CA). 
7. If there are unused lanes, return gel on tray to buffer tank for use later (1-2 
days) and secure lid so that the buffer does not evaporate 
 
 
6. Sacred Stock of Plasmid 
 
If plasmid is properly constructed, store the remaining sample at -20°C.  Never use this 
aliquot for transfections, etc.  It should be saved as a “sacred” stock to be used ONLY 
for future transformations, in the unfortunate scenario that they may be necessary.  
 
 
7. Purification of Larger Batches of Plasmid 
 
a. Large-Scale Plasmid Prep 
  
Depending on the amount of plasmid needed, different commercially available 
plasmid purifications kits were used.  
 
- QIAGEN or QIAfilter Endofree Giga Prep Kit (yield: 10 mg from 2.5 L 
bacterial culture) 
 
- QIAGEN or QIAfilter Endofree Mega Prep Kit (yield: 2.5 mg from 500 ml 
bacterial culture) 
 
- Promega Wizard ® Plus Midipreps Kit (yield: 200 µg from 100 ml bacterial 
culture)  
 
Note 1: The non-endofree versions of the QIAGEN kits can also be used. 
Note 2: I usually performed two Wizard Midipreps and combined the plasmid solutions 
after purification. 
 
i. For each kit, inoculate a starter culture of 10 ml LB + selective antibiotic with a 
single bacterial colony from the most recent agar plate made.  
 
ii. Allow the cells to grow in a 37°C shaker (~250 rpm) for ~8 hrs and then dilute the 
culture as indicated by the manufacturer’s instructions into the appropriate 
volume of LB with selective antibiotics. 
 
iii. Remember to read the instructions, warnings, and tips before beginning this part 
of the protocol – there are multiple steps where you have additional options to 
consider that may increase your DNA yield or purity. 
 
b. Check Plasmid Prep 
 
Repeat steps 4 and 5 with a sample of your large-scale prep. If you have any lanes 
left over from the gel used 1-2 days ago, you may use them here. 
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c. Quantify Plasmid by Spectrophotometry 
 
The concentration of the purified plasmid can be determined by UV 
spectrophotometery. At a wavelength of 260 nm, 50 µg/ml of double stranded DNA 
has an optical density of 1.0. The concentration of the plasmid can be calculated 
based on this relationship. By taking the ratio of the optical density at 260 nm to that 
at 280 nm, an indication of the purity of the plasmid solution can be obtained. Pure 
DNA solutions have ratios approximately equal to 1.8 (ratios between 1.8 and 2.0 
are acceptable). A ratio less than 1.8 or greater than 2.0 indicates the presence of 
contaminating impurities and requires the re-precipitation of the DNA (see Step 9). 
 
i. Turn on spectrophotometer, select dsDNA program (or manually set λ=260), and 
allow UV light to warm up. 
 
ii. Put 1 ml ddH2O in a quartz cuvette, place in the spec, and blank the machine 
against it. (If your DNA is suspended in TE buffer, then use that to blank the 
machine). 
 
iii. If frozen, thaw DNA sample to be tested on ice. 
 
iv. Dilute 1 – 5 µl DNA solution into a quartz cuvette containing 1 ml ddH2O. 
 
v. Cover the top of the cuvette with parafilm and invert to mix. 
 
vi. Place the cuvette into the spec, making sure to orient the cuvette such that the 
light beam will pass through the clear windows of the cuvette. 
 
vii. Close the spec lid and record the readings at λ = 260 nm and at λ = 280 nm. 
 
viii. If you have enough sample, repeat steps iv – vii twice more and average the 
readings. 
 
ix. Take the average A260 reading and multiply it by 50 to obtain the concentration in 
µg/ml. Then multiply by the appropriate dilution factor (e.g., 1000 for 1 µl DNA; 
200 for 5 µl DNA) to obtain the final concentration. 
 












8. Preparation of Glycerol Stocks of Bacteria 
 
Frozen stocks of bacterial culture should be maintained for use in future plasmid 
purifications. All steps should be carried out in media containing the appropriate 
antibiotics. 
 
1. Inoculate a 10 ml volume of LB with a single colony for overnight growth in a 
37°C shaker. 
 
2. From the resulting stationary phase culture, subculture 0.5 ml into 2.0 ml LB.   
 
3. Grow in shaker-incubator for 2 to 3 hours, until culture is at mid-log phase of 
growth. 
 
4. To resulting 2.5 ml culture, add 0.5 ml 50% glycerol (filter-sterilized).  Make 3 X 1 
ml aliquots and freeze at -80°C.  Glycerol is toxic to the bacteria, but necessary for 
freezing. Therefore, freeze aliquots as quickly as possible after addition of glycerol 
to reduce bacterial death. 
 
Only a small amount of the glycerol stock needs to be inoculated onto a plate or into 
liquid media.  Therefore, glycerol stocks may be conserved by scraping the frozen 
stock with a sterile loop or wooden stick, without allowing the stock to thaw, and 
inoculating LB or streaking on a plate. Alternatively, if stock does not need to 
preserved, thaw and spread the solution onto a plate containing appropriate antibiotics.   
 
 
9. DNA Precipitation and Resuspension 
 
If your DNA concentration is low after the large scale plasmid prep or if your solution 
has impurities, it is possible to re-precipitate the DNA with isopropanol and then 
resuspend it. 
 
1. Add 1 ml isopropanol to <600 µL DNA (if > 600 µl, split into 2 tubes) and mix 
until white threads are visible. Can also add 0.7 volume of isopropanol to DNA 
solution. 
 
2. Spin 10 minutes at highest speed (13,000 rpm) in benchtop centrifuge at room 
temperature.  Carefully pour off isopropanol. 
 
3. Wash pellet once with 0.5 ml 70% EtOH. Add EtOH to tube containing pellet and 
vortex – do not pipet (which will shear your plasmid DNA). 
 
4. Spin 5 minutes as in step 2.  Carefully pour off EtOH. 
 
5. Drain excess EtOH from tube by inverting onto a paper towel. 
 
6. Dry pellet in heat block or incubator at ~37°C for 5 minutes or less. 
 
7. Suspend pellet in desired volume Elution buffer (if using Qiagen prep), dH2O, or 









 Use: GFP expression vector 
 Source: Clontech 
 Map: available from manufacturer 
 Competent Cell Line:  MAX® Efficiency DH5α Competent Cells (Invitrogen) 
 Antibiotic Selection: kanamycin (30 µg/ml) 
 Restriction Enzyme(s): XhoI and NotI (yield 2 fragments) 
 Example Restriction Digest (note Buffer type): 
   
 Uncut Cut 
ddH2O 25 µl 23 µl 
pEGFP-N1 (~1.5 µg) 2 µl 2 µl 
Buffer 3 3 µl 3 µl 
XhoI --- 1 µl 
NotI --- 1 µl 
Total Volume 30 µl 30 µl 
    




 Use: luciferase expression vector 
 Source: Promega 
 Map: available from manufacturer 
Competent Cell Line: MAX® Efficiency DH5α Competent Cells (Invitrogen) 
 Antibiotic Selection: ampicillin (100 µg/ml) 
 Restriction Enzymes: XhoI and BamH I (yield 2 fragments) 
 Example Restriction Digest (note Buffer type): 
 
 Uncut Cut 
ddH2O 24 µl 22 µl 
pGL3 (~1.5 µg) 3 µl 3 µl 
Buffer 2 3 µl 3 µl 
XhoI --- 1 µl 
BamH I --- 1 µl 
Total Volume 30 µl 30 µl 
    











 Use: HA-tagged IκBα expression vector 
 Source: Neish Laboratory 
Map: not available  
 Competent Cell Line: SoloPack™ Gold Supercompetent Cells (Stratagene) 
Antibiotic Selection: ampicillin (100 µg/ml) 
 Restriction Enzymes: SmaI and BglII (yield 2 fragments) 
Example Restriction Digest: since both enzymes were not 100% active in a 
single buffer, the digest had to be carried out in two parts.  
 
 Digest #1:  
 Uncut Cut 
ddH2O 39 µl 37 µl 
pIkB-HA (~2 µg) 6 µl 6 µl 
Buffer 4 5 µl 5 µl 
SmaI --- 2 µl 
Total Volume 50 µl 50 µl 
 Let run overnight at 25°C 
Digest #2:  
 Cut 
Cut Digest #1 25 µl 
ddH2O 10 µl 
Buffer 3 4 µl 
BglII 1 µl 
Total Volume 50 µl 






 Use: CAT expression vector with IL-8 promoter 
 Source: Neish Laboratory 
 Map: not available 
 Competent Cell Line: probably DH5α 
 Antibiotic Selection: ampicillin (100µg/ml) 
 Restriction Enzymes: XhoI and BamH I (yield 2 fragments) 
 Restriction Digest: 
  
 Uncut Cut 
ddH2O 21.5µl 19.5 µl 
pIL8-CAT (~1.5 µg) 1 µl 1 µl 
Buffer 2 2.5 µl 2.5 µl 
XhoI --- 1 µl 
BamH I --- 1 µl 
Total Volume 25 µl 25 µl 












 Use: luciferase expression vector with NFκB promoter 
 Source: Stratagene 
Map: available from manufacturer 
 Competent Cell Line: MAX® Efficiency DH5α Competent Cells (Invitrogen) 
 Antibiotic Selection: ampicillin (100µg/ml) 
 Restriction Enzymes: (yields ?? fragments) 
 Restriction Digest: 
 
 Uncut Cut 
ddH2O 44 µl 42 µl 
pNFκB-Luc (~1.5 µg) 1 µl 1 µl 
Buffer 4 5 µl 5 µl 
Eco0109I --- 2 µl 
Total Volume 50 µl 50 µl 





 Use: luciferase expression vector 
 Source: Neish laboratory 
 Map: not available 
 Competent Cell Line: MAX® Efficiency DH5α Competent Cells (Invitrogen) 
 Antibiotic Selection: ampicillin (100µg/ml) 
Restriction Enzymes: BamH I and EcoRI (yield 2 fragments). Can also cut with 
just EcoRI, which also yields 2 fragments. 
 Restriction Digest: 
 
 Uncut Cut 
ddH2O 42.2 µl 40.2 µl 
pCMV-Luc (~1.5 µg) 2.8 µl 2.8 µl 
EcoRI Buffer 5 µl 5 µl 
EcoRI --- 1 µl 
BamH I --- 1 µl 
Total Volume 50 µl 50 µl 




D. Western Blots: From Start To Finish 
Protocols adapted from several sources and written up by Amelia Tomlinson of Dr. Neish’s Laboratory. More detail has been added 
when necessary.  
 
1. Sample Lysis in SDS Lysis/Loading Buffer 
  
SDS-Loading Buffer Recipe for Cell Lysates 
 10 ml at 1X 10 ml at 2X 
1M Tris pH 6.8 625λ 1250λ 
Glycerol 1000λ 2000λ 
20% SDS 1000λ 2000λ 
1M DTT 500λ 100λ 
Type II Water 6875λ 3750λ 
Bromophenol Blue just a tiny pinch 
 λ = microliters (µl) 
2X SDS-Loading Buffer can be kept in aliquots at -20°C indefinitely.  Thaw and 
dilute to 1X with dH2O for use.  Do not re-freeze. 
 
Have ready:   
1. Enough ice buckets to spread out all of your plates in a single layer 
2. Chilled SDS-Lysis/Loading buffer 
3. Cold 1X PBS or HBSS(+) on ice 
4. A rubber policeman 
5. Microtubes for samples (keep in ice) 
 
To lyse (for 4.7 cm2 inserts)*: 
1. Take six-well plates with monolayers on inserts out of incubator and place 
directly on ice. 
2. Wash all monolayers twice with ice-cold PBS or HBSS(+).  Wash gently so 
that cells are not detached from inserts (i.e., don’t pipet PBS/HBSS directly 
onto center of monolayer – pour it down the inside of the insert). 
3. Add 500λ cold SDS-Lysis/Loading buffer to each monolayer.  Scrape cells 
with a rubber policeman until you are certain that all cells have been collected.  
Make sure you rinse the rubber policeman in a beaker of PBS or HBSS(+) 
between scraping each sample, to avoid contamination. 
4. Transfer lysed samples to labeled microtubes (2 aliquots per sample). 
5. Keep tubes on ice until all samples are collected, then transfer to -80°C freezer. 
 
*For the 0.33 cm2 inserts, monolayers were lysed in 50 µl of lysis buffer 
 
Remember: 
Keep everything as cold as possible by working as quickly as possible and having all 
samples directly on the ice as much as possible (as opposed to, say, holding the 




2. SDS-PAGE Gels 
Protein electrophoresis was carried out using the Lamelli discontinuous gel system 
(Sambrook and Russell, 2001), which is composed of a lower separating gel and an 
upper stacking gel. The stacking gel compresses the samples into thin bands before 
they enter the separating gel, thus providing better band resolution. The Mini-
PROTEAN 3 Cell System from Bio-Rad was used for all SDS-PAGE. 
 
 a. Solutions 
 
4X Stacking (Upper) Buffer 
100 ml total volume: 
50 ml 1M Tris-HCl pH 8.6 [0.5M] 
4 ml 10% SDS [0.4%] 
46 ml ddH2O 
 
4X Separating (Lower) Buffer 
100 ml total volume: 
75 ml 2M Tris-HCl pH 8.8 
4 ml 10% SDS 
21 ml ddH2O 
 
10% SDS solution 
50 ml total volume 
5.0 g Sodium dodecylsulfate (SDS) 
 
Add mqH2O to slightly less than full volume, place on stir plate until dissolved.  
Bring pH to approximately 7.0. Bring solution to volume with mqH20, and filter 
through a 0.22 micron vacuum filter. 
 
10% APS solution 
1 ml total volume 
0.1 g Ammonium persulfate (APS) 
1 ml mqH2O 
 
Gently mix APS into mqH2O.  Store 200 µl aliquots in -20°C freezer.  Some 
protocols recommend making fresh APS for each experiment, but I have not 
found it to be necessary. 
 
SDS-polyacrylamide gel running 10X buffer 
1 L total volume 
30 g Tris base 
144 g glycine 
100 ml 10% SDS  
 
Add mqH2O to slightly less than full volume.  Adjust to pH 8.3 with 




Acrylamide Stock Solution 
National Diagnostics EC-890 30% (w/v) acrylamide: 0/8% (w/v) bis-acrylamide 
 
 
 b. SDS-Page Gel Formulations 
 
Recipes for separating gel are for 4 gels.  Recipe for stacking gel is for 2 gels. 
 
 Separating Gel Stacking Gel 
 15% 12.5% 7.5% 4.5% 
Acrylamide (30:0.8) 10 ml 8.3 ml 5 ml 0.75 ml 
4X Lower Buffer 5 ml 5 ml 5 ml ----- 
4X Upper Buffer ----- ----- ----- 1.25 ml 
ddH2O 9.86 ml 6.6 ml 8.2 ml 3 ml 
10% APS 125 µl 125 µl 125 µl 20 µl 
TEMED 20 µl 10 µl 10 µl 6 µl 
 
1. Make sure that you clean your glass plates extremely well prior to pouring 
gels.  I usually re-wash them and then wipe them down with ethanol. 
 
2. Combine components of gel formulation in the order indicated. Mix reagents 
for separating gel first.  Mix well after adding water. 
 
3. Add APS and TEMED. As soon as the APS and TEMED are added, the gel 
will begin to polymerize.  Mix well.  
 
4. Pour into gel apparatus to 1.8 cm from top of short glass (~4.5 ml).   
 
5. Add a thin layer of water (1 ml) to top of separating gel (it will float on top, 
really) as it is polymerizing to create a strongly defined meniscus. 
 
6. When separating gel has polymerized (30-45 min), pour off the water, and 
wick up any remaining water with chromatography paper without touching 
the gel. 
 
7. Mix reagents for stacking gel.  Fill gel apparatus to the top with stacking gel, 
and insert combs. Watch for bubbles. It is fine if solution overflows.  
 
NOTE: You may choose to save time by formulating the stacking gel 
without APS or TEMED at the same time that you formulate the resolving 
gel, adding the APS and TEMED when ready to pour the stacking gel. 
 
8. Allow stacking gel to polymerize (20-30 min), carefully remove combs and 




 c. Sample Preparation, Gel Loading, and Trimming  
  
 Supplies: 
• Heat block 
• Benchtop microcentrifuge 
• Gel loading pipet tips 
• Kaleidoscope protein standards 
 
 Gel Electrophoresis Protocol 
1. Heat frozen cell lysate samples for 5 minutes at 95°C to inactivate proteases 
that might degrade the proteins.  (Be careful when removing tubes, since 
lids are prone to popping off after heating.) 
2. Spin down samples at 13,000 rpm (?? g) for 5 minutes on a tabletop 
centrifuge (Biofuge Pico, Heraeus Instruments, Hanau, Germany).   
3. Set up the gel in the vertical electrophoresis system (Mini-PROTEAN 3 
Cell System, Bio-Rad). 
4. Load 10 – 12 µl of a standard containing several proteins of known 
molecular weight (Kaleidoscope Standards, Bio-Rad).  
5. Load an appropriate amount of sample (depending on well size, can be as 
little as 5 µl. I loaded 15 - 30 µl) into individual wells in the stacking gel. 
Try to load samples as quickly and neatly as possible to keep the sample 
from becoming too diffuse. 
6. Connect electrophoresis system to a DC power supply (PowerPac 300, Bio-
Rad), and run at a constant 100 V until the dye front of the cell lysates runs 
off the bottom of the gel (~2 hrs).  
7. Remove the gel from the electrophoresis chamber and carefully separate the 
glass plates so as not to break the gel. 
8. Trim the stacking gel from the separating gel and throw it (stacking gel) 
away.  
9. If running multiple gels, notch one or more corners of the gel to distinguish 
it from the others. 
 
 
3. Wet Electrophoretic Transfer - Protocol adapted from Antibodies:  A laboratory manual (Harlow and Lane, 




4 L total volume 
12.5 g Tris base 
57.6 g glycine 
800 ml methanol 
  
Add mqH2O to slightly less than full volume.  Stir in cold room until fully 






 b. Transfer Protocol 
 
1. Equilibrate the gel in cold transfer buffer, for approximately 15 minutes. 
2. Cut 1 nitrocellulose membrane and 2 pieces filter paper to size for each gel 
to be transferred, and soak for 15 minutes in transfer buffer.  Additionally, 
soak fiber pads in transfer buffer. 
3. Pour transfer buffer into a Pyrex dish (or other suitable container).  Put black 
(-) panel of the transfer apparatus into this container.  On this panel, layer the 
following in the order indicated: 
 
pre-wetted fiber pad  saturated filter paper  pre-equilibrated gel  pre-wetted 
nitrocellulose transfer sheet  saturated filter paper  pre-wetted fiber pad. 
 
4. Push out all air bubbles before closing the apparatus.  One method which 
works well is to gently roll a tube or scoopula over the entire sandwich from 
center to edge after laying down the nitrocellulose sheet, and again after the 
final fiber pad.   
5. Close the transfer apparatus, and place in the transfer-running tank.  Pay 
close attention to direction of current (negative to positive):    
 
black panel = cathode = negative 
red or clear panel = anode = positive 
 
6. Place a stir bar in the transfer-running tank, and fill with transfer buffer. 
7. Place apparatus on stir plate in cold room, and run transfer at 200 mA for 2 
hours at 4°C.   
8. Remove gel sandwich from apparatus, trim nitrocellulose membrane to size 
of gel and mark it with the same notch(es) used for the gel.  
9. Throw away filter paper, nitrocellulose remnants and gel. 
 
 




1 L total volume 
12.1 g Tris base 
40.0 g NaCl 
 
Add mqH2O to slightly less than full volume, place on stir plate until dissolved.  
Adjust pH to 7.6 with concentrated HCl.  Bring solution to volume. 
 
1X TBS-Tween (TBS-T)  
500 ml total volume 
100 ml TBS 
500 µl Tween 20 
 





5% (w/v) nonfat milk powder in 1X TBS-T 
 
Mix and bring to volume. Filter solution to eliminate any clumps of milk powder 
(may not be necessary).  Store solution at 4°C for no more than 24 hours.  It 
shouldn’t matter, but it does:  we get the cleanest blots using Kroger brand dried 
milk. 
 
ECL™ Western Blotting Detection Reagents - emits light in a chemiluminescent reaction with 
horseradish peroxidase 
2-part solution available from Amersham Pharmacia Biotech (RPN 2106).  Store 
reagents at 4°C.  Do not mix until immediately prior to use, as ECL remains 
active for only approximately 1 hour after mixing. 
 
 
b. Immunoblotting Protocol 
1. Place the trimmed and marked nitrocellulose blots in 5% Blotto solution for 
1 hour at room temperature on a shaker.  Alternatively, the blots can be 
placed in blotto overnight at 4°C.  Block each blot in a separate container, so 
that they are all equally exposed to the blotto. 
2. Dilute primary antibody in blotto.  Pour blotto off of blots and replace with 
antibody solution.  Incubate at room temperature for one hour on a shaker, or 
overnight at 4°C on a shaker. 
3. Pour off antibody solution, and rinse each blot in 1X TBS-T.  Wash blots in 
approximately 15 ml TBS-T three times each, 5 minutes per wash. 
4. During final wash, dilute secondary antibody in blotto.  Pour TBS-T from 
blots, and replace with antibody solution.  Incubate at room temperature for 
one hour on a shaker, or overnight at 4°C on a shaker. 
5. Pour off antibody solution, and rinse each blot in 1X TBS-T.  Wash blots in 
approximately 15 ml TBS-T three times each, 5 minutes per wash.  
6. Pour off TBS-T and wash blot twice (5 min per wash) with TBS to remove 
Tween, which can cause high back ground. 
7. Drain off excess TBS from blot on filter paper and place blots in ECL 
(mixed in equal parts) for one minute each.   
8. Blot nitrocellulose blots on blot paper to dry, and wrap in plastic wrap.  Be 
sure to avoid any wrinkles or bubbles in the plastic wrap, as this will affect 
the quality of the exposures.  Side-opening sheet protectors actually work 
quite well for this, with much less hassle. 
9. As quickly as possible, expose blots to autoradiograph film (XOMAT; 
Eastman Kodak, Rochester, NY) in the darkroom. Make exposures ranging 
from a couple of seconds to several minutes.  I used the following times: 5 s, 
30 s, 1 min, 2 min, 5 min, and 30 min. These exposure times can be adjusted 
depending on how strong or weak the signal is. Be sure to notch one corner 
of film before exposing to maintain orientation. 
10. Develop films (M35 XOMAT Processor, Kodak) and observe the exposed 




c. Re-exposing or Re-Probing a Blot 
 
If problems arise during the exposure of the blots, they can be rinsed with TBS-
T followed by TBS as described earlier and then placed in ECL reagent again. 
They can then be exposed as usual.  
 
Sometimes you may want to detect two different proteins in the same sample or 
redo the immunoblotting procedure. In these cases, it is necessary to strip the 
antibodies from the blot and probe the blots with new antibodies or with the 
same antibodies. The procedures for doing this are outlined below. 
 
Solutions 
• 0.2M NaOH – for stripping 
• 1X TBS-T – for washing 




1. If blots have dried out since last exposure, it will be necessary to rehydrate 
the blots before stripping.  To rehydrate, wash blot 3 times in 1X TBS-T, 20 
minutes per wash.  If stripping blot immediately after exposing, wash 3 
times in 1X TBS-T, 5 minutes per wash. 
 
2. Incubate blot in 0.2M NaOH for 5 - 10 minutes, at room temperature, on 
shaker. Do not leave in NaOH for long periods or you will strip your 
proteins off as well. 
 
3. Wash blot 3 times in 1X TBS-T, 5 minutes per wash. 
 
4. Repeat immunoblotting procedure, beginning with the blocking step.  Blots 
will always need to be re-blocked after stripping. 
 
5. Be aware that stripping is not always complete.  You may see bleed-
through on your exposures (bands for both the first antibody and the 




E. Immunofluorescence Staining 
 
There are many different protocols for immunofluorescence staining. Each lab seems to 
have its own way of doing it. I’ve provided two protocols that I used in my experiments. 
The first was used to check for recombinant IκB protein delivery and the second was 
used to stain for lamin A/C during the siRNA experiments. The results I obtained with 
first were not as good as the second, but this could have been due to the nature of the 
different experiments. 
 
Reagents for all protocols 
 
Paraformaldehyde (3.7% in PBS or HBSS) 
Total volume = 50 ml 
Add 1.85 g paraformaldehyde to 25ml 1X PBS.  Heat while stirring, and add several 
drops of 1N NaOH.   Do not boil! Check pH with pH paper, adjust to 7.4, and bring 
up to volume with 1X PBS or HBSS. Can store at 4°C for no more than three days. 
 
P-Phenylenediamine (in glycerol) – fluorescence antifade reagent 
Dissolve 50 mg p-phenylenediamine in 5ml 1X PBS.  Add this to a solution of 40ml 
glycerol and 5 ml 10X PBS and mix. Using pH paper, adjust pH to approximately 8.0 
with 0.5M carbonate/bicarbonate buffer.  Immediately aliquot and freeze in a light-
proof container at -70°C.  Do not refreeze. 
 
0.5M carbonate/bicarbonate buffer 
Dissolve 2.65 g Na2CO in 50ml mqH2O.  Add powdered NaHCO3 until pH reaches 
approximately 9.0 to 9.4. 
 
0.5% (v/v) Triton X-100 
Total volume = 10 ml 
Dissolve 50 µl Triton X-100 (Sigma Chemical) in 10 ml HBSS(+). Mix well. 
 
Blocking Buffer 1 (0.2% (w/v) gelatin-0.08% (w/v) saponin) 
Total volume = 25 ml 
Dissolve 50 mg gelatin (Cat. No. GX00456, EM Science) and 20 mg saponin (Cat. 
No. 16109, Sigma Aldrich) in HBSS+. If necessary, warm the solution in 37°C water 
bath to help speed the dissolution process. 
 
Blocking Buffer 2 (5% (w/v) BSA) 
Total volume = 20 ml 
Dissolve 1g BSA in HBSS+. Mix well. Try to avoid foam formation. 
 
95% to Pure Ethanol 




1. Immunofluorescence Protocol #1 – used for recombinant IκB protein delivery 
experiments. Reported volumes are for the large (4.7 cm2) cell culture inserts. 
 
1. Wash monolayers 3 times (5 min each) with 500 µl HBSS(+) after treatment (in 
my case, electroporation of T84’s with recombinant IkBα protein) 
 
2. Fix monolayers by adding 500 µl of 3.7% paraformaldehyde and incubating for 
10-20 min at room temperature. 
 
3. Wash 2X (5 min each wash) with HBSS(+). 
 
4. Permeabilize monolayers with 0.5% Triton X-100 for 30 min at room temp. 
 
5. Wash 2X (5 min each wash) with HBSS(+). 
 
6. Block with 500 µl blocking buffer 1(0.2% gelatin-0.08% saponin) for 1 hour at 
room temp. (Can leave overnight in blocking buffer if necessary) Remove 
blocking buffer.  
 
7.  Place in 1o antibody (diluted in blocking buffer) for 1 hour at room temperature. 
 
8.  Wash 1X (5 min) with HBSS(+) 
 
9.  Wash 1X (5 min) with blocking buffer. 
 
10.  Place in 2o antibody (diluted in blocking buffer) for 1 hour at room temperature. 
Cover with foil-covered top to protect fluorescence. 
 
11.  Wash 2X in HBSS(+). (Can leave overnight if necessary) 
 
12.  Trim membrane down and cut into two or more pieces to prevent ripples during 
mounting. 
 
13.  Mount membrane pieces in p-phenylenediamine on a microscope slide. Might be 
wise to mount some cell-side up and some membrane-side up in case membrane 
flips over during the process. 
 





2. Immunofluorescence Protocol #2 – used for lamin siRNA transfection 
experiments. Reported volumes are for the small (0.33 cm2) cell culture inserts. 
 
1. Wash monolayers 3X with 100µl HBSS+ (5 min each wash). 
 
2. Fix and permeabilize monolayers with 100 µl ice cold ethanol (at least 95% pure) 
for 20 minutes at -20°C. 
 
3. Wash monolayers 3X with 100 µl HBSS+ (5 min each wash) to rehydrate the 
cells. 
 
4. Block with 100 µl blocking buffer 2 (5% BSA) for 1 hour at room temp or 
overnight at 4°C.  
 
5. Aspirate off blocking buffer and add 60 µl of 1° antibody (diluted in blocking 
buffer). Incubate for 1 hour at room temperature. 
 
6. Wash monolayers 3X with 100 µl HBSS+ (5 min each wash). 
 
7. Add 60 µl of 2° antibody (diluted in blocking buffer) and incubate monolayers for 
1 hour at room temperature. 
 
8. Wash monolayers 3X with 100 µl HBSS+ (5 min each wash). 
 
9. If desired, add counterstain, e.g. Hoechst nuclear stain, at this point. 
 
10. Wash monolayers 2X with 100 µl HBSS+ (5 min each wash). 
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